close

February 2022

Prescription drugs

Letter to the Editor – About Prescription Drugs | Opinion

As a Registered Nurse with decades of professional experience, I have provided health care to hundreds of rural Iowas. From treating traumatic injuries to chronic disease care to helping patients manage medications, we healthcare providers gain valuable insight into the inner workings of one of the largest sectors of the economy. And sometimes that hands-on experience and training in healthcare can be incredibly frustrating.

The high cost of life-saving drugs and prescription drugs is at the top of my list of concerns. I’m not alone. 83% of Americans say the cost of prescription drugs is unreasonable, according to an October 2021 public opinion poll conducted by the nonpartisan health care organization Kaiser Family Foundation (KFF).

The KFF poll also shows strong, bipartisan public support – more than 80% in favor – for government actions that:

facilitate the marketing of generic drugs

limit the drug company’s ability to raise prices above inflation

limit out-of-pocket spending for people on Medicare

allow governments to negotiate with pharmaceutical companies for lower prices on Rx drugs covered by Medicare and private insurance

Federal action to implement these grassroots policy changes has been blocked primarily by Senate Republicans and filibuster rules that Democrats seem unwilling to change.

Fortunately, we have an opportunity here in Iowa this legislative session to make prescription drugs more affordable and accessible. House File 263 would cap the cost of insulin at $100 per month for state-regulated health care plans in Iowa. House File 262 would allow those who need insulin, Epi-Pens and inhalers to receive emergency prescriptions from their pharmacist if their doctor is unavailable for a prescription. Both bills would help tens of thousands of Iowans.

Both of these bills passed the Iowa House of Representatives last year 91-0 and 89-2. Unfortunately, the state senate took no action. Sen. Jeff Edler (R, State Center), who chairs the Senate Human Resources Committee, declined to schedule votes on these incredibly popular and important bills.

Senator Edler is certainly aware of his role in this process. For example, regular Iowans who rely on insulin to manage their diabetes have called and met with Senator Edler to implore him to allow a yes or no vote on these issues. Senator Edler needs to stop playing political games with people’s lives. After all, over 10% of adults in Iowa have diabetes, with diabetes rates over 20% for Iowans earning less than $25,000 a year.

If Senator Edler isn’t supporting Iowans with diabetes, who is he protecting? U.S. Senator Charles Grassley (R-IA), who was a key leader of Edler’s party for half a century, led an investigation into how drug companies measured insulin prices in 2019 when Grassley was Chairman of the Senate Finance Committee. The Grassley Committee report found that pharmaceutical companies Eli Lilly, Sanofi and Novo Nordisk have dramatically increased the prices of long- and short-acting insulins over the past decade, in some cases by more than 70% by only 5 years old.

It’s not a complicated question. To refuse to provide basic cost controls for life-saving prescription drugs is simply cruel and cynical policy. Pharmaceutical companies are among the most profitable companies in the world. Our political leaders, both in Washington DC and here at the Des Moines Statehouse, have allowed corporate power to block grassroots reform for too long. Now is the time to act, and it starts with Senator Edler scheduling a vote on House Items 262 and 263 before it’s too late during this year’s legislative session.

Barb Kalbach is a 4th generation family farmer, registered nurse, and board member of Iowa Citizens for Community Improvement. Barb can be reached at [email protected]

read more
Medical products

Metal Fiduciary Marks Market Analysis by 2030

New Jersey, United States,-The Metal Fiduciary Marks Market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, actual value, overall size, share and future development factors.

Metal Fiduciary Marks Market Overview:

The research report on global “Metal Fiduciary Marks Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Metal Fiduciary Marks market study provides up-to-date information on the technical advancements and potential market opportunities based on the local landscape.

This Metal Fiduciary Marks Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=245961

The report includes a detailed segmentation study of the global Metal Fiduciary Brands market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Metal Fiduciary Marks Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Metal Fiduciary Marks Market.

Key Players Covered in Metal Fiduciary Marks Markets:

  • CIVCO Radiotherapy
  • IZI medical products
  • Naslund Medical AB
  • IBA
  • Boston Scientific Society
  • Medtronic

Metal Fiduciary Marks Market Split By Type:

  • pure gold
  • Gold alloys
  • Other metal-based markers

Metal Fiduciary Marks Market Split By Application:

  • Hospitals and outpatient facilities
  • Independent radiotherapy centers
  • Cancer research centers

The Metal Fiduciary Marks Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Metal Fiduciary Brands Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Metal Fiduciary Marks market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=245961

Scope of the Metal Fiduciary Marks Market Report

Report attribute Details
Market size available for years 2022 – 2029
Reference year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Metal Fiducial Marks Market analysis can be represented as follows:

Each regional Metal Fiduciary Brands industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global metal fiat brands market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-metal-fiducial-marks-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical supplies

NPMC Acquires GNG Medical Supplies, Another Milestone By NPMC Spokesperson Khaniya Gupta

Dr. Gautam Arora

Dr. Gautam Arora

Dr. Gautam Arora

Dr. Gautam Arora

Dr. Gautam Arora

This would further improve patient care by NPMC Dr Gautam Arora

This would improve patient outcomes and reduce the cost of healthcare”

—Dr. Gautam Arora

MONROE, NJ, USA, February 28, 2022 /EINPresswire.com/ — NPMC, a diversified company founded by Dr. Gautam Arora focused on synergistic acquisitions in critical, fast-growing sectors, acquired a majority stake in medical supplies company GNG. GNG’s primary revenue drivers focus on providing globally sourced heavy duty consumable medical supplies. These include hygiene products, syringes, dressings and sterilization equipment.

Among other elements, the acquisition of GNG brings immediate revenues to NPMC, a high level of operational profitability and an order book of 1.8 Cr for 2021. The company is also engaged in other sales of personal care products. related healthcare and in the development of products that could bear considerable fruit in future quarters.

GNG Medical supply is currently on track to generate revenue of 2.7 Cr in 2022 and is targeting revenue of 3.6 Cr in 2023. In comparison, in 2020 the company generated revenue of 86 Lakhs with an EBITDA of 32.8 Lakhs. Dr. Gautam Arora, MD, CEO, of NPMC commented, “The acquisition of GNG’s medical supply business further strengthens our revenue estimate of Cr3.6 for FY2023. The acquisition provides NPMC a channel to leverage its existing relationships in the medical supply chain to increase GNG’s medical revenue. and global supply chain footprint.”

GNG Medical Supply Background:
Mr. Gavin Kumar founded GNG Medical Supply in 2017 as a sole proprietorship before incorporating in 2019. The company provides the market with globally sourced medical supply products. In addition, it is a financial partner at all stages of enterprise and post-enterprise, private and public – partnership in the sector of biotechnology and sustainable medical equipment.

About NPMC
NPMC started as a clinical practice and is now a diversified company focusing on acquisitions in the following sectors: Healthcare and real estate. NPMC is an acquisition-driven company. The company’s strategy is to acquire majority stakes in undervalued companies and play an active role in improving their performance – accelerating their growth by providing them with both access to capital and management expertise. .

Gautam Arora
NPMC Neurology and Pain Management Clinic
+91 85951 68656
write to us here

read more
Generic drugs

Global Multi-Cancer Generic Drugs Market 2021 Manufacturer Landscape, Revenue and Volume Analysis to 2027 – Business Ethics

The research report MarketQuest.bizto Global market for generic drugs for several cancers reviews important industry and market trends, as well as historical and anticipated market data. The research has implications for the stock market as well as other terms and definitions. Analytics promotes its products by application, sort and location in terms of volume and value.

The market accurately reflected the total sales and marketing volume, maximum production and consumption costs, profit margins, import and export, cost structure analysis, in-depth price analysis , vendor landscapes, and other critical market variables. The research helps identify new marketing opportunities and offers a complete picture of the existing global market for generic drugs for multiple cancers.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/45315

The study is significant for organizations or individuals looking to enter the Generic Drugs for Multiple Cancers industry as it provides detailed qualitative and quantitative insights. It also examines how changing patterns, COVID-19, and inflation are affecting market growth. Additionally, supply chain analysis, profit margin analysis, and price research are all covered in depth to help businesses and give them an estimate of how much money they will need to join this market.

Market segmentation based on region:

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
  • South America (Brazil, Argentina, Colombia and rest of South America)
  • Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa and Rest of Middle East and Africa)

Player Market Segmentation:

  • Pfizer
  • GlaxoSmithKline
  • Novartis
  • Merck
  • Celgene
  • Teva pharmaceutical
  • Mylan
  • Aurobindo Pharmacy
  • Hikma Pharmaceuticals
  • rock
  • Redsenol

Segment the market by product type:

  • Cytotoxic drug
  • Non-cytotoxic drugs

Market segmentation based on application

  • Hospital pharmacy
  • Retail pharmacies
  • Online pharmacies

ACCESS FULL REPORT: https://www.marketquest.biz/report/45315/global-generic-drugs-for-multiple-cancers-market-2021-by-key-countries-companies-type-and-application

In addition, a framework of study has been created to emphasize future events and possibilities in the global Generic Multiple Cancer Drugs industry in recent years. According to the research study, the market will face a variety of drivers and restraints, opportunities and challenges throughout the forecast period. The report also examines the geographical characteristics of the market, which will impact its growth from 2021 to 2027.

Report customization:

This report can be customized to meet customer requirements. Please contact our sales team ([email protected]), who will ensure that you get a report tailored to your needs. You can also get in touch with our executives at +1-201-465-4211 to share your research needs.

Contact us
mark the stone
Business Development Manager
Call: +1-201-465-4211
E-mail: [email protected]

read more
Prescription drugs

REUTHER: Prescription Drugs: America’s Scam | Opinion

By DAVID REUTHER

The continued rise in prescription drug prices remains a long-term hardship for many American families. Overall, US residents spend significantly more on prescription drugs than residents of other comparable developed countries.

Soaring drug prices, coupled with an aging population in dire need, have led many congressional lawmakers and public groups to tackle the current pricing system with increasing urgency.

It is a harsh reality that many people have to choose between food, shelter and medicine. According to an AARP report, applying the drug price increase rate to everyday items would mean a gallon of milk would cost $13, a loaf of bread $4.21, and a gallon of gasoline $12.20.

When President Biden visited Culpeper on Feb. 10, Rep. Abigail Spanberger (D-Va.) introduced him to Shannon Davis and her 12-year-old son Joshua, who, like his father, has diabetes from type 1 and whose insulin is expensive. the family about $1,000 a month. It’s not an optional expense, it’s vital to preserve their lives.

People also read…

To shed some light on the problem, Rep. Spanberger, along with five bipartisan colleagues, introduced the Public Disclosure of Drug Rebates Act, which would require that rebates, rebates, and price concessions negotiated by intermediaries be made public on a website through the Department. health and social services. The bill originally passed the House unanimously in 2019 and now sits in the divided Senate, where it languishes in committee.

The Elijah Cummings Reduce Drug Costs Now Act of 2021 was also originally passed by the House in 2019; all Democrats voted for the measure and all but two Republicans voted against. The Republican-controlled Senate never picked it up. This would have allowed Medicare to negotiate drug prices like Veterans Affairs and Medicaid do with drug companies.

The Congressional Budget Office estimated the Cummings bill would save $345 billion in federal spending over seven years, and the Centers for Medicare & Medicaid Services found it could reduce out-of-pocket costs by $158 billion. dollars over a decade. It was reintroduced in 2021 and was later included in the President’s Build Back Better bill, which passed the House along party lines in November 2021. Facing unanimous Republican opposition, the bill died in the Senate.

The Build Back Better Act would have included a $2,000 annual cap on out-of-pocket expenses for people enrolled in Medicare Part D drug plans and a $35 co-pay cap on certain insulins. It also reportedly allowed Medicare to begin negotiating the price of certain prescription drugs. From 2025, 10 drugs in addition to insulin would have been traded, with this number increasing to 20 drugs in 2028 and beyond.

Out of control drug prices, so difficult for so many Americans, translate into out of control profits for pharmaceutical companies, a problem unheard of in most other developed countries.

In a democratic republic, the people choose representatives to act for them and for the good of the country. Today, there appears to be a major disconnect between citizens and Congress, as well as hyper-partisanship within and between the two chambers.

The BBB is just one indicator of this unsatisfactory inaction, and the drug companies will happily continue to make obscene profits. If we don’t demand that our representatives meet the challenges we face, nothing will happen.

David Reuther, a retired US foreign service officer, is a former chairman of the Culpeper Democratic committee.

read more
Medical supplies

Medical supplies for Ukraine stuck in warehouse in Tempe | Arizona News

TEMPE, AZ (3TV/CBS 5) – Thousands of dollars worth of medical supplies for Ukraine sit in a warehouse in Tempe, unable to be delivered amid escalating conflict.

“It’s heartbreaking for us to know that what’s sitting here could save lives out there right now,” said Charles Irion, with Project CURE “They’re going to be needed more now because of all the injuries and suffering that is So the sooner we can hopefully get this container out, the better.

Project CURE is a non-profit organization that collects donations of medical supplies and equipment from hospitals in Arizona and ships them to 138 different countries that may not have access to these items.

“I’ve been seeing this equipment for two weeks, and I myself have wondered why it’s sitting here? And yesterday it got even sadder and heartbreaking that it’s not going where it’s supposed to go to help people. people…mothers, children, the elderly, the Ukrainian community. They can’t get their supplies,” said Ruth Sanchez, executive director of Project CURE in Arizona.

Sanchez says between $250,000 and $1 million goes into 40-foot shipping containers.

“It’s all medical. We don’t do pharmaceuticals. We do equipment, biomedical, x-rays, ultrasound, and then PPE – the gowns, the gloves, the masks, the syringes, that’s there too,” Sanchez explained. “We have wheelchairs, we have baby warmers. Everything you see in the boxes you see for Ukraine is what you and I easily have at any facility here in the United States. United.” This shipment was due to leave the warehouse for Ukraine yesterday. “We actually planned two weeks, and we finally got confirmation two days ago that it would be here, and overnight it changed, and the freight forwarder said we weren’t there. comfortable sending anything to this area.”

Sanchez says Project CURE is working with government officials to find a safe way to get supplies to Ukraine. They plan to ship the container to Poland or Germany. “We’re working really hard to fix this and another two weeks, and we’re talking about saving lives here,” Sanchez said.

The CURE project now has a donation campaign to help Ukraine. If you would like to donate, click here.


Copyright 2022 Gray Media Group, Inc.

read more
Medical products

Tongue Depressor Market Forecast 2022 by 2029

New Jersey, United States,-The Tongue Depressor Market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, actual value, overall size, share and future development factors.

Overview of the Tongue Depressor market:

The research report on “Global Tongue Depressor Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Tongue Depressor market study provides up-to-date information on technical advancements and potential market opportunities based on the local landscape.

This Tongue Depressor Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=208333

The report includes a detailed segmentation study of the global Tongue Depressor market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Tongue Depressor Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Tongue Depressor Market.

Major Players Covered in Tongue Depressor Market:

  • Puritan Medical Products
  • Agaplastic
  • medical dtr
  • Fazzini
  • Fl Medical
  • FASA Group
  • Francois Mensch
  • Parburch Medical Developments
  • Plasti Lab
  • Dental Shufa
  • timesco
  • We Ophthalmic
  • A. Algeo
  • Dental Asa

Tongue Depressor Market Split By Type:

  • wooden tongue depressor
  • Metal tongue depressor
  • plastic tongue depressor

Tongue Depressor Market Split By Application:

  • Hospitals
  • Clinics
  • Academic research institutes

The Tongue Depressor Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Tongue Depressor Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a comprehensive picture of the global Tongue Depressor market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=208333

Scope of the Tongue Depressor Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Tongue Depressor Market Analysis can be represented as follows:

Each regional Tongue Depressor industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global Tongue Depressor market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/%ef%bb%bftongue-depressors-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Generic drugs

Generic Drugs Market Continues to Grow Due to Rising Incidence of Chronic Diseases Worldwide | Teva Pharmaceutical Industries, Mylan NV, Novartis International AG, Pfizer, Inc.

Market Overview:

Generic drugs are those that have the same active chemical substance as a brand name drug. Before generics became available, generic drugs were made using identical active ingredients, the only difference being the chemical makeup or dosage. Generic drugs can be sold without any authorization from the Food and Drug Administration. Generic drugs can also be manufactured and approved at the same time as the patented drug if the company that holds the patent for the drug can meet the necessary requirements. Once these requirements are met, a generic drug can be marketed. Generic drugs, however, are not available without a doctor’s prescription because generic drugs lack the safety offered by brand name drugs.

Request a PDF brochure here @ https://www.coherentmarketinsights.com/insight/request-pdf/1132

Key Market Drivers:

Rising cases of chronic diseases across the world is the major factor that is expected to drive the growth of the global generic drugs market. For example, according to the World Health Organization, approximately 422 million people worldwide have diabetes and approximately 1.6 million deaths are directly related to diabetes each year. Generic drugs are manufactured using the same facilities and methods as brand name drugs. In fact, it is usually the same product created with the same quality and consistency. However, generic drugs are manufactured to meet or exceed the safety and efficacy requirements of the United States Food and Drug Administration. Generic drugs can be sold without the need for an expensive marketing campaign because generic drugs can be manufactured at lower prices than brand name drugs. Increase in product launches by major market players is estimated to propel the growth of the global generic drugs market.

Covid-19 impact analysis:

The rising incidence of COVID-positive cases globally has significantly affected the growth of the global generic drugs market. For example, according to Springer, in April 2020, the number of individuals infected with SARS-CoV-2 was approximately 0.9 million with a fatality rate of approximately 1.38%. Additionally, increasing transportation restrictions and lockdown restrictions in several countries has also affected the market growth.

Key points to remember:

  • The global generic drugs market size was valued at around US$263 billion in 2020 and at a CAGR of 6.58%, it is estimated to reach around US$385 billion in 2026, owing to the increase in chronic diseases worldwide. For example, according to the International Agency for Research on Cancer, in 2020 the global cancer burden was approximately 19.3 million.
  • North America is expected to hold a major share of the global generic drug market, owing to the growing prevalence of drug manufacturers in the region. For example, according to Pharmapproach, in 2019 the United States generated approximately US$490 billion in revenue.
  • Asia-Pacific is expected to experience high growth in the global generic drug market, owing to the growing prevalence of pharmaceutical companies in developing regions. For example, according to India Briefing, there are over 3,000 pharmaceutical companies in India, along with 10,500 manufacturing units.

Buy this report directly with a fixed discount of 2000 USD @ https://www.coherentmarketinsights.com/promo/buynow/1132

Reasons to Buy this Generic Drugs Market Report

➡ Save time conducting entry-level research by identifying the size, growth and key players in the emerging Generic Drugs market

➡Use five forces analysis to determine the competitive intensity and hence the attractiveness of the emerging generic drugs market

➡Key Company Profiles Reveals Details of Major Generic Drugs Market Players Emerging from Five Transactions and Financial Performance

➡Add weight to presentations and presentations by understanding the future growth prospects of the emerging Generic Drugs market with five-year historical forecasts

➡Compares data from North America, South America, Asia-Pacific, Europe and the Middle East, as well as individual chapters on each region.

Contents

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Scope of research
1.4 Market Analysis by Regions
1.5 Generic Drugs Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Impact on Generic Drugs Industry

Chapter 2 Global Generic Drug Competition by Types, Applications and Top Regions and Countries
2.1 Global Generic Drugs (Volume and Value) by Type
2.3 Global Generic Drugs (Volume and Value) by Regions

chapter 3 Generation market analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Generic Drug Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Generic drugs market To analyse
Chapter 6 Analysis of the generic drugs market in East Asia
Chapter 7 Analysis of the generic drugs market in Europe
Chapter 8 South Asia Generic Drugs Market Analysis
Chapter 9 Southeast Asia Generic Drugs Market Analysis
Chapter 10 Analysis of the generic drugs market in the Middle East
Chapter 11 Analysis of the generic drugs market in Africa
Chapter 12 Analysis of the Generic Medicines Market in Oceania
Chapter 13 Analysis of the generic drugs market in South America
Chapter 14 Company profiles and key figures of the generic drugs sector
Chapter 15 Global Generic Drugs Market Forecast (2021-2027)
Chapter 16 conclusion
Research Methodology

Get Sample PDF Copy of Report (Including Full TOC, List of Tables & Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-sample/1132

About Us:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We’re known for our actionable insights and genuine reports in a variety of fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insights in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Contact:

Consistent market information
1001 4th Ave, #3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

read more
Medical supplies

Ukraine Assistance: Vienna sends trucks with medical supplies to Kyiv and Odessa – Vindobona.org

The man is in uniform with his wife and daughter in front of their burning house. Here, the soldier could no longer protect his family. The Red Cross became the main relief association and in 1917 received the only Nobel Peace Prize during the war years. / Photo: © Wikimedia Commons / Eybl, Plakatmuseum Wien/Wikimedia Commons / CC BY-SA 4.0

The fact that the aid material donated by Vienna consists mainly of medical products such as FFP2 masks as well as protective equipment for hospital staff is somewhat reminiscent of the 5,000 helmets that the world’s fourth largest economy, Germany, wanted give to the Ukrainians. .

According to information from the city government, three trucks carrying relief supplies are already on their way to the war zone.

When loading, Mayor Michael Ludwig stressed that Vienna stands for cohesion and unity.

“The images reaching us today from Ukraine are deeply moving. It is a sad and deeply depressing day. Our thoughts are first and foremost with the innocent civilians who are the main victims. Austria is perhaps neutral in international law, but we are not neutral when it comes to our values. That is why Vienna is also ready to help people in need.”

“Especially in the current situation, it is important that we show solidarity,” continued Ludwig. “Let us reflect on the humanitarian traditions of our history and bring solidarity aid!”

He also highlighted the close urban network between Vienna and Ukraine. “Especially in an international crisis like the one we are currently experiencing, Vienna is there to help people.”

“Vienna has been involved in Ukraine for a long time, even independently” of the current crisis,” Ludwig explained.

Among other things, associations and organizations such as Caritas and Volkshilfe have been helping for years in the fields of education and health care, as well as in the treatment of drinking water in eastern Ukraine.

“We will continue to expand these aid programs in the future,” Ludwig said. He also said the city has already ordered more aid trucks. In the coming weeks, seven more trucks are expected to travel to Ukraine.

Vienna City Hall – Magistrate of the Stadt Wien

read more
Generic drugs

FDA OGD Releases Guidance Documents to Accelerate Generic Market Entry | Morgan Lewis – As Prescribed

As the Biden administration and the US Congress continue to debate ways to address perceived concerns about prescription drug prices, the Food and Drug Administration (FDA) is taking action. Under its Drug Competition Action Plan (DCAP), administered by the Office of Generic Drugs (OGD), the FDA has issued approximately 24 guidance documents since 2017, directing industry stakeholders on how to develop, prepare and submit abbreviated new drug applications (ANDAs), so generic drugs can gain timely FDA approval and reach the market faster. In January 2022, the FDA released three more guidance documents in the DCAP series.

By helping to make additional generic drugs available at lower prices, the FDA believes this can impact the overall drug price burden. For example, according to the latest Congressional Budget Office (CBO) Reportt, the average net price of a prescription drug in the Medicare Part D and Medicaid programs fell from 2009 to 2018, and this decline “reflects the increased use of cheaper generic drugs.” In the words of the FDADCAP “helps break down barriers to generic drug development and market entry with the goal of driving competition so consumers can get the drugs they need at affordable prices.”

When we asked other departments about the importance of the last three guidelines, Maryll Toufanian, Director of the Office of Generic Drug Policy, replied:

As stated in the DCAP, the FDA understands that it is essential to provide as much transparency as possible in our regulatory expectations. This allows for maximum efficiency for claimants submitting generic drug claims and for our assessment of those claims. Guidance like the one recently released is a key tool in our toolbox to achieve this.

Below is a list of recently released DCAP guidance documents and a brief description of each. Although much of the information has already been provided to industry stakeholders in various forms, it is important for every company considering submitting an ANDA (or has an ANDA pending) to carefully review these published versions of the guidance from the FDA and update their regulatory procedures. Therefore.

REQUESTS FOR INFORMATION AND DISCIPLINE REVIEW LETTERS UNDER GDUFA, GUIDANCE FOR INDUSTRY

Updating a 2017 draft, these final guidelines detail how the DMO will provide ANDA applicants with “preliminary thoughts on possible gaps” after the DMO’s initial assessment for ANDAs submitted between 2018 and 2022 in the under the 2017 Generic Drug User Fee Amendments (GDUFA II). Although future “GDUFA III” legislation will likely change some details, this guidance is also instructive for planning purposes for ANDAs to be filed in 2023 and later.

The guidelines explain that midway through the FDA’s evaluation of an ANDA’s first evaluation cycle (the mid-cycle date), the DMO will issue a Discipline Review Letter (DRL) to ANDA’s applicant to share their preliminary thoughts on a possible application. deficiencies. Alternatively, a Request for Information (RI) can be sent to request additional information or clarification needed to conduct a discipline assessment (eg bioequivalence, labeling or quality). However, these letters will not be sent when the discipline considers that it can act on the ANDA with the information contained in the request.

The use of these letters is intended to provide applicants with the FDA’s thoughts as soon as possible so that they can modify the ANDAs and continue the evaluation process. The FDA hopes that this mid-cycle communication will minimize the number of review cycles needed for approval. Candidates’ responses will not be categorized as a major or minor change to the ANDA and, therefore, will not delay the assessment clock (formerly, the “Exam Clock”), unless the response does not contain information not requested by the FDA or information that requires further evaluation. The letters do not guarantee that a Complete Response Letter (CRL) will not be issued, as the letters reflect feedback from the assessment team, but not feedback from all levels of supervision within other departments.

ANDA SUBMISSION GOOD PRACTICES, INDUSTRY TIPS

In this guide, the OGD highlights common ANDA shortcomings and provides detailed recommendations, so that ANDA applicants can file compliant submissions under GDUFA II and avoid CRLs, data cycles multiple reviews and long approval times. The information is an update of an OGD guide published in 2018 and details the OGD program improvements developed under GDUFA II. By outlining common errors, OGD intends to foster the development of high quality submissions and promote the prompt correction of ANDA deficiencies.

The guidelines cover almost all types of information required in an ANDA, such as patent certifications and exclusivity requirements, labeling, drug substance and drug product descriptions, impurities and intermediates, product quality and manufacturing processes, as well as bioequivalence and dissolution data. Other departments have specific submission and formatting requirements for each eCTD module in all of these areas, so the gap descriptions are helpful and may answer questions that have plagued regulatory affairs staff.

The guide also provides useful information for keeping ANDAs pending, since the initial filing of an ANDA is only the first step to obtaining ANDA approval. During the evaluation cycle, applicants must continually update the information in the ANDA related to many topics, including patent litigation in paragraph IV, orange book changes, manufacturing changes , batch validation and stability data, risk assessment and implementation of mitigation strategy and commercial launch plans. Avoiding submission gaps when submitting updates to a pending ANDA is just as critical as the initial ANDA submission.

ANDA LABELING REVISION FOLLOWING RLD LABELING REVISION, INDUSTRY GUIDANCE PROJECT

These draft guidelines update information that the DMO had previously published in April 2000 via a directive of the same name. Twenty-two years later, FDA reminds ANDA holders of their continued obligation to ensure product labeling is accurate, not false or misleading, and “the same” as the labeling of the corresponding reference medicinal product (RLD). For these reasons, once the FDA approves relevant RLD labeling changes, an ANDA holder should update their labeling “as soon as possible.” To learn about RLD labeling changes, ANDA applicants and ANDA holders should proactively monitor public information, such as the [email protected] web page and the CDER New ListServ.

The DMO also explains that ANDA labeling changes must be organized according to eCTD modules and submitted in electronic format via the electronic submission gateway. An annotated side-by-side comparison of the proposed ANDA labeling and the approved RLD labeling continues to be required.

read more
Prescription drugs

Making prescription drugs more affordable

The rising cost of prescription drugs is a growing concern, especially for those who depend on their medications to stay healthy. Spending on prescription drugs is only expected to risehttps://payorsolutions.cvshealth.com/updates/consultant-briefing-december-2021 with the specialty drug market expected to reach $373 billion in 2025. As more therapies come to market, they provide new options for patients who may previously have had no treatment available for their condition or who have not found the right medication for them – this has been true for conditions such as migraines and weight loss. However, new treatments on the market can also increase the overall cost of drugs, which increases the pressure on consumers. For example, autoimmune diseases were the main contributor to specialty growth, accounting for 54% of all specialty utilization trend.

Reduce the cost of prescription drugs

That’s why we’re committed to working with employers and health insurance plans to make prescription drugs more affordable. From ensuring appropriate use of treatment to negotiating with drug manufacturers for the lowest prices, we use every tool possible to increase member affordability – and our Trends Report in medicine proves that we can deliver. In fact, we delivered an overall drug trend of 2.4% for our customers.

Through our clinical-first approach, innovative new programs, and digital tools, we’ve kept out-of-pocket expenses low, consistently reduced member cost share, and passed millions in savings on to members. We’re proud of the work we do — and invite you to dig deeper into how CVS Health partners with employers and health plans to reduce costs and make prescription drugs more accessible and affordable for members.

read more
Medical supplies

Jacksonville medical supply store offers eco-friendly medical supplies and rental options

Many people want to live in a more environmentally friendly way, but this can be difficult for those who regularly use medical products. Medco Inc makes it easy with its selection of rental equipment and eco-friendly medical supplies for Jacksonville customers.

Concerns about single-use plastic and disposable items containing environmentally harmful chemicals have led some First Coast residents to adopt greener shopping habits. However, many medical items pose challenges for such a purpose because they must be sterilized before or after use, often requiring the use of harsh chemicals or disposable plastic that accumulates in landfills.

Medco Inc., a local medical supply store, offers green options for customers looking to reduce their waste. Their inventory includes a diverse line of products suitable for many different health needs, from CPAP devices to bath safety products. Customers are encouraged to ask their staff about the reuse and recyclability of their products to find an item that meets their needs and eco-friendly lifestyle goals.

Medco Inc. helps its customers reduce their waste generation through its medical equipment rental service. Rather than buying an item that is destined for a landfill when it’s no longer needed, customers can rent mobility aids, hospital beds and more for temporary use. Also, renting instead of buying is often much cheaper. Short and long term rentals are welcome. Their team also offers free local delivery for rentals for added convenience.

Call (904) 264-8154 to learn more about green medical supplies and rental options available from Medco Inc. Information about their various medical products and services is also available at their website. Their store is located in Orange Park, Florida and serves customers from across the community, as well as Jacksonville, Fleming Island, Middleburg and surrounding areas.

Media Contact
Company Name: Medco inc.
Contact: Shane Olson
E-mail: Send an email
Call: (904) 834-0764
Address:653 Kingsley Ave.
Town: Orange Park
State: Florida
The country: United States
Website: http://medicalsupplies-jacksonville.com/

read more
Generic drugs

FDA OGD Releases Guidance Documents to Accelerate Generic Market Entry

As the Biden administration and the US Congress continue to debate ways to address perceived concerns about prescription drug prices, the Food and Drug Administration (FDA) is taking action. Under its Drug Competition Action Plan (DCAP), administered by the Office of Generic Drugs (OGD), the FDA has issued approximately 24 guidance documents since 2017, directing industry stakeholders on how to develop, prepare and submit abbreviated new drug applications (ANDAs), so generic drugs can gain timely FDA approval and reach the market faster. In January 2022, the FDA released three more guidance documents in the DCAP series.

By helping to make additional generic drugs available at lower prices, the FDA believes this can impact the overall drug price burden. For example, according to the latest report from the Congressional Budget Office (CBO), the average net price of a prescription drug in the Medicare Part D and Medicaid programs fell from 2009 to 2018, and this drop “reflects the increased use of lower cost generic drugs. drugs.” In the words of the FDA, DCAP “helps remove barriers to generic drug development and market entry with the goal of stimulating competition so consumers can have access to the drugs they need. need at affordable prices”.

When we asked other departments about the importance of the last three guidelines, Maryll Toufanian, Director of the Office of Generic Drug Policy, replied:

As stated in the DCAP, the FDA understands that it is essential to provide as much transparency as possible in our regulatory expectations. This allows for maximum efficiency for claimants submitting generic drug claims and for our assessment of those claims. Guidance like the one recently released is a key tool in our toolbox to achieve this.

Below is a list of recently released DCAP guidance documents and a brief description of each. Although much of the information has already been provided to industry stakeholders in various forms, it is important for every company considering submitting an ANDA (or has an ANDA pending) to carefully review these published versions of the guidance from the FDA and update their regulatory procedures. Therefore.

REQUESTS FOR INFORMATION AND DISCIPLINE REVIEW LETTERS UNDER GDUFA, GUIDANCE FOR INDUSTRY

Updating a 2017 draft, these final guidelines detail how the DMO will provide ANDA applicants with “preliminary thoughts on possible gaps” after the DMO’s initial assessment for ANDAs submitted between 2018 and 2022 in the under the 2017 Generic Drug User Fee Amendments (GDUFA II). Although future “GDUFA III” legislation will likely change some details, this guidance is also instructive for planning purposes for ANDAs to be filed in 2023 and later.

The guidelines explain that midway through the FDA’s evaluation of an ANDA’s first evaluation cycle (the mid-cycle date), the DMO will issue a Discipline Review Letter (DRL) to ANDA’s applicant to share their preliminary thoughts on a possible application. deficiencies. Alternatively, a Request for Information (RI) can be sent to request additional information or clarification needed to conduct a discipline assessment (eg bioequivalence, labeling or quality). However, these letters will not be sent when the discipline considers that it can act on the ANDA with the information contained in the request.

The use of these letters is intended to provide applicants with the FDA’s thoughts as soon as possible so that they can modify the ANDAs and continue the evaluation process. The FDA hopes that this mid-cycle communication will minimize the number of review cycles needed for approval. Candidates’ responses will not be categorized as a major or minor change to the ANDA and, therefore, will not delay the assessment clock (formerly, the “Exam Clock”), unless the response does not contain information not requested by the FDA or information that requires further evaluation. The letters do not guarantee that a Complete Response Letter (CRL) will not be issued, as the letters reflect feedback from the assessment team, but not feedback from all levels of supervision within other departments.

ANDA SUBMISSION GOOD PRACTICES, INDUSTRY TIPS

In this guide, the OGD highlights common ANDA shortcomings and provides detailed recommendations, so that ANDA applicants can file compliant submissions under GDUFA II and avoid CRLs, data cycles multiple reviews and long approval times. The information is an update of an OGD guide published in 2018 and details the improvements to the OGD program developed under GDUFA II. By outlining common errors, OGD intends to foster the development of high quality submissions and promote the prompt correction of ANDA deficiencies.

The guidelines cover almost all types of information required in an ANDA, such as patent certifications and exclusivity requirements, labeling, drug substance and drug product descriptions, impurities and intermediates, product quality and manufacturing processes, as well as bioequivalence and dissolution data. Other departments have specific submission and formatting requirements for each eCTD module in all of these areas, so the gap descriptions are helpful and may answer questions that have plagued regulatory affairs staff.

The guide also provides useful information for keeping ANDAs pending, since the initial filing of an ANDA is only the first step to obtaining ANDA approval. During the evaluation cycle, applicants must continually update the information in the ANDA related to many topics, including patent litigation in paragraph IV, orange book changes, manufacturing changes , batch validation and stability data, risk assessment and implementation of mitigation strategy and commercial launch plans. Avoiding submission gaps when submitting updates to a pending ANDA is just as critical as the initial ANDA submission.

ANDA LABELING REVISION FOLLOWING RLD LABELING REVISION, INDUSTRY GUIDANCE PROJECT

These draft guidelines update information that the DMO had previously published in April 2000 via a directive of the same name. Twenty-two years later, FDA reminds ANDA holders of their continued obligation to ensure product labeling is accurate, not false or misleading, and “the same” as the labeling of the corresponding reference medicinal product (RLD). For these reasons, after the FDA approves relevant labeling changes for the RLD, an ANDA holder must update their labeling “as soon as possible.” To learn about RLD labeling changes, ANDA applicants and ANDA holders should proactively monitor public information, such as the [email protected] CDER web page and new mailing list.

The DMO also explains that ANDA labeling changes must be organized according to eCTD modules and submitted in electronic format via the electronic submission gateway. An annotated side-by-side comparison of the proposed ANDA labeling and the approved RLD labeling continues to be required.

read more
Medical products

Laryngeal Stents Sales Market Outlook Forecast by 2029

New Jersey, United States,-The Laryngeal Stents Sales Market report contains a detailed overview of the industry along with gross margin, other basic manufacturing, cost structure, selling price, network direction, service provision, the actual value, overall size, share and future development factors.

Laryngeal Stent Sales Market Overview:

The research report on the global “Laryngeal Stents Sales Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification . The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, the Laryngeal Stents Sales market research provides up-to-date information on the technical advancements and potential market opportunities based on the local landscape.

This Laryngeal Stents Sales Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=524591

The report includes a detailed segmentation study of the global Laryngeal Stents sales market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the segment attractiveness index, allowing players to inform about profitable revenue pockets in the global Laryngeal Stents Sales Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Laryngeal Stents Sales market.

Key Players Covered in Laryngeal Stents Sales Markets:

  • Boston Medical Products (bess AG)
  • Hood Laboratories
  • Stening S.r.l.

Laryngeal Stents Sales Market Split By Type:

  • Hooded laryngeal stent
  • Laryngeal Tubular Stent Segment by Users
  • Child
  • Competitive landscape for adults: factors such as cost analysis
  • marketing strategy
  • factor analysis
  • distributors
  • sourcing strategy
  • and industrial chain

Laryngeal Stents Sales Market Split By Application:

The Laryngeal Stents Sales Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Laryngeal Stents Sales Market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Laryngeal Stents sales market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=524591

Scope of the Laryngeal Stents Sales Market Report

Report attribute Details
Market size available for years 2022 – 2029
Reference year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Laryngeal Stents Market Analysis Sales can be represented as follows:

Each regional Laryngeal Stents Sales Industry is carefully researched to understand their current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global laryngeal stent sales market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/laryngeal-stents-sales-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Medical products

Thermoplastic Orthotics Market Size 2031

New Jersey, United States,-The Orthopedic Thermoplastics market report contains a detailed overview of the industry along with the gross margin, other basic manufacturing, cost structure, selling price, network direction, service delivery, value actual, overall size, share and future development factors.

Orthopedic Thermoplastics Market Outlook:

The research report on the global “Orthopedic Thermoplastics Market” provides qualitative and quantitative insights into the growth rate, market size, revenue, study analysis, demand and company classification. The study examines the factors shaping the future prospects of the industry. The report delves into the existing business environment for the demonstration of current and future Covid-19 markets. Additionally, orthopedic thermoplastics market research provides up-to-date information on technical advancements and potential market opportunities based on the local landscape.

This Thermoplastic Orthotics Market report provides analysis and insights based on original consultations with prominent players such as CEOs, managers, suppliers, manufacturers, and distributors.

Get | Download sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=520938

The report includes a detailed segmentation study of the global orthopedic thermoplastics market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the segment attractiveness index, allowing players to inform about the profitable revenue pockets of the global orthopedic thermoplastics market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus on the right areas of the global orthopedic thermoplastics market.

Major Players Covered by Orthopedic Thermoplastics Markets:

  • Medical clarity
  • Performance Health
  • Chesapeake Medical Products
  • Orfit Industries
  • T-Tape Company
  • Allard International
  • Breg
  • North

Orthopedic Thermoplastics Market Split By Type:

  • Minimum stretch resistance
  • Moderate resistance to stretching
  • Maximum stretch resistance

Orthopedic Thermoplastics Market Split By Application:

  • hand and arm
  • Foot and Knee

The Thermoplastic Orthotics Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global orthopedic thermoplastics market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Orthopedic Thermoplastics market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=520938

Scope of the Orthopedic Thermoplastics Market Report

Report attribute Details
Market size available for years 2022 – 2029
Base year considered 2022
Historical data 2019 – 2021
Forecast period 2022 – 2029
Quantitative units Revenue in USD Million and CAGR from 2023 to 2029
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Orthopedic Thermoplastics Market Analysis can be represented as follows:

Each regional Orthopedic Thermoplastics industry is carefully researched to understand their current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global thermoplastic orthotics market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/orthotic-thermoplastics-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Generic drugs

FDA OGD Releases Guidance Documents to Accelerate Generic Market Entry – As Prescribed – 02

As the Biden-Harris administration and the US Congress continue to debate ways to address perceived concerns about prescription drug prices, the Food and Drug Administration (FDA) is taking action. Under its Drug Competition Action Plan (DCAP), administered by the Office of Generic Drugs (OGD), the FDA has issued approximately 24 guidance documents since 2017, directing industry stakeholders on how to develop, prepare and submit abbreviated new drug applications (ANDAs), so that generic drugs can gain timely FDA approval and reach the market faster. In January 2022, the FDA released three more guidance documents in the DCAP series.

By helping to make additional low-cost generic drugs available, the FDA believes this can impact the overall drug price burden. For example, according to the latest report from the Congressional Budget Office (CBO), the average net price of a prescription drug in the Medicare Part D and Medicaid programs fell from 2009 to 2018, and this drop “reflects the increased use of lower cost generic drugs. drugs.” In the words of the FDA, DCAP “helps remove barriers to generic drug development and market entry with the goal of stimulating competition so consumers can have access to the drugs they need. need at affordable prices”.

When we asked the OGD about the importance of the last three guidelines, Maryll Toufanian, Director of the Office of Generic Drug Policy, replied:

As stated in the DCAP, the FDA understands that it is essential to provide as much transparency as possible in our regulatory expectations. This allows for maximum efficiency for claimants submitting generic drug claims and for our assessment of those claims. Guidance like the one recently released is a key tool in our toolbox to achieve this.

Below is a list of recently released DCAP guidance documents and a brief description of each. Although much of the information has already been provided to industry stakeholders in various forms, it is important for every company considering submitting an ANDA (or has an ANDA pending) to carefully review these published versions of the guidance from the FDA and update their regulatory procedures. Therefore.

Information Requests and Disciplinary Review Letters under GDUFA, Industry Guidance

Updating a 2017 draft, these final guidelines detail how the DMO will provide ANDA applicants with “preliminary thoughts on possible gaps” after the DMO’s initial assessment for ANDAs submitted between 2018 and 2022 in the under the 2017 Generic Drug User Fee Amendments (GDUFA II). Although future “GDUFA III” legislation will likely change some details, this guidance is also instructive for planning purposes for ANDAs to be filed in 2023 and beyond.

The guidelines explain that midway through the FDA’s evaluation of an ANDA’s first evaluation cycle (the mid-cycle date), the DMO will issue a Discipline Review Letter (DRL) to ANDA’s applicant to share their preliminary thoughts on a possible application. deficiencies. Alternatively, a Request for Information (RI) can be sent to request additional information or clarification needed to conduct a discipline assessment (eg bioequivalence, labeling or quality). However, these letters will not be sent when the discipline considers that it can act on the ANDA with the information contained in the request.

The use of these letters is intended to provide applicants with the FDA’s thoughts as soon as possible so that they can modify the ANDAs and continue the evaluation process. The FDA hopes that this mid-cycle communication will minimize the number of review cycles needed for approval. Candidates’ responses will not be categorized as a major or minor change to the ANDA and, therefore, will not delay the assessment clock (formerly, the “Exam Clock”), unless the response does not contain information not requested by the FDA or information that requires further evaluation. The letters do not guarantee that a Complete Response Letter (CRL) will not be issued, as the letters reflect feedback from the assessment team, but not feedback from all levels of supervision within other departments.

ANDA Submission Best Practices, Industry Tips

In this guide, the OGD highlights common ANDA shortcomings and provides detailed recommendations, so that ANDA applicants can file compliant submissions under GDUFA II and avoid CRLs, data cycles multiple reviews and long approval times. The information is an update of an OGD guide published in 2018 and details the OGD program improvements developed under GDUFA II. By outlining common errors, OGD intends to foster the development of high quality submissions and promote the prompt correction of ANDA deficiencies.

The guidelines cover almost all types of information required in an ANDA, such as patent certifications and exclusivity requirements, labeling, drug substance and drug product descriptions, impurities and intermediates, product quality and manufacturing processes, as well as bioequivalence and dissolution data. Other departments have specific submission and formatting requirements for each eCTD module in all of these areas, so the gap descriptions are helpful and may answer questions that have plagued regulatory affairs staff.

The guide also provides useful information for keeping ANDAs pending, since the initial filing of an ANDA is only the first step to obtaining ANDA approval. During the evaluation cycle, applicants must continually update the information in the ANDA related to many topics, including Paragraph IV patent litigation, Orange Book changes, manufacturing changes , batch validation and stability data, risk assessment and mitigation strategy implementation, and commercial launch plans. Avoiding submission gaps when submitting updates to a pending ANDA is just as critical as the initial ANDA submission.

ANDA labeling revision following RLD labeling revision, draft guidance for industry

This draft guidance updates information that the DMO had previously published in April 2000 via a guidance of the same name. Twenty-two years later, FDA reminds ANDA holders of their continued obligation to ensure product labeling is accurate, not false or misleading, and “the same” as the corresponding reference medicinal product labeling (RLD). For these reasons, once the FDA approves relevant RLD labeling changes, an ANDA holder should update their labeling “as soon as possible.” To learn about RLD labeling changes, ANDA applicants and ANDA holders should proactively monitor public information, such as the [email protected] webpage and the CDER New ListServ.

The DMO also explains that ANDA labeling changes must be organized according to eCTD modules and submitted in electronic format through the electronic submission gateway. An annotated side-by-side comparison of the proposed ANDA labeling and the approved RLD labeling continues to be required.

read more
Medical products

Pneumatic Compression Devices for Lymphedema Consumption Market Size 2031

New Jersey, United States,-Pneumatic Compression Devices for Lymphedema Consumption 2022 Industry Outlook Analysis: Pneumatic Compression Devices for Lymphedema Consumption Market 2022 is expected to be profitable. As the trends rise, investors, research methodologies, CEOs, traders, vendors, directors, presidents, research and media, and a better understanding of the Consumer Pneumatic Compression Devices market of lymphedema.

The report specifically focuses on the Virtual Reality Cardboards in North America, Europe, Asia-Pacific, South America, Middle East and Africa, and global market. The report categorizes the market based on manufacturer, region, type and application. QYResearch market research analysts believe factors such as low cost of VR headsets to drive the market growth over the next five years. The assembly parts used to make the VR cartons are cost effective and do not require heavy machinery or huge manufacturing plants to produce these VR cartons. This low cost of VR cardboard is a prediction period for pneumatic compression devices for consumption of lymphedema. a new GIR (Global Information Research) study, of XX million US $ in 2017.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=429826

The report includes a detailed segmentation study of the global Pneumatic Compression Devices for Lymphedema Consumption market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment attractiveness index, allowing players to inform about profitable revenue pockets of the global Pneumatic Compression Devices for Lymphedema Consumption Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Pneumatic Compression Devices for Lymphedema Consumption market.

Key Players Covered in Pneumatic Compression Devices for Lymphedema Consumer Markets:

  • Devon Medical Products
  • Medical Touch
  • ArjoHuntleigh (Getinge AB)
  • LymphaPress?
  • Global DJO
  • Inc.
  • XIAMEN SENYANG CO.
  • LTD
  • Medline Industries
  • Inc.
  • Biocompression systems
  • Inc.
  • B?sl Medizintechnik

Pneumatic Compression Devices for Lymphedema Consumption Market Split By Type:

  • Pneumatic compression pump
  • Pneumatic compression garments

Pneumatic Compression Devices for Lymphedema Consumption Market Split By Application:

The Pneumatic Compression Devices for Lymphedema Consumption Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Pneumatic Compression Devices for Lymphedema Consumption market in the coming years. This segmental analysis will surely prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Pneumatic Compression Devices for Lymphedema Consumptions market and its growth potential in coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=429826

Scope of Pneumatic Compression Devices for Lymphedema Consumption Market Report














Report attribute Details
Market size available for years 2021 – 2028
Base year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

The regional analysis of Pneumatic Compression Devices for Lymphedema Consumption Market can be represented as follows:

Each regional Pneumatic Compression Devices for Lymphedema Consumption industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global Pneumatic Compression Devices for Lymphedema Consumption market has been segmented as follows:

    • North America includes the United States, Canada and Mexico

    • Europe includes Germany, France, UK, Italy, Spain

    • South America includes Colombia, Argentina, Nigeria and Chile

    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-pneumatic-compression-devices-for-lymphedema-consumption-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Prescription drugs

Sleeping Pills (Prescription Drugs) Market Share of APAC, Europe & Americas Application will grow at XX% CAGR to 2026





Abstract:

The latest Sleeping Pills (Prescription Drugs) Market research report offers an in-depth assessment of this business sphere and highlights the key driving factors, growth barriers and lucrative prospects influencing the earnings trajectory over the period 2021-2026.

Request a sample copy of this report @ https://www.getnewsalert.com/request-sample/28757

The Sleeping Pills (Prescription Drugs) industry is expected to register a CAGR of xx% over the forecast period. To arrive at such projections, the research relies on the history of the market increase as well as proven research mythologies.

The document also includes data pertaining to the regional scope of the industry and emphasizes the factors fueling segmental development. Additionally, it provides in-depth company profiles of key players to offer a comprehensive view of this vertical’s competitive dynamics.

Market overview:

Regional outlook:

  • Regionally, the Sleeping Pills (Prescription Drugs) market is classified into North America, Europe, Asia-Pacific, South America, Middle East & Africa, Southeast Asia.
  • The study examines economic indicators for key geographies along with their implications for the overall expansion of the industry.
  • The market share as well as the consumption growth rate of each of the listed regional segments are also presented.

Product Land Overview:

  • According to the report, product portfolio of Sleeping Pills (Prescription Drugs) Market is divided into Zolpidem Eszopiclone (Lunesta) Ramelteon (Rozerem) Ativan (Lorazepam) Adapin (Doxepin).
  • The document shows the consumer market share of each product segment.
  • Information on prices, sales and revenue generated by each product category is specifically covered in the study.

Overview of scope:

  • Based on scope, the sleeping pills (prescription drugs) market is divided into hospital pharmacy and retail pharmacy.
  • The document includes forecasts of the consumption value and consumption share of each application category over the analysis period.
  • The market share captured by each application segment is also listed.

Review of the competitive landscape:

  • The competitive atmosphere of the Sleeping Pills (Prescription Drugs) market is defined by top performers such as Sanofi Abbott Laboratories Takeda Pharmaceutical Apotex Aurobindo Pharma Actellon Pharmaceuticals Allegiant Health Cayman Chemical Ambitropin Hayao.
  • The report presents basic company information and a summary of each company.
  • Statistical data relating to sales, price structure, revenue share and gross margins are also presented.
  • The research document identifies major manufacturing bases, distribution channels and operational areas of key players.
  • Updated information on new product launches, market concentration rate, potential entrants, mergers and acquisitions, and development trends are also offered in the research document.

Research objective:

  • Focuses on the key global Sleeping Pills (Prescription Drugs) Market manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans over the next few years.
  • Moreover, the business contributors, as business analysts of the whole value chain, have made extensive efforts to carry out this group action and the bulk of the work adds order to produce the actors keys with useful primary and secondary data regarding the global Sleeping Pills (Prescription Drugs) market
  • Analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • Establish a strategic profile of key players and analyze in depth their growth strategies.

Influence of the Sleeping Pills (Prescription Drugs) Market Report:

  • Comprehensive assessment of all opportunities and risks in the Sleeping Pills (Prescription Drugs) Market.
  • Recent innovations and major happenings in the Sleeping Pills (Prescription Drugs) Market.
  • A detailed study of business strategies for growth of the Sleeping Pills (Prescription Drugs) Market-leading players.
  • Revealing study on the growth area of ​​the Sleeping Pills (Prescription Drugs) Market for the forthcoming years.
  • In-depth understanding of Sleeping Pills (Prescription Drugs) market drivers, restraints, and major and minor markets.
  • Favorable impression amid vital technological and market latest trends striking the Sleeping Pills (Prescription Drugs) Market.

Main points covered in the table of contents:

  • Overview of the Sleeping Pills (Prescription Drugs) Market
  • Market competition by manufacturers
  • Production market share by regions
  • Consumption by regions
  • Global Sleeping Pills (Prescription Drugs) Production, Revenue, Price Trend by Type
  • Global Sleeping Pills (Prescription Drugs) Market Analysis by Applications
  • Sleeping Pills (Prescription Drugs) Business Profiles and Key Figures
  • Manufacturing Cost Analysis of Sleeping Pills (Prescription Drugs)
  • Marketing channel, distributors and customers
  • Market dynamics
  • Global Sleeping Pills (Prescription Drugs) Market Forecast
  • Research results and conclusion
  • Methodology and data source

Customization request on this report @ https://www.getnewsalert.com/request-for-customization/28757





read more
Generic drugs

Generic Drugs Market Share, Size, Business Opportunity, Supply Chain Analysis, Companies and Forecast Report by 2026

global generic drug market

SHERIDAN, USA, Feb. 22, 2022 /EINPresswire.com/ — IMARC Group’s latest research report, titled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021- 2026”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

The global generic drug market share reached a value of US$386 billion in 2020. Looking ahead, IMARC Group expects the market to show moderate growth during the period 2021-2026. A generic drug is an off-patent drug that is identical to other brand name drugs in terms of effect, form, dosage, intended use, quality, and safety. These drugs can only be manufactured after the brand name drug’s patent has expired. Compared to other branded drugs, these are cheaper and do not require extensive research and testing.

Get Free Sample Copy of Report at – https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

Important Attribute and Report Highlights:
• Detailed global market share analysis
• Market segmentation by therapeutic area, drug delivery and distribution channel.
• Historical, current and projected market size in terms of volume and value
• Latest industry trends and developments
• Competitive landscape for the generic drugs market
• Strategies of key players and product offerings

The global market is mainly driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, Alzheimer’s disease and Parkinson’s disease. Additionally, significant growth in the pharmaceutical industry has boosted the growth of the market across the globe. Apart from this, increased expenditure by the government as well as private companies to manufacture generic drugs that can improve the healthcare system has created a positive outlook for the market. Additionally, the growing geriatric population has positively influenced the growth of the market. Additionally, the upcoming patent expiration of many branded drugs is expected to drive the market towards growth.

Key Players Covered in the Generic Drugs Market Research Report:
• Teva Pharmaceuticals Industries Ltd.
• Mylan SA
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Fresenius SE & Co.
• Lupine Limited
• Endo Pharmaceuticals Inc.
• Aurobindo Pharma Limited
• Aspen Pharmacare Holdings Limited

Do you know more information, contact our analyst at– https://www.imarcgroup.com/generic-drug-manufacturing-plant

Overview of the impact of COVID-19:

We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

Key Market Segmentation:

Breakdown by therapeutic area:
• Central nervous system
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Rupture by administration of drugs:
• Oral
• Injectables
• Dermal/Topical
• Inhalers

Breakdown by distribution channel:
• Retail pharmacies
• Hospital pharmacies

Breakdown by region:
• North America (United States, Canada)
• Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, others)

Table of Contents of Generic Drugs Market Research Report:
• Preface
• Scope and methodology
• Abstract
• Introduction
• Global generic drugs market
• SWOT analysis
• Value chain analysis
• Price analysis
• Competitive landscape

Other related reports from the IMARC group:
WiFi chipset market: https://www.imarcgroup.com/wifi-chipset-market
Biometrics Market: https://www.imarcgroup.com/biometrics-market
Bakery Ingredients Market: https://www.imarcgroup.com/bakery-ingredients-market
Plant-Based Meat Market: https://www.imarcgroup.com/plant-based-meat-market
Kidney/Renal Function Test Market: https://www.imarcgroup.com/kidney-renal-function-test-market
Aircraft Seating Market: https://www.imarcgroup.com/aircraft-seating-market
Cochlear implants market: https://www.imarcgroup.com/cochlear-implants-market
Shape memory alloys market: https://www.imarcgroup.com/shape-memory-alloys-market
Submersible pumps market: https://www.imarcgroup.com/submersible-pumps-market
Night Vision Devices Market: https://www.imarcgroup.com/night-vision-devices-market

Who we are:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

Elena Anderson
IMARC Group
+16317911145
write to us here

read more
Medical products

Smith+Nephew appoints new CEO as medical device maker navigates pandemic

Feb 22 (Reuters) – Smith+Nephew (SN.L) on Tuesday appointed Deepak Nath of Siemens Healthineers AG (SHLG.DE) as chief executive to succeed Roland Diggelmann after the medical device maker narrowly missed the analysts’ estimate of annual profit.

Diggelmann was recruited by Smith+Nephew after his former boss left his salary at the end of 2019, and the British company was counting on his more than 20 years of experience in the orthopedic and diagnostic sectors to accelerate the growth of its income.

However, the pandemic hit soon after, forcing hospitals to delay surgeries and elective services to accommodate COVID-19 patients, and slumping demand for hip and knee replacement surgeries. business, while supply chain issues have also weighed it down.

Join now for FREE unlimited access to Reuters.com

Register

The UK company’s revenue rose 10.3% to $5.21 billion in the 12 months to December 31 on an underlying basis, recovering steadily from 2020, while trading profit was $936 million, compared to $683 million the previous year.

Healthcare networks around the world are once again under pressure from the novel coronavirus variant Omicron, and the company is targeting underlying revenue growth in the range of 4.0% to 5.0% for 2022.

“(Deepak Nath) joins us at an inflection point for the business and will bring his drive, experience and expertise to lead the team as we execute on our rapid growth strategy,” said Chairman Roberto. Quarter in a press release.

Analysts had expected a profit of $945 million in 2021 on sales of $5.22 billion at the median, a consensus provided by the company show.

Join now for FREE unlimited access to Reuters.com

Register

Reporting by Pushkala Aripaka in Bengaluru; Editing by Subhranshu Sahu

Our standards: The Thomson Reuters Trust Principles.

read more
Generic drugs

Generic Drugs Market – EIN Presswire

generic drugs market report

SHERIDAN, USA, Feb. 22, 2022 /EINPresswire.com/ — IMARC Group’s latest research report, titled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021- 2026”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

The global generic drug market share reached a value of US$386 billion in 2020. Looking ahead, IMARC Group expects the market to show moderate growth during the period 2021-2026. A generic drug is an off-patent drug that is identical to other brand name drugs in terms of effect, form, dosage, intended use, quality, and safety. These drugs can only be manufactured after the brand name drug’s patent has expired. Compared to other branded drugs, these are cheaper and do not require extensive research and testing.

Get Free Sample Copy of Report at – https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

Important Attribute and Report Highlights:
• Detailed global market share analysis
• Market segmentation by therapeutic area, drug delivery and distribution channel.
• Historical, current and projected market size in terms of volume and value
• Latest industry trends and developments
• Competitive landscape for the generic drugs market
• Strategies of key players and product offerings

The global market is mainly driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, Alzheimer’s disease and Parkinson’s disease. Additionally, the significant growth in the pharmaceutical industry has boosted the growth of the market across the globe. Apart from this, increased expenditure by the government as well as private companies to manufacture generic drugs that can improve the healthcare system has created a positive outlook for the market. Additionally, the growing geriatric population has positively influenced the growth of the market. Additionally, the upcoming patent expiration of many branded drugs is expected to drive the market towards growth.

Key Players Covered in the Generic Drugs Market Research Report:
• Teva Pharmaceuticals Industries Ltd.
• Mylan SA
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Fresenius SE & Co.
• Lupine Limited
• Endo Pharmaceuticals Inc.
• Aurobindo Pharma Limited
• Aspen Pharmacare Holdings Limited

Do you know more information, contact our analyst at– https://www.imarcgroup.com/generic-drug-manufacturing-plant

Overview of the impact of COVID-19:

We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

Key Market Segmentation:

Breakdown by therapeutic area:
• Central nervous system
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others

Rupture by administration of drugs:
• Oral
• Injectables
• Dermal/Topical
• Inhalers

Breakdown by distribution channel:
• Retail pharmacies
• Hospital pharmacies

Breakdown by region:
• North America (United States, Canada)
• Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, others)

Table of Contents of Generic Drugs Market Research Report:
• Preface
• Scope and methodology
• Abstract
• Introduction
• Global generic drugs market
• SWOT analysis
• Value chain analysis
• Price analysis
• Competitive landscape

Other related reports from the IMARC group:
WiFi chipset market: https://www.imarcgroup.com/wifi-chipset-market
Biometrics Market: https://www.imarcgroup.com/biometrics-market
Bakery Ingredients Market: https://www.imarcgroup.com/bakery-ingredients-market
Plant-Based Meat Market: https://www.imarcgroup.com/plant-based-meat-market
Kidney/Renal Function Test Market: https://www.imarcgroup.com/kidney-renal-function-test-market
Aircraft Seating Market: https://www.imarcgroup.com/aircraft-seating-market
Cochlear implants market: https://www.imarcgroup.com/cochlear-implants-market
Shape memory alloys market: https://www.imarcgroup.com/shape-memory-alloys-market
Submersible pumps market: https://www.imarcgroup.com/submersible-pumps-market
Night Vision Devices Market: https://www.imarcgroup.com/night-vision-devices-market

Who we are:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

Elena Anderson
IMARC Group
+1 631-791-1145
write to us here

read more
Prescription drugs

Prescription Drugs Market Global Production, Growth, Share, Demand and Application Forecast to 2027 – ZNews Africa

Prescription Drug Market Research Overview

Global Prescription Drugs Market exhibits comprehensive information which is a valuable source of insightful data for business strategists during the decade 2017-2027. Based on historical data, the Prescription Drugs market report provides key segments and their sub-segments, revenue and demand and supply data. Given the technological breakthroughs in the market, the prescription drug industry is likely to emerge as a laudable platform for emerging investors in the prescription drug market.

The results of recent scientific endeavors towards the development of new prescription drug products have been studied. Nonetheless, factors affecting major industry players to adopt synthetic sourcing of market products have also been studied in this statistical survey report. The findings provided in this report are of great value to major industry players. Every organization involved in the global production of the Prescription Drugs Market products has been mentioned in this report, to study the information on cost-effective manufacturing methods, competitive landscape and new application avenues.

This report contains an in-depth analysis of pre-pandemic and post-pandemic market scenarios. This report covers all recent developments and changes recorded during the COVID-19 outbreak.

Get a sample report: https://www.marketresearchupdate.com/sample/355929

Major Key Players in the Market:
F. Hoffmann-La Roche AG, Eli Lilly and Company, Pfizer, Inc, Novo Nordisk A/S, Amgen, Inc, Merck & Co., Inc, Sanofi, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Bristol- Myers Squibb Company, AbbVie, Inc, GlaxoSmithKline PLC, Allergan PLC, Bayer AG, Celgene Corporation, Novartis International AG, Boehringer Ingelheim GmbH, Gilead Sciences, Inc, Shire PLC

The types covered in this report are:
brand name drugs
General medicine

Based on the app:
Sold online
Hospital
Clinical
Other

With the current market norms being revealed, the Prescription Drugs market research report has also illustrated the latest strategic developments and patterns of the market players in an unbiased manner. The report serves as a presumptive business document that can help the buyers in the global market to plan their next courses towards the future position of the market.

Check Prescription Drugs Market Report @ https://www.marketresearchupdate.com/discount/355929

Regional Analysis of the Prescription Drugs Market

North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa)

Why B2B companies around the world rely on us to grow and sustain revenue:

  • Get a clear understanding of the prescription drugs market, how it works, and the different stages of the value chain.
  • To understand the current market situation and future growth potential of the Prescription Drugs Market throughout the forecast period.
  • Develop marketing strategies, market entry, market expansion and other business plans by understanding the factors that influence market growth and buyer buying decisions.
  • Understand your competitors’ business structures, strategies and prospects and react accordingly.
  • Make more informed business decisions using relevant primary and secondary research sources.

This report provides:

  1. A detailed overview of the global prescription drugs market.
  2. Assessment of global industry trends, historical data from 2015, projections for the upcoming years and anticipation of compound annual growth rates (CAGR) by the end of the forecast period.
  3. Discoveries of new market insights and targeted marketing methodologies for Global Prescription Drugs
  4. Discussion on R&D and demand for new product launches and applications.
  5. Varied company profiles of major industry players.
  6. The composition of the market, in terms of dynamic molecule types and targets, highlighting the key industry resources and players.
  7. The growth of patient epidemiology and market revenue for the global market and among key players and market segments.
  8. Study the market in terms of generic and premium product revenues.
  9. Determine business opportunities in the market sales scenario by analyzing trends in licensing and co-development agreements.

Get the full report @ https://www.marketresearchupdate.com/industry-growth/prescription-drugs-report-2022-2027-355929

Ultimately, the Prescription Drugs Market report includes analysis of investments and development trends. Present and future opportunities of the fastest growing international industry segments are covered throughout this report. This report additionally presents the product specification, manufacturing method, product cost structure, and price structure.

Contact us:
[email protected]

read more
Medical products

Disposable Pressure Transducers Market Outlook by 2030

New Jersey, United States,-The latest report published by Market Research Intellect presents an in-depth analysis of the global disposable pressure transducers market. This research report assesses ever-changing market dynamics that are expected to affect the trajectory of the overall market. Analysts have studied historical market performance and compared it to current market trends, charting the trajectory. For a detailed discussion of the global disposable pressure sensors market, analysts have segmented the market based on applications, products, and end users. The research reports have been collated using primary as well as secondary research methodologies to provide readers with a precise understanding of the ongoing development of the Disposable Pressure Transducers market.

Analysts used Porter’s Five Forces Analysis, Study Worm Analysis, and Pestle Analysis to determine the path major vendors should follow in the coming years. The research report also includes the assessment of these vendors’ financial outlook, Disposable Pressure Sensors market growth strategy and expansion plan during the forecast period. All the information presented in the Global Disposable Pressure Sensors Market research report has been certified by market experts.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=403765

The report includes a detailed segmentation study of the global Disposable Pressure Sensors market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the global Disposable Pressure Transducers Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Disposable Pressure Transducers market.

Key Players Covered in Disposable Pressure Transducers Market:

  • Edwards life sciences
  • Utah Medical Products
  • Smith’s Medical
  • Elcam Medical
  • Medical intensive care
  • Argon Medical
  • Biosensors International
  • Medical Merit Systems
  • Shenzhen Antmed
  • B. Braun
  • Cook Regentec
  • PendoTECH
  • SCW Medicath
  • George Phillips
  • DeRoyal Industries
  • Lepu Medical
  • copper medical technology
  • medical ace
  • Biometrix B.V.
  • Metko Ltd.
  • Guangdong Baihe Medical
  • Tianck Medical

Disposable Pressure Transducers Market Split By Type:

  • Single channel transducers
  • Dual channel transducers
  • Three-channel transducers

Disposable Pressure Transducers Market Split By Application:

The Disposable Pressure Transducers Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Disposable Pressure Transducers Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Disposable Pressure Sensors market and its growth potential in the coming years.

Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=403765

Scope of the Disposable Pressure Transducers Market Report

Report attribute Details
Market size available for years 2021 – 2028
Base year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
Segments Covered Types, applications, end users, and more.
Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

Regional Disposable Pressure Transducers Market Analysis can be represented as follows:

Each regional Disposable Pressure Sensors industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

Based on geography, the global disposable pressure sensors market has been segmented as follows:

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-disposable-pressure-transducers-market-size-and-forecast/

About Us: Market Research Intellect

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. customers, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
USA: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US toll free: +1 (800)-782-1768

Website: –https://www.marketresearchintellect.com/

read more
Prescription drugs

Anti-Obesity Prescription Drugs Market Key Vendors, Opportunities, In-Depth Analysis by Regional and Country Perspective

the Prescription Anti-Obesity Drugs Market The report covers the whole scenario of the global market including key players, their future campaigns, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. Its objective is to rationalize the company’s costs. You can also find interest and expense points on current income here. The best thing about the Prescription Anti-Obesity Drugs market report is the provision of guidelines and strategies followed by leading market players. The investment opportunities in the market that are highlighted here will go a long way in moving the business forward. Knowing the current market situation is the most important thing discussed here to help major players survive in the deadly market.

This Prescription Obesity Drugs Market study outlines the economic catastrophe caused by the covid-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to various industrial closures and loss of income. A high degree of information is offered here to assess the market situation.

Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://reportsglobe.com/download-sample/?rid=109105

The authors of the report draw up an encyclopedic assessment of the most important regional markets and their evolution in recent years. Readers are provided with accurate facts and figures about the Prescription Anti-Obesity Drugs market and its important factors such as consumption, production, revenue growth, and CAGR. The report also shares gross margin, market share, attractiveness index, and value and volume growth for all segments studied by analysts. It highlights key developments, product portfolio, markets served and other areas depicting business growth of major companies profiled in the report.

The report has been prepared using the latest primary and secondary research methods and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports, and public and private interviews to gather data and information about the market in which they operate.

Major Players Covered in Anti-Obesity Prescription Drugs Markets:

  • F Hoffmann La Roche SA
  • Alizyme
  • Arena Pharmaceuticals
  • Therapeutic Ordemanden
  • Boehringer Ingelheim
  • Novo Nordisk A/s
  • Lived
  • Glaxosmithkline

    Prescription Anti-Obesity Drugs Market Split By Type:

  • Orlistat
  • Phentermine and Topiramate
  • Bupropion and Naltrexone
  • Lorcaserin
  • Liraglutide

    Anti-Obesity Prescription Drugs Market Split By Application:

  • Pediatric
  • Adult

    The Prescription Anti-Obesity Drugs Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is rated based on CAGR, participation, and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Keyword Market in the coming years. This segment analysis is sure to prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Keyword Market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://reportsglobe.com/ask-for-discount/?rid=109105

    Scope of Anti-Obesity Prescription Drugs Market Report

    ATTRIBUTES

    The description

    ESTIMATED YEAR

    2022

    YEAR OF REFERENCE

    2021

    FORECAST YEAR

    2022 to 2028

    HISTORICAL YEAR

    2020

    SECTORS COVERED

    Types, applications, end users, and more.

    REPORT COVER

    Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

    BY REGION

    North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

    Geographic segment covered in the report:

    The Anti-Obesity Prescription Drugs report provides information about the market, which is divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate for each region, country and sub-region over the estimated period.

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Aims and objectives of Anti-Obesity Prescription Drugs Market Research

    • Understanding the opportunities and advancements in Anti-Obesity Drugs determines the market strengths, along with the key regions and countries involved in the market growth.
    • Study the various segments of the Prescription Anti-Obesity Drugs market and the dynamics of the Prescription Anti-Obesity Drugs in the market.
    • Categorize the Anti-Obesity Prescription Drugs segments with increasing growth potential and assess the market for the futuristic segment.
    • To analyze the most important trends related to the various segments which help decipher and convince the Prescription Anti-Obesity Drugs market.
    • Check region-specific growth and development in the Prescription Anti-Obesity Drugs Market.
    • Understand the major stakeholders of the Prescription Anti-Obesity Drugs market and the competitive image value of the Prescription Anti-Obesity Drugs market leaders.
    • To study the key plans, initiatives, and strategies for the development of the Prescription Anti-Obesity Drugs Market.

    The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Anti-obesity prescription drug historical distribution data from 2016 to 2021 and forecast for 2022-2028.

    Ask questions about personalization at @ https://reportsglobe.com/need-customization/?rid=109105

    Some highlights from the table of contents:

    1 Presentation of the report

    2 Market Trends and Competitive Landscape

    3 Prescription Obesity Drugs Market Segmentation by Types

    4 Prescription Obesity Drugs Market Segmentation by End Users

    5 Market Analysis by Major Regions

    6 Core Products of Anti-Obesity Drugs Market by Major Countries

    7 North America Anti-Obesity Drugs Landscape Analysis

    8 Europe Obesity Drugs Landscape Analysis

    9 Asia-Pacific Obesity Drugs Landscape Analysis

    10 Latin America, Middle East and Africa Obesity Drugs Landscape Analysis

    11 Profile of Key Players

    How Reports Globe is different from other market research providers:

    The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

    Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

    Contact us:

    Mr. Mark Williams

    Account Manager

    WE: +1-970-672-0390

    E-mail: [email protected]

    Website: Reportsglobe.com

  • read more
    Medical supplies

    Prepackaged Medical Supplies Market Overview, High Growth Opportunities, Segmentation, Trends by 2022-2028

    the Prepackaged Medical Supplies Market The report covers the whole scenario of the global market including key players, their future campaigns, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. Its objective is to rationalize the company’s costs. You can also find interest and expense points on current income here. The best thing about the Prepackaged Medical Supplies market report is the provision of guidelines and strategies followed by major market players. The investment opportunities in the market that are highlighted here will go a long way in moving the business forward. Knowing the current market situation is the most important thing discussed here to help major players survive in the deadly market.

    This Prepackaged Medical Supplies Market study describes the economic disaster caused by the covid-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to various industrial closures and loss of income. A high degree of information is offered here to assess the market situation.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://reportsglobe.com/download-sample/?rid=134558

    The authors of the report draw up an encyclopedic assessment of the most important regional markets and their evolution in recent years. Readers are provided with accurate facts and figures about the Prepackaged Medical Supplies market and its important factors such as consumption, production, revenue growth, and CAGR. The report also shares gross margin, market share, attractiveness index, and value and volume growth for all segments studied by analysts. It highlights key developments, product portfolio, markets served and other areas depicting business growth of major companies profiled in the report.

    The report has been prepared using the latest primary and secondary research methods and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports, and public and private interviews to gather data and information about the market in which they operate.

    Major Players Covered in Prepackaged Medical Supplies Market:

  • Angiokard Medizintechnik
  • Scientific Boston
  • B Braun Melsung
  • Med-Italia Biomedica
  • Molnlycke Healthcare
  • Social
  • Teleflex Medical
  • 3M Healthcare
  • Cardinal Health
  • Covidian
  • Cypress Medical Products
  • Hogy Medical
  • Medical action industries
  • Smith and nephew

    Prepackaged Medical Supplies Market Split By Type:

  • Needle and Syringe
  • Anesthesia kit
  • Protective equipment
  • General surgery and instrument kit
  • Other

    Prepackaged Medical Supplies Market Split By Application:

  • Hospital
  • Clinical
  • Family first aid
  • Other

    The Prepackaged Medical Supplies market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is rated based on CAGR, participation, and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Keyword Market in the coming years. This segment analysis is sure to prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Keyword Market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://reportsglobe.com/ask-for-discount/?rid=134558

    Scope of the Prepackaged Medical Supplies Market Report

    ATTRIBUTES

    The description

    ESTIMATED YEAR

    2022

    YEAR OF REFERENCE

    2021

    FORECAST YEAR

    2022 to 2028

    HISTORICAL YEAR

    2020

    SECTORS COVERED

    Types, applications, end users, and more.

    REPORT COVER

    Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

    BY REGION

    North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

    Geographic segment covered in the report:

    The Prepackaged Medical Supplies report provides information on the market area, which is divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate for each region, country and sub-region over the estimated period.

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Goals and Objectives of Prepackaged Medical Supplies Market Research

    • To understand the Prepackaged Medical Supplies opportunities and advancements determines the market highlights, along with the key regions and countries involved in the market growth.
    • Study the various segments of the Prepackaged Medical Supplies market and the dynamics of the Prepackaged Medical Supplies in the market.
    • Categorize the prepackaged medical supplies segments with increasing growth potential and assess the futuristic segment market.
    • To analyze the most important trends related to the different segments that help decrypt and convince the Prepackaged Medical Supplies market.
    • Check region-specific growth and development in the Prepackaged Medical Supplies Market.
    • Understand the major stakeholders in the Prepackaged Medical Supplies market and the competitive image value of the Prepackaged Medical Supplies market leaders.
    • To study the key plans, initiatives, and strategies for the development of the Prepackaged Medical Supplies Market.

    The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical distribution data for prepackaged medical supplies from 2016 to 2021 and forecast for 2022-2028.

    Ask questions about personalization at @ https://reportsglobe.com/need-customization/?rid=134558

    Some highlights from the table of contents:

    1 Presentation of the report

    2 Market Trends and Competitive Landscape

    3 Prepackaged Medical Supplies Market Segmentation by Types

    4 Prepackaged Medical Supplies Market Segmentation by End Users

    5 Market Analysis by Major Regions

    6 Product Commodity Medical Devices Market by Major Countries

    7 North America Prepackaged Medical Supplies Landscape Analysis

    8 Europe Prepackaged Medical Supplies Landscape Analysis

    9 Asia Pacific Prepackaged Medical Supplies Landscape Analysis

    10 Latin America, Middle East and Africa Prepackaged Medical Supplies Landscape Analysis

    11 Profile of Key Players

    How Reports Globe is different from other market research providers:

    The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

    Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

    Contact us:

    Mr. Mark Williams

    Account Manager

    WE: +1-970-672-0390

    E-mail: [email protected]tsglobe.com

    Website: Reportsglobe.com

  • read more
    Medical supplies

    Med Surgical Supplies presents an easy way to buy medical supplies in the USA

    Medical and surgical supplies logo

    EDISON, NEW JERSEY, USA, February 21, 2022 /EINPresswire.com/ — Healthcare professionals face increasing challenges in their daily work, but solutions exist to help them operate effectively. Medical-surgical suppliesoften called MedsurgicalSupplies.com offers a wide range of supplies and equipment to help ensure top quality patient care. Supplies include everything from surgical instruments and patient reusable products to infection prevention tools and skin care products.

    The one-stop-shop program makes ordering supplies easy and convenient! Users can access the entire catalog, including diagnostic and surgical instruments, exam tables and more.

    Surgical equipment, plastic surgery fillers, injections, diagnostics, laboratory products, CPAP and oxygen equipment, respiratory therapy products, pharmaceuticals and vaccines all make up the more than 700,000 products available through Med Surgical Supplies.

    In-house ordering and inventory tools help nursing homes, laboratories, home health agencies, long term care facilities, nursing homes, healthcare professionals, CHWs, post care -treble with more than just control.

    Supply professionals and order nurses can easily track expenses by facility or location, enter purchase orders, approve invoices, access real-time health product information and availability through the Med Surgical Supplies website.

    Medical Surgical Supplies is a partner of Pipeline Medical, a market leader in medical technology. Their nationwide delivery network provides 48-hour next-day delivery to 95% of customers with 99.8% order accuracy and also benefits from a personal touch, with account managers assisting with backorder fulfillment.

    When you’re in the wholesale industry, you’re looking to be more than just a supplier. You want to be a partner in the success of your customers and provide them with expertise, advice and assistance so that they succeed. It’s not just about delivering their products or services; it’s about making sure they have the resources they need to start their business and keep it running smoothly.

    Anyone can sell medical supplies, but it takes an expert in the wholesale medical supplies industry to make sure everything runs smoothly, from the initial sale to any follow-up work. Med Surgical Supplies aims to keep customers healthy and prosperous by providing life-saving products such as equipment, instruments and medications. And of course, working in the regulated healthcare environment, paying attention to the smallest details.

    It’s no secret that supply chain has been a major issue in the healthcare industry for the past 18 months. Even as the pandemic itself begins to fade, supply chain issues persist.

    Hospitals and health systems are reporting supply issues, and many fear old problems could resurface. The health sector is taking steps to mitigate future disasters and learn from its mistakes, but there are always risks of further disruption.

    A recent survey of healthcare executives asked their opinion on the state of supply chain management. Many were confident about what they had learned from the pandemic, but insisted continued vigilance was needed to face future challenges.

    Med Surgical Supplies sees itself as part of the solution to providing a quick and efficient way to obtain supplies for all medical and surgical practices.

    The website provides a fast and efficient experience for physicians. The site is ideal for the medical supply chain.

    Medical-surgical supplies
    Medical surgical supplies
    write to us here

    read more
    Medical supplies

    Samaritan’s Purse transports medical supplies to Ethiopia | News

    The Samaritan’s Purse DC-8 cargo plane carried more than 13 tons of essential medical supplies from Piedmont Triad International Airport in Greensboro to Ethiopia on February 15.

    These supplies, including two anesthesia machines, an X-ray machine and an ultrasound machine, were sent to Mersa Regional Hospital, which is the main provider of medical care for some 350,000 people.

    A Samaritan’s Purse press release said the hospital had been significantly affected by the violent internal conflict in the region and lacked the resources to effectively treat the sick and injured. It is in the Amhara region.

    “The situation in Ethiopia is heartbreaking. Many innocent people are caught up in the conflict and local healthcare facilities are unable to serve their patients due to a lack of resources,” said Franklin Graham, President of Samaritan’s Purse.

    “We are airlifting these desperately needed supplies to save lives and let the people of Ethiopia know that God loves them. Please join me in praying for peace and unity in this conflict-torn country.

    Fitsum Arega, Ethiopian Ambassador to the United States, joined Edward Graham, Vice President of Operations for Samaritan’s Purse, to see the plane take off and spoke about the partnership and the airlift.

    “I would like to thank you on behalf of the Ethiopian people for this generous donation,” Arega said. “People in the northern regions of Ethiopia have suffered greatly from the conflict and many hospitals and health centers have been looted and damaged due to the war. So many people are in distress. That you come to bless us with this kind of support tells us who you are. Thank you a lot. God bless you. We really need your prayers for the conflict to end and for peace to be restored in Ethiopia.

    Edward Graham said: “This is the fifth flight of our DC-8 to Ethiopia to some areas where hundreds of thousands of people are without medical care,” he said. “At the invitation of the Ethiopian government and the Ministry of Health, Samaritan’s Purse is able to respond and meet these immediate needs. And we do all of this in the name of Jesus Christ.

    He continued: “We want our neighbors to know that we care for them, and just like the story of the Good Samaritan, we meet the immediate need of those who are suffering and also take care of them in the long term and share the hope of Jesus Christ. , our Lord and Saviour.

    In addition to hospital resupply, Samaritan’s Purse launched a food program in eight schools in the conflict region to provide families with basic necessities.

    The scope of work includes a three-month food supply for at least 1,600 school-aged children. We will also provide water, sanitation facilities and hygiene items including soap, toothbrushes, toothpaste and water treatment supplies to provide safe drinking water.

    The plane was greeted upon arrival in the Ethiopian capital, Addis Ababa, by the country’s Minister of Health, Dr Lia Tadesse, as well as members of the Samaritan’s Purse Disaster Response Team. , which have responded to the needs created by the conflict in the Tigray and Amhara regions over the past year.

    Samaritan’s Purse has a long history in Ethiopia, dating back to 1989 when we installed fresh water wells and instituted agricultural programs in the country during widespread drought and famine.

    Samaritan’s Purse is based in Boone but has a major presence in North Wilkesboro with offices and warehouses.

    read more
    Medical supplies

    Australia donates more medical supplies – Solomon Star News

    THE Department of Health and Medical Services (MHMS) is today receiving tons of medical supplies and bespoke equipment kits to help provinces respond to COVID-19 from the Australian Government.

    A statement from the Australian High Commission in Honiara said Minister of Health and Medical Services Dr Culwick Togamana and Australian High Commissioner Dr Lachlan Strahan welcomed six two-tonne pallets of medical supplies and bespoke equipment kits to help provinces respond to COVID-19 in a small event at Henderson Airport.

    “Known as ‘Bricks,’ these kits consist of essential health supplies and equipment specifically used to treat and manage severe cases of COVID-19,” the statement said.

    He said each “brick” includes oxygen concentrators and consumables for oxygen therapy, rapid antigen tests, essential medicines and more than 32,000 pieces of personal protective equipment, including masks, face shields, gloves. and hand sanitizer.

    “The delivery of the COVID-19 bricks will further strengthen the medical supplies available and the response capabilities of health workers in provincial areas,” the Australian High Commission said.

    He said the bricks will be flown by the Royal Australian Airforce’s two C-27J Spartans in the coming week to support immediate to longer-term COVID-19 responses in the provinces.

    read more
    Prescription drugs

    Representative Glenn backs plan to reduce Michigan prescription drug costs


    Representative Annette Glenn, R-Midland, continued her work to reduce prescription drug costs in Michigan.

    Glenn voted in favor of House Bill 4348, which will help patients save on drug prices by reforming regulations and improving transparency related to Pharmacy Benefit Managers (PBMs). The legislation passed the House with overwhelming bipartisan support and advances to Governor Whitmer for his consideration.

    “Michigan families are grappling with the rising cost of prescription drugs,” Glenn said. “This is an important step to help bring prices under control so people can get the medicines they need for themselves, their children and their parents.”


    PBMs act as intermediaries between health plans, drug manufacturers and pharmacists. The PBM industry’s unregulated practices have contributed to the rising prices consumers pay for prescription drugs. House Bill 4348 would provide specific requirements for PBMs to improve transparency and combat unfair trade practices that unnecessarily increase drug prices.

    The reforms target additional fees charged retroactively to pharmacies, discriminatory purchase limits and price increases for certain pharmacies, and restrictions that prevent pharmacies from providing relevant medical information to patients or discussing and selling alternatives. less expensive.

    The measure is just one of the many ways Glenn is fighting to make health care more affordable. She co-sponsors House Bill 4346, which would reduce out-of-pocket expenses for many diabetics who need insulin. Insurance companies could charge no more than $50 for each 30-day supply.

    read more
    Medical supplies

    Zipline expands drone medical supply deliveries to Kenya

    Zipline, a global leader in instant logistics, is launching operations in another African country with on-demand drone deliveries of medical supplies to Kisumu County in Kenya.

    Under the agreement between the two parties, Zipline will establish a mode of operation similar to that originally rolled out in Rwanda in 2016, and has since improved and expanded through partnerships with Ghana, Nigeria and Côte d’Ivoire. ‘Ivory. Once its storage and flight management center in Kenya is ready, Zipline will conduct automated drone flights of medicines and supplies to health facilities in Kisumu County.

    The link is another example of how officials across Africa have turned to Zipline to create regular drone delivery networks of medical supplies to remote or hard-to-reach areas that often need them the most. . It’s part of a rapidly spreading ambition across the continent to create universal healthcare by taking treatment by air to underserved locations.

    “We have made great efforts to improve the overall delivery of health care to our people,” said Kisumu County Governor, HE Prof. Anyang’ Nyong’o. “It is therefore heartening to note that our mission to achieve universal health coverage is well on its way with this historic partnership which will ensure that no one is left behind because of their location.”

    Under the agreement, the new UAV logistics center in Kisumu County – a member of the Lake Region Economic Bloc (LREB) representing 14 million people, or 30% of Kenya’s population, will gradually serve health projects and clinics in 16 other western counties as well.

    “It is our commitment as LREB to deliver an aggressive program of building a robust health care delivery system that will serve not just the few, but the vast majority of people in LREB counties,” said LREB Chairman Wycliffe Oparany. “Zipline’s technology is one we can use to accelerate the transformation of our healthcare systems to deliver timely healthcare solutions to the people whose mandate we serve.”

    Once the new Zipline Logistics Center is operational, it will oversee on-demand drone deliveries of up to 1.8 kg of blood products, COVID-19 vaccines and other potentially life-saving medical supplies. The drone can cruise up to 110 km/h on round trips of up to 160 kilometers, even in adverse weather conditions, and it will operate seven days a week to ensure that healthcare payloads reach their destination in 30 minutes.

    In addition to just-in-time deliveries of urgent medications, routine flights of medical supplies by Zipline drones will help facilities avoid running dangerously low on supplies.

    “We’ve seen how on-demand automated delivery can transform healthcare systems to make them more efficient, effective and equitable,” said Keller Rinaudo, CEO of Zipline, which also operates in the United States. “Zipline’s expansion into Kenya, our seventh country, in partnership with Kisumu County, is a critical step in extending these important benefits to more communities around the world.”


    Subscribe to DroneDJ on YouTube for exclusive videos

    read more
    Medical products

    Himachal Pradesh government plans to deliver agricultural and medical products by drones and strikes a deal

    Explore the use of drone in various departments, Himachal Pradesh state government reached an agreement with Drone delivery service company skye air. Under the agreement, the company will deliver medicines and agricultural products by drones.

    As part of this strategic partnership, Skye Air has launched a 3-day BVLOS trial in the Chamba district of Himachal Pradesh to connect over 6 PHCs/CHCs and hospitals in the region via multiple point-to-point flights covering an air distance of 170 km throughout the trial. The drone delivery technology company will use advanced drones and technology to provide real-time deliveries of vaccines and drugs within a specified temperature range of 2 to 8 degrees Celsius. There will be several reverse logistics flights that will also be conducted to aid in the adoption of drone technology to enable cost effective deliveries in the state.

    In the trial run. the drone flights, equipped with shipments of medical supplies, hovered at an altitude of 400 feet above the ground in a designated green area in Chamba district. The flights took place in 3 air corridors – Chaned, Tissa and Mehla.

    Commenting on the development, Mukesh Repaswal, Director, Information Technology Department, Government. of Himachal Pradesh said, “The demonstration in Chamba will help determine the benefits of using drones in drug delivery and the benefits of drone governance. We look forward to the success of the BVLOS trials in Chamba and the expansion of the drone delivery ecosystem in Himachal Pradesh to medical and agri-food deliveries.

    Commenting on the deal, Swapnik Jakkampundi, co-founder of Skye Air, said: “To begin with, we will operate around 25 flights during the trial phase overcoming the challenges of harsh weather and terrain. In the coming months, as we look forward to enabling commercial flights in the district, we will be able to directly benefit over 5.19 lakh people through improved accessibility to healthcare and local job creation. in the drone delivery ecosystem.

    Skye Air recently made headlines for delivering India’s first agri-food product via drones to Meghalaya, enabling 1st mile logistics for farmers.

    read more
    Medical products

    2021 Enforcement Review: FDA Regulated Medical Products – Food, Drug, Healthcare, Life Science


    United States: 2021 Enforcement Review: FDA Regulated Medical Products

    To print this article, all you need to do is be registered or log in to Mondaq.com.

    Although the continuing public health emergency related to COVID-19 remained an obstacle to many Food and Drug Administration (“FDA”) inspections in 2021, the pandemic did not prevent criminal and civil actions. related to major violations of FDA regulations, particularly matters that have been under investigation since before the pandemic. The Department of Justice (“DOJ”) has announced numerous indictments, civil and criminal settlements, and criminal convictions involving individuals accused of violating the Federal Food, Drug, and Cosmetic Act (“FDCA”) ) and other laws related to product schemes. COVID-19 fraud remained a top priority, as did cases involving opioids and clinical trial fraud.

    This app review of 2021 covers major criminal and civil actions against life sciences companies, starting with those related to the ongoing COVID-19 pandemic. It then discusses actions involving the illicit distribution of opioids, which continue to be a DOJ priority, and then focuses on a new area of ​​interest for law enforcement: clinical trial fraud. The article then examines other enforcement actions brought under the FDCA and related criminal statutes, as well as civil misrepresentation law, which are based on a somewhat broader variety of alleged violations of the FDA regulations. The article ends by looking forward to what FDA-regulated companies can expect on the enforcement horizon in 2022.

    The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

    POPULAR ARTICLES ON: US Food, Drugs, Healthcare, Life Sciences

    read more
    Medical products

    Analysis of investments in the axillary crutches market

    A new research study from JCMR with the title Global Axillary crutches Market Research Report 2021 provides an in-depth assessment of Armpit Crutches, including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies and strategies. Research Study Provides Predictions For Axillary Crutches investments until 2029.

    The report includes the latest post-pandemic market research on the Axillary Crutches market.

    Competitive Analysis: Cardinal Health, Home Medical Products Inc, New York Millennium Pharmaceutical, AMG Medical, BREG, Chinesport, Dr. Med, Mikirad, Ossenberg GmbH,

    Request Free Sample PDF Report @: jcmarketresearch.com/report-details/97013/sample

    Frequently Asked Questions:

    • How fast is the market expected to grow

    Year-over-year growth for 2021 is estimated at XX% and additional growth for Armpit Crutches market is estimated to be USD xxx million.

    Get Up To 40% Off Corporate Copy & Customization available for the following regions and countries: North America, South and Central America, Middle East and Africa, Europe, Asia-Pacific

    • Who are the key players in the Axillary Crutches market?

    Cardinal Health, Home Medical Products Inc, New York Millennium Pharmaceutical, AMG Medical, BREG, Chinesport, Dr. Med, Mikirad, Ossenberg GmbH,

    • What are the key drivers and challenges for the Axillary Crutches Market?

    The demand for ASW capacity building is one of the major factors driving the axillary crutches market.

    • What is the size of the armpit crutches market in North America?

    The North America region will contribute XX% of the Axillary crutches market share

    Survey for Axillary Crutches Segment [email protected]/report-details/97013/enquiry
    This customized Arm Crutches report will also help clients track new product launches in the direct and indirect markets related to COVID-19, upcoming vaccines and pipeline analysis, and significant developments in the operations of the suppliers and government regulations.

    Geographical analysis of axillary crutches:

    • Axillary crutches industry North America: United States, Canada and Mexico.

    • Axillary crutches industry South and Central America: Argentina, Chile and Brazil.

    • Axillary crutches industry Middle East and Africa: Saudi Arabia, United Arab Emirates, Turkey, Egypt and South Africa.

    • Armpit crutches industry Europe: United Kingdom, France, Italy, Germany, Spain and Russia.

    • Asia-Pacific armpit crutches industry: India, China, Japan, South Korea, Indonesia, Singapore and Australia.

    Market Analysis by Types & The market analysis by applications is as follows:

    [Segments]

    Some of the Points Covered in the Global Axillary Crutches Market Research Report are:

    Chapter 1: Global Axillary Crutches Market Overview (2013-2025)
    • Definition of axillary crutches
    • Specifications of axillary crutches
    • Classification of axillary crutches
    • Applications of axillary crutches
    • Axillary crutches regions

    Chapter 2: Axillary Crutches Market competition by players/suppliers 2013 and 2018
    • Axillary Crutches Manufacturing Cost Structure
    • Raw material and suppliers of axillary crutches
    • Axillary crutches manufacturing process
    • Industry Chain Structure of Armpit Crutches

    Chapter 3: Axillary Crutches Sales (Volume) and Revenue (Value) by Region (2013-2021)
    • Sales of axillary crutches
    • Axillary crutches revenue and market share

    Chapter 4, 5 and 6: Global Axillary Crutches Market by Type, Application and Player/Supplier Profiles (2013-2021)
    • Armpit Crutches Market Share by Type and Application
    • Growth rate of Underarm Crutches by type and application
    • Factors and opportunities of axillary crutches
    • Basic information about axillary crutches company

    Continue……………

    Note: Please share your budget by call/mail. We will try to meet your needs. @ Call: +1 (925) 478-7203 / E-mail: [email protected]
    Find more research reports on Axillary crutches industry. By JC Market Research.

    Thank you for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

    About the Author:

    JCMR’s global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities, but also to empower and inspire you to create visionary growth strategies for the future, through our extraordinary depth and breadth of thought leadership, research, tools, events and experience. that help you turn your goals into reality. Our understanding of the interplay between industry convergence, megatrends, technologies and market trends provides our clients with new business models and opportunities for expansion. We are focused on identifying the “Accurate Forecast” in each industry we cover so that our clients can reap the benefits of being early market entrants and can achieve their “Goals and Objectives”.

    Contact us: https://jcmarketresearch.com/contact us

    JCMARKETRESEARCH

    Mark Baxter (Business Development Manager)

    Call: +1 (925) 478-7203

    E-mail: [email protected]

    Connect with us at – LinkedIn

    read more
    Medical supplies

    An ambulance and medical supplies headed from the capital region to the epicenter of last year’s deadly earthquake in Haiti – The Daily Gazette

    Ballston Spa and Schenectady Rotarians, along with Saratoga County officials, recently joined forces to ship a used ambulance and medical supplies to one of the world’s least developed countries.

    Thanks to two local Rotarians, a surplus ambulance belonging to the Community Emergency Corps. from Ballston Spa is en route to Port-au-Prince, the capital of Haiti, with its ultimate destination Les Cayes, a port city about an eight-hour drive southwest.

    Les Cayes was the chosen destination for the ambulance as it is the epicenter of a 7.2 magnitude earthquake which struck on August 14, killing more than 2,200 people, injuring nearly 13,000 and more of 300 missing, as well as property damage estimated at $1.5. billion.

    The non-profit organization Ballston Spa had to take the ambulance out of service because it had received a new one, Ray Otten, executive director of the Community Emergency Corps, said this week.

    The trade-in value for used ambulances is $3,000 to $5,000, basically peanuts for a vehicle that costs between $150,000 and $200,000 when bought new, said Otten, a Rotarian from Ballston. Spa.

    The director determined that donating it to the country in need would be the best course of action, and with proper maintenance, the ambulance could still have five to 10 years of life, he said.

    Otten said he had heard of responders in Haiti using pickup trucks and station wagons — anything they could get their hands on — to transport sick patients.

    Additionally, Otten said he hates waste.

    “So when you combine those values, we being EMTs, we tend to understand that we need to help where we can,” Otten said. “If we have something that maybe someone could use, why not? We have to take care of each other.”

    Otten contacted Brian Merriam, a Rotarian from Schenectady who drove the capital area ambulance about 1,800 miles to Miami last week.

    While this project was in motion, Merriam solicited donations from his own Rotary club and others in the area. The effort generated more than $8,000, which was transferred to the Rotary Club of Camp-Perrin in Les Cayes.

    Merriam also carried 500 pounds of medical equipment — items such as backboards, stethoscopes, leg splints, EMS bags and even three CPR training dummies — that Saratoga County officials donated.

    Merriam cited Mike McEvoy of the Saratoga County Office of Emergency Services, Lori Prock of Saratoga County Public Health Services and Tracy Weir and the Waterford Rescue Squad for providing the medical equipment.

    In addition, Ellis Hospital donated a used ultrasound machine along with a stand and operating software, Merriam said.

    Medical equipment had to be shipped separately, rather than inside the ambulance, due to freight company rules.

    This posed a problem for boxing nine 6-foot panels, Merriam said. Luckily, a local funeral director had cremation “caskets” to hold the panels in place.

    Merriam said he traveled to Florida because he didn’t want to incur the cost of renting a flat bed. The cost of diesel was $3.80 to $4.19 a gallon, and on their best day of travel they got 15 miles per gallon.

    Otten said he was pleased to hear the ambulance had no mechanical problems en route to Miami.

    “These rigs don’t usually take those long runs,” he said.

    Merriam’s travel companion was his friend Chris Hedlund, a former EMT from Eau Claire, Wisconsin.

    This is the second time Merriam and Hedlund have driven and shipped a used ambulance to Carrefour, Haiti.

    In 2019, they drove a used ambulance that Hedlund helped secure from Mohawk Ambulance and the Mayo Clinic Ambulance Service. They drove 1,100 miles from Wisconsin to Schenectady, held a press conference in Electric Town, then drove 600 miles to Baltimore to have the ambulance dispatched to Haiti.

    Prior to this effort, Merriam said he mentioned to Hedlund to keep an eye out for ambulances, due to the huge need in Carrefour, Haiti.

    Merriam said his friend, Dr Dorgu Pettit-homme president of the Rotary Club of Camp-Perrin in Lecayes, will receive the ambulance which has been donated by the Ballston Spa organization.

    Although there is a fear that the ambulance will be stolen by gang communities in Port-au-Prince, Dr. Pettit-homme, who runs a Haitian clinic, and the others are hopeful that it will reach its destination, being given that it will be used to help a lot, Merriam said.

    Merriam, whose 126-year-old former family insurance company in Schenectady, Merriam Agency, was acquired last year by Arthur J. Gallagher & Co., says he wants to keep helping Haitians .

    “It’s really hard to appreciate how needy a country can be unless you’ve been there – and I’ve been going there since 1999,” he said. “I just fell in love with the place. The average Haitian earns $1,900 a year – so just a few dollars a day, if you’re doing well.

    Due to its corruption, violence, and gang activity—along with an average Haitian living to be 62 and an infant mortality rate 14 times higher than in the United States—Haiti is “a terrible place to live”, and Merriam said “anytime I can do anything for these people, I’m always happy to do it.

    Merriam said he would also like to help Carrefour with its garbage crisis.

    He said the town mayor asked him to dispatch a garbage truck.

    But it will be a challenge, Merriam said.

    “The garbage problem in Haiti is just amazing to see,” he said. “When you drive from the airport, you pass rivers filled with garbage. You can’t go in the water. It’s just wall-to-wall trash. And there are piles of garbage. Some of the piles will be set on fire. Others, you will have pigs digging and you will have humans digging.

    Merriam said he came to recognize the huge need in other parts of the world at the age of 15, when his father took him on trips to 24 countries covering most major continents in three month.

    “So when each of my three children turned 15, I brought them to Haiti with me so they could see how many people actually live in the world,” he said. “It’s only a four hour flight from JFK airport. It’s only a 90 minute flight from Miami. It is therefore a neighboring country to ours and the people live in terrible conditions.

    Contact journalist Brian Lee at [email protected] or 518-419-9766.

    More from The Daily Gazette:

    Categories: News, Saratoga County, Schenectady County

    read more
    Prescription drugs

    D’Augusta – Ensuring Access to Prescription Medicines and Protecting Mainers

    In our community, I know many of us are concerned about the cost of health insurance and the availability of life-enhancing or life-saving drugs. This year alone, pharmaceutical companies have raised the wholesale and retail prices of 450 drugs. When it comes to drug availability, recent surveys have found doctors and physicians struggling with cumbersome prior authorization protocols that slow or restrict their ability to prescribe drugs to their patients.

    Anne Carney

    Fortunately, two of my colleagues — Sen. Heather Sanborn (D-Portland) and Rep. Amy Roeder (D-Bangor) — have introduced bills to help protect Mainers from an unfair practice that some insurance companies use and to ensure that patients can obtain their prescription drugs.

    Sanborn’s bill would protect Mainers from double billing. For those who don’t know, double billing occurs when a patient’s insurance company uses a “co-pay accumulator program” that – usually unknown to the patient – prevents manufacturer assistance coupons to co-pay to count for both the patient’s deductible and the maximum out-of-pocket expense. Unfortunately, the patient ends up paying more for the prescription drug, even though he needed financial assistance to pay for it in the first place. Patients can suffer financial hardship, especially when they need expensive drugs.

    For example, a patient can take a pre-exposure prophylaxis (PreP) to prevent HIV named Descovy, which retails for $2,165.79. The drugmaker, Gilead, has a co-pay (voucher) assistance program that helps patients pay for their medications. However, if the patient’s insurance company uses a copayment accumulation program, the patient’s discounted copayment does not count toward the patient’s annual out-of-pocket maximums. Eventually, the patient will end up paying their entire deductible. Sanborn’s bill, LD 1783, would prevent double billing, which would protect Mainers from financial hardship and ruin when they need expensive prescription drugs.

    My colleagues and I are working in other ways to ensure patients can access their prescription medications. Roeder’s bill, LD 1776, would allow pharmacists to dispense emergency supplies of medication to a patient when a prescription authorization is not available. As long as the pharmacist has a record of a previous prescription, he can dispense medication to the patient.

    The bill would require insurance companies to cover emergency drug supplies. The bill would also give patients with chronic conditions, such as asthma, diabetes or heart disease, the peace of mind of being able to access their medications in an emergency.

    On these issues, and more, my colleagues and I remain committed to helping Mainers live happy, healthy, and full lives. I know there is still a lot of work to be done to make health care affordable for everyone, but I also know that these two bills will ease the financial strain caused by high health care costs and uncertain access to medicines. on prescription.

    If you have questions about healthcare and medications, please contact Consumers for Affordable Healthcare. Its consumer help line is 1-800-965-7476. If you ever need further assistance or would like to share your comments and thoughts with me, please contact me.

    Anne Carney represents Senate District 29: Cape Elizabeth, South Portland and part of Scarborough. She can be reached at [email protected] or 207-287-1515.

    ” Previous

    read more
    Medical products

    Tetra Bio-Pharma partners with Avicanna to bring medical cannabinoid products to LATAM

    Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) is teaming up with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to bring Tetra’s products to Latin America.

    On Monday, the Ottawa-based cannabinoid drug developer revealed a non-binding terms sheet with Avicanna consisting of three strategic areas.

    The first involves the registration and marketing of Tetra’s prescription cannabinoid products through Avicanna’s sales channels in Latin America. The second provides co-development and support for Avicanna’s pharmaceutical pipeline through level clinical development and registration with Canadian regulatory authorities.

    The partnership also involves a supply of active pharmaceutical ingredients (APIs) from Avicanna for Tetra’s pharmaceutical pipeline.

    In a statement, Tetra’s chief commercial officer, Steeve Neron, said his company will need multiple reliable API vendors to support operations related to its painkiller QIXLEEF, which has a fixed ratio of THC and CBD that complies with regulations. cGMP from the United States.

    “QIXLEEF is Tetra’s proprietary investigational new drug and is currently being evaluated in two US FDA-cleared clinical trials,” says Neron.

    Avicanna’s established distribution channels in Latin America could help advance the commercialization of Tetra’s products in certain jurisdictions, he adds.

    Other Tetra products slated for commercialization include anti-nausea, cannabinoid drug REDUVO, bio-delivery technology AdVersa and painkiller CAUMZ.

    Read more: Avicanna Reports Record Sales of $1 Million

    Read more: Avicanna subsidiary obtains GACP certification in Colombia

    Avicanna CEO Aras Azadian said Tetra has proven to be a pioneer in cannabinoid-based pharmaceuticals.

    “As the global industry continues to mature and focus on evidence-based medicines, the two companies are well positioned to work synergistically on multiple projects and leverage their leadership position to achieve successful business outcomes. “

    Under the Aureus brand, Avicanna sells raw materials in 12 countries and offers seeds, flowers, full-spectrum extracts and other isolated cannabinoids like CBD.

    The products come from its majority-owned Colombian subsidiary Santa Marta Golden Hemp SAS, which is GACP-certified and has USDA National Organic Program certification for its hemp cultivar.

    The company also has patent-pending drug candidates that are in various stages of clinical development and commercialization.

    Its RHO Phyto brand includes medical and wellness products with different ratios of CBD and THC in different forms such as creams, pills and transdermal patches.

    Follow Mugglehead on Twitter

    Like Mugglehead on Facebook

    Follow Natalia Buendia Calvillo on Twitter

    [email protected]

    read more
    Medical supplies

    Essential Medical Supplies Hospitals Should Always Have — Hometown Station | KHTS FM 98.1 & AM 1220 — Santa Clarita Radio

    These are the supplies that help keep patients healthy and comfortable while they visit, undergo treatment or recover. It is important that hospitals are prepared with enough of these materials, so they never run out in the middle of a crisis or emergency! Supplies such as bandages, gauze, gloves, sterile needles, syringes, etc. are essential for hospital staff to handle all kinds of situations.

    Supplies for patients with respiratory problems

    Hospitalized patients will undergo many procedures, some of which may require anesthetic gases such as nitrous oxide. To get this gas to patients who need it, hospitals need to have nasal prongs and masks on hand at all times. These are used to ensure that these patients are breathing properly while under anesthesia or sedation. Without these respiratory care supplies, hospitals would not be able to efficiently supply anesthetic gases. Hospitals performing surgery need to ensure they have the right tools on hand for every circumstance.

    Supplies used to deliver

    Many women choose to give birth in the hospital because it is the safest place to give birth. Although some may think that this type of facility is simply one where medicines or drugs are administered to mothers in labor, hospitals play an even more important role during childbirth by delivering babies! Keeping medical gloves and scissors on hand ensures professionals can handle any emergency as it arises. Other medical equipment during childbirth includes forceps, scissors, and cord clamps. New mothers will also need wipes, blankets and clothes to keep their newborns warm.

    Bone fracture supplies

    Hospitals are the place of choice for people who have suffered bone fractures. Indeed, they can provide these patients with casts, splints and slings to ensure proper healing. Without these essential medical supplies, hospitals would not be able to provide the comfort patients need when recovering from a fracture. These items help keep affected areas secure, so bones heal faster without shifting or shifting too much during recovery. Additionally, hospitals should ensure they have other essential supplies like thermometers and tongue depressors for injuries that do not require casting.

    Supplies to ensure patient comfort

    When patients are recovering or undergoing tests and examinations, it is important that they are as comfortable as possible at all times. Although morphine can also help with this, hospitals should keep syringes and other essential medical supplies on hand to administer this drug. These tools help control pain and anxiety, which can help patients feel more relaxed throughout their hospital stay. This also includes blankets and small pillows for those who need to rest after a long day of getting stuffed and pushed.

    Surgical supplies

    Hospitals need to ensure they always have sharp surgical instruments like needles and scalpels readily available, so doctors can keep working while treating patients. Other supplies like sponges, surgical tape, and protective aprons are also important as they help keep everyone safe during the operation. Some of the most vital medical supplies used by hospitals relate to surgery. This line of work is very involved and requires certain instruments and tools to ensure that each procedure runs smoothly. Hospital staff will have to manage everything, from sterilizing equipment to repairing fractures. Without these surgical devices, such as forceps and suction cups, many patients would not receive proper treatment or care during procedures. Surgical supplies are essential for doctors, nurses, and surgeons treating patients with traumatic injuries or life-threatening illnesses at various stages of recovery.

    Necessary medical machines

    To function, hospitals need medical equipment that provides essential services. X-ray machines are great examples of these types of devices, as they allow doctors to see inside the patient’s body without having to perform surgery. ultrasound and heart monitors also help staff diagnose internal organ problems quickly and efficiently, so procedures can begin immediately. To get a better idea of ​​what medical supplies to keep on hand at all times, you can visit a medical supply warehouse or stock company. They will have an inventory of items available for immediate purchase, so hospitals can get what they need right away.

    Scalpels, sponges and gloves are just some of the supplies that hospitals should always have on hand. When patients arrive at the facility, they want to be sure that the medical staff knows how to handle any situation that arises. From bone fractures to pregnant women in labor, all kinds of emergencies require different types of equipment and devices. Hospitals can’t care for patients if they don’t have the proper tools and supplies in stock at all times!

    Do you have any current advice? Call us at (661) 298-1220 or email [email protected] Don’t miss a thing. Get the latest KHTS Santa Clarita News alerts straight to your inbox. Report a typo or error, email [email protected]

    KHTS FM 98.1 and AM 1220 is Santa Clarita’s only local radio station. KHTS mixes a combination of news, traffic, sports and features with your favorite adult contemporary hits. Santa Clarita News and Features are broadcast throughout the day on our airwaves, on our website and on various social media platforms. Our KHTS award-winning daily newsletters are now read daily by over 34,000 residents. A vibrant member of the Santa Clarita community, the KHTS broadcast signal reaches the entire Santa Clarita Valley and parts of the high desert communities located in Antelope Valley. The station broadcasts its talk shows on the web, reaching potentially global audiences. Follow @KHTSRadio on Facebook, Twitterand instagram.

    KHTS FM 98.1 & AM 1220 - Santa Clarita News - Radio Santa Clarita

    read more
    Prescription drugs

    Missouri lawmaker admits illegally selling prescription drugs, says it wasn’t intentional • Missouri Independent

    Missouri lawmaker facing 23-count federal indictment for allegedly sold bogus stem cell treatments and fraudulently used federal pandemic relief funds settled with the state health department, which resulted in a three-year probation of her narcotics license while admitting to illegally purchasing and prescribing pharmaceutical drugs.

    The bylaw, signed Jan. 28 with the Missouri Department of Health and Senior Services’ Bureau of Narcotics and Hazardous Drugs, acknowledges that state Rep. Patricia Derges, R-Nixa, violated laws Federal and State Controlled Substances.

    It also includes details of Derges illegally prescribing oxycodone, an opioid and amphetamines and illegally purchasing and stockpiling tramadol, an opioid used for pain management, at his clinics in Ozark Valley, Southwest. from Missouri.

    The settlement was obtained by the Documenting the COVID-19 project through a Sunshine Law request, in an ongoing collaboration with The Missouri Independent. (The full settlement agreement can be found here.)

    The settlement does not address some of the other charges Derges faces, including administering amniotic fluid, which she said contained stem cells, as a treatment for erectile dysfunction, Lyme disease and incontinence. urinary, among other ailments.

    Although he admitted breaking the law, Derges’ attorney, Albert Watkins of Kodner Watkins in St. Louis, said the drug purchases and prescriptions “are not criminal” because Derges had no intended to break a law of which she had little or no understanding. .

    Derges is still fighting the case against criminal charges in US District Court and she has repeatedly maintained her innocence in public and on social media. A jury trial has been set for June.

    “The settlement is the proper action, not a criminal prosecution that requires intent,” Watkins said. “[The prosecution] makes no sense, it’s wrong, it’s inappropriate and it’s a heinous waste of taxpayers’ money.

    derges said state health department investigators that controlled substance laws were not taught at her medical school and that she could not find a place in a medical residency program. Derges is a Licensed Physician Assistant, which is a mid-level practitioner under a board-certified physician, and she received her medical training at Caribbean Medical University in the Netherlands Antilles.

    The agreement notes that Derges began “practicing with controlled substances and learned as he went. The violations revealed were unintentional and were because she didn’t know. Once she learned of the violations, she took prompt corrective action.

    She also failed to document and record the prescriptions and did not keep receipts or transfer records, the settlement says.

    Derges, who was elected to represent Christian County for a two-year term in November 2020, did not directly respond to requests for comment.

    Shortly after the charges against her were announced a year ago, Derges was called to resign by House GOP leadership, expelled from the Republican caucus and stripped of his committee positions. During her first legislative session, she introduced 10 bills, four of which deal with medical licensing in a way that could allow her to convert her license from physician assistant to physician.

    Refusing to resign she was relegated to a tiny windowless room reserved for defrocked lawmakers.

    A spokesman for House Speaker Rob Vescovo, R-Arnold, noted that the speaker has asked Derges to step down and has not changed his position on the matter.

    Derges still has no intention of resigning from his elected position, his lawyer said.

    Jason Hancock of The Independent contributed to this story.

    The Documenting COVID-19 Project, supported by Columbia University’s Brown Institute for Media Innovation and MuckRock, collects and shares government documents related to the COVID-19 pandemic and works on investigative journalism projects with partner newsrooms.

    read more
    Generic drugs

    Bridion’s Generic Drugs Get Mass Approval in Korea


    Korean pharmaceutical companies recently obtained generic marketing authorization for Bridion (sugammadex) from MSD, a muscle relaxant antagonist.


    As the original drug’s patent expires in April, local drugmakers are expected to engage in fierce competition to sell generic copies, observers said.


    Bridion Inj. from MSD Korea. is an agent that reverses neuromuscular blockade induced by general anesthetics during surgery.


    The Ministry of Food and Drug Safety said on Friday that JW Pharmaceutical, GC Pharma and Daewoong Pharmaceutical had received Bridion’s generic drug license.


    Bridion arrived in Korea in February 2013. During surgery, the injection is used to reverse neuromuscular blockade induced by the general anesthetics Rocuronium Bromide or Vecuronium Bromide.


    The government has approved Bridion’s generic drugs since December 29, when Hanlim Pharm won the first license.


    Nineteen Bridion generics have won local approval, and half of them are expected to be manufactured at Huons’ third plant in Jecheon, North Chungcheong Province.


    Industry watchers said the generic Bridion market will heat up in April.


    Bridion’s patent, registered in Korea, is titled “6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block”. It expires on April 12, 2022.


    Korean drugmakers tried unsuccessfully to revoke Bridion’s patent.


    CTC Bio sued to invalidate the patent, and Intro Bio Pharma, Hana Pharm, Huons Global, and Chong Kun Dang also sued to invalidate the patent extension, but the court dismissed them all.


    No local company has succeeded in invalidating Bridion’s patent, which means that no company has obtained the exclusive right to sell a generic drug for a certain period.


    A company that quickly secures the generic drug market with patent expiration should have an advantage. Thus, observers said that market competition among Korean pharmaceutical companies will become severe.

    read more
    Generic drugs

    Bureau of Generic Medicines 2021 Annual Report

    Message from the director

    Welcome to the seventh annual report of the Office of Generic Drugs (OGD) of the Center for Drug Evaluation and Research (CDER) of the United States Food and Drug Administration (FDA).

    Ensuring that patients who need safe and effective drugs have better access to them is a public health priority for the FDA. As you will read in this report, the priority of access to more affordable medicines goes hand in hand with OGD’s mission to ensure that affordable, high-quality generic medicines are available to the American public. In this report, I am pleased to share with you a snapshot of our successes.

    Currently, 90% (9 out of 10) of all prescriptions dispensed in the United States are for generic drugs. To make this possible, the Generic Drug Program approves safe, effective, high-quality drugs and monitors these drugs once they hit the market.

    How did we do in 2021?

    Last year, the Generic Drug Program approved hundreds of abbreviated new drug applications (ANDAs) and thousands of application supplements. Our office has prioritized the evaluation of generic drug submissions for potential treatments and supportive therapies for patients with COVID-19, approving more than 75 original ANDAs, some in record time,1 and since the start of the pandemic, more than 1,200 supplements. We have funded approximately $20 million in science and generic drug research programs. We published 149 product-specific guidelines for generic drug development, including 54 for more difficult-to-develop complex drugs, to support agency thinking on the most appropriate methodology and evidence needed to support development specific generic drugs.

    Innovation has helped ensure public access to more affordable medicines

    In 2021, OGD’s scientific and programmatic innovations supported our generic drug evaluation work. For example, we have established the scientific basis to support alternative bioequivalence (BE) approaches for several generic drugs. One such example included a novel in vitro BE approach that directly led to the development, evaluation and approval of the first generic difluprednate (Generic Durezol) ophthalmic emulsion used to treat ocular swelling and pain after eye surgery.

    Another innovation came with the approval this year of the first generic paliperidone palmitate extended-release injectable suspension (Generic Invega Sustenna), a long-acting injectable indicated for the acute and maintenance treatment of schizophrenia in ‘adult. The FDA has developed modeling and simulation approaches for pharmacokinetic study designs and BE assessments, which the applicant has used. In yet another example, we approved the first generic complex for injection of ferumoxytol (generic Feraheme), a parenteral (non-oral) iron product that treats iron deficiency anemia. Our scientific investment in product characterization and advanced BE study designs were key to this approval. Another programmatic innovation successfully deployed was increasing the frequency of certain updates from monthly to bi-monthly in the FDA’s electronic Orange Book. This change in the frequency of updates provides even more timely information on listed pharmaceutical products, including their market status.

    Scientific and regulatory collaboration has moved the needle

    Sally Choe, Ph.D. Director, Bureau of Generic Drugs

    Scientific and regulatory collaborations have helped us create new approaches to support generic drug review in 2021.

    FDA’s partnership with the University of Maryland and the University of Michigan (the Complex Generics Research Center) has reached thousands of stakeholders around the world with workshops that have stimulated innovative dialogue and generated new insights into science and research crucial to the development of complex generic drugs.

    Additionally, the continued implementation of the Competitive Generic Therapy (CGT) pathway established by Congress helped us reach an important milestone in 2021: approving 100 ANDAs designated as CGTs. The CGT pathway for generic drugs helps incentivize market entry of drugs with ‘inadequate generic competition’. This milestone is a sign that the CGT program is achieving its goal – the development and marketing of safe and effective generic drugs in areas of the market that previously had little or no competition.

    Globally, 2021 marked the launch of a joint FDA and European Medicines Agency pilot program to provide parallel scientific advice to developers of complex generic drugs. The pilot project allows reviewers from both agencies to simultaneously communicate their views on scientific issues, in real time, to manufacturers working on the development of complex generic drugs. This collaboration can help shorten the time it takes for these important products to gain regulatory approval. The FDA also launched the Global Generic Drug Cluster, the first forum created for major regulatory agencies to increase scientific alignment around topics relevant to generic drug development.

    In 2021, despite the unique challenges caused by the ongoing pandemic, OGD continued to innovate and conduct scientific research to advance the generic drug agenda. Today, the generic drug program is stronger than ever and continues to take timely steps to improve access to generic drugs. As always, this is good news for the American public.

    Sally Choe, Ph.D.
    Director, Bureau of Generic Drugs

    read more
    Medical products

    Proctology Table Market Size and Forecast by 2029

    New Jersey, United States,-The latest report published by Market Research Intellect presents an in-depth analysis of the global Proctology Table Market. This research report assesses ever-changing market dynamics that are expected to affect the trajectory of the overall market. Analysts have studied historical market performance and compared it to current market trends, charting the trajectory. For a detailed discussion of the global proctology table market, analysts have segmented the market on the basis of applications, products, and end users. The research reports have been collated using primary as well as secondary research methodologies to provide readers with a precise understanding of the ongoing development of the Proctology Table market.

    Analysts used Porter’s Five Forces Analysis, Study Worm Analysis, and Pestle Analysis to determine the path major vendors should follow in the coming years. The research report also includes the evaluation of these vendors’ financial outlook, proctology table market growth strategy and expansion plan during the forecast period. All information presented in the Global Proctology Table Market research report has been certified by market experts.

    Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=308775

    The report includes a detailed segmentation study of the global Proctology Table market, in which all the segments are analyzed in terms of market growth, share, growth rate, and other significant factors. It also provides the segment Attractiveness Index, allowing players to inform about profitable revenue pockets in the Global Proctology Table Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus in the right areas of the global Proctology Table Market.

    Major Players Covered in Proctology Table Markets:

    • AR-EL MEDICAL PRODUCTS
    • promotional
    • INDUSTRIAL ECHOME
    • SCHMITZ and. Sohne
    • B?Çakc?lar
    • NQR
    • Wardray premise

    Proctology Table Market Split By Type:

    • Adjustable Proctology Table
    • Non-Adjustable Proctology Table

    Proctology Table Market Split By Application:

    • Hospital
    • Clinical
    • Ambulatory surgery centers

    The Proctology Table Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the global Proctology Tables market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a comprehensive picture of the global Proctology Tables market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=308775

    Scope of the Proctology Tables Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Reference year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    The Regional Proctological Table Market Analysis can be represented as follows:

    Each regional sector of the Proctological Table is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    On the basis of geography, the global Proctology Table market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-proctologic-table-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. clients, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US Toll Free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Prescription drugs

    Hundreds of prescription drug pills, including pregabalin, seized by police

    A huge amount of prescription drugs have been removed from the streets of Manchester.

    Hundreds of tablets were found by police on Harris Street in the downtown Strangeways area.

    The seizure off Bury New Road in Cheetham Hill included boxes marked with pregabalin – a prescription drug used to treat nerve pain and anxiety.

    It has been linked to a growing number of deaths in England and Wales – and the Manchester Evening News previously reported that tablets were widely sold on city streets, with the area around Bury New Road and Strangeways on the outskirts of Manchester city center being a hotspot.

    There are concerns that pregabalin is increasingly being used among the homeless and drug addicts in the inner city.

    Police said the seizure was part of a dedicated operation – codenamed ‘Cranium’ – to tackle the street sale of prescription drugs only in north Manchester.

    Greater Manchester Police shared an image which they said showed only part of the drugs found.

    Boxes labeled flucloxacillin, an antibiotic, and zopiclone, a type of sleeping pill, were also revealed, along with blister packs of nitrazepam.



    The seizure took place in Bury New Road

    No arrests were referenced by force.

    In a Facebook post, GMP Manchester North said: “While proactively patrolling this weekend a large amount of controlled drugs were found on Harris Street in the Strangeways area of ​​Manchester.

    “Officers from the local Neighborhood Team carry out regular patrols as part of Operation Cranium – a dedicated investigation into the illicit supply of prescription drugs only in areas of North Manchester.

    “The photo is just a few of these found tablets.

    “If you are the owner of these, please contact us, we could have a chat.”

    Last year pregabalin was linked to 344 deaths in England and Wales – 60 in the North West alone.

    No other details were revealed.

    Sign up for MEN’s email newsletters to get the latest on sports, news, current affairs and more by following this link

    read more
    Medical supplies

    In-depth research of the global latex-free medical supplies market, industry statistics 2022

    the Latex-Free Medical Supplies Market The report covers the entire global market scenario including key players, their future campaigns, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. Its objective is to rationalize the company’s costs. You can also find interest and expense points on current income here. The best thing about the Latex-Free Medical Supplies market report is the provision of guidelines and strategies followed by leading market players. The investment opportunities in the market that are highlighted here will go a long way in moving the business forward. Knowing the current market situation is the most important thing discussed here to help major players survive in the deadly market.

    This Latex-Free Medical Supplies Market study describes the economic disaster caused by the covid-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to various industrial closures and loss of income. A high degree of information is offered here to assess the market situation.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://reportsglobe.com/download-sample/?rid=131898

    The authors of the report draw up an encyclopedic assessment of the most important regional markets and their evolution in recent years. Readers are provided with accurate facts and figures about the Latex-Free Medical Supplies market and its important factors such as consumption, production, revenue growth, and CAGR. The report also shares gross margin, market share, attractiveness index, and value and volume growth for all segments studied by analysts. It highlights key developments, product portfolio, markets served and other areas depicting business growth of major companies profiled in the report.

    The report has been prepared using the latest primary and secondary research methods and tools. Our analysts rely on government documents, white papers, press releases, reliable investor information, financial and quarterly reports, and public and private interviews to gather data and information about the market in which they operate.

    Key Players Covered in Latex-Free Medical Supplies Market are:

  • Unigloves
  • Davis Schottlander and Davis
  • Hair salon
  • Ansel
  • Aurelia gloves
  • BM Polyco
  • Medline Industries
  • Robinson Healthcare
  • Paul Hartman
  • HPC Healthline
  • Biological examination
  • shermond
  • Ambu
  • Cardinal Health Inc.
  • Fannin
  • Alliance Rubber Co.

    Latex-Free Medical Supplies Market Split By Type:

  • Latex-free tourniquets
  • Latex-free glove
  • Latex-free breathing bag

    Latex-Free Medical Supplies Market Split By Application:

  • Hospital
  • Clinical
  • Other

    The Latex-Free Medical Supplies Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is rated based on CAGR, participation, and growth potential. In the regional analysis, the report highlights the potential region, which is expected to generate opportunities in the global Keyword Market in the coming years. This segment analysis is sure to prove to be a useful tool for readers, stakeholders, and market players to get a complete picture of the global Keyword Market and its growth potential in the coming years.

    Get | Discount on the purchase of this report @ https://reportsglobe.com/ask-for-discount/?rid=131898

    Scope of the Latex-Free Medical Supplies Market Report

    ATTRIBUTES

    The description

    ESTIMATED YEAR

    2022

    YEAR OF REFERENCE

    2021

    FORECAST YEAR

    2022 to 2028

    HISTORICAL YEAR

    2020

    SECTORS COVERED

    Types, applications, end users, and more.

    REPORT COVER

    Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends

    BY REGION

    North America, Europe, Asia-Pacific, Latin America, Middle East and Africa

    Geographic segment covered in the report:

    The Latex-Free Medical Supplies report provides information on the market area, which is divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate for each region, country and sub-region over the estimated period.

    • North America includes the United States, Canada and Mexico
    • Europe includes Germany, France, UK, Italy, Spain
    • South America includes Colombia, Argentina, Nigeria and Chile
    • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    Goals and Objectives of Latex-Free Medical Supplies Market Research

    • To understand the Latex-Free Medical Supplies opportunities and advancements determines the market highlights, along with the key regions and countries involved in the market growth.
    • Study the various segments of the Latex-Free Medical Supplies market and the dynamics of Latex-Free Medical Supplies in the market.
    • Categorize the latex-free medical supplies segments with growing growth potential and assess the market for the futuristic segment.
    • To analyze the most important trends related to the various segments which help decipher and convince the Latex-Free Medical Supplies market.
    • Check region-specific growth and development in the Latex-Free Medical Supplies Market.
    • Understand the major stakeholders in the Latex-Free Medical Supplies market and the competitive image value of the Latex-Free Medical Supplies market leaders.
    • To study the key plans, initiatives, and strategies for the development of the Latex-Free Medical Supplies Market.

    The study thoroughly examines the profiles of major market players and their key financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers KEYWORD production, revenue, market share and growth rate for each key company and covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Historical breakdown data for latex-free medical supplies from 2016 to 2021 and forecast for 2022-2028.

    Ask questions about personalization at @ https://reportsglobe.com/need-customization/?rid=131898

    Some highlights from the table of contents:

    1 Presentation of the report

    2 Market Trends and Competitive Landscape

    3 Latex-Free Medical Supplies Market Segmentation by Types

    4 Latex-Free Medical Supplies Market Segmentation by End Users

    5 Market Analysis by Major Regions

    6 Product Commodity Latex-Free Medical Supplies Market by Major Countries

    7 North America Latex-Free Medical Supplies Landscape Analysis

    8 Europe Latex-Free Medical Supplies Landscape Analysis

    9 Asia Pacific Latex-Free Medical Supplies Landscape Analysis

    10 Latin America, Middle East and Africa Latex-Free Medical Supplies Landscape Analysis

    11 Profile of Key Players

    How Reports Globe is different from other market research providers:

    The creation of Reports Globe has been underpinned by providing clients with a holistic view of market conditions and future possibilities/opportunities to derive maximum benefit from their business and assist in decision making. Our team of in-house analysts and consultants work tirelessly to understand your needs and provide the best possible solutions to meet your research needs.

    Our team at Reports Globe follows a rigorous data validation process, which allows us to publish publisher reports with minimal or no deviation. Reports Globe collects, separates and publishes over 500 reports each year covering products and services in many areas.

    Contact us:

    Mr. Mark Williams

    Account manager

    WE: +1-970-672-0390

    E-mail: [email protected]

    Website: Reportsglobe.com

  • read more
    Prescription drugs

    Prescription Animal Drugs Market Size and Forecast by 2029 – Sox Sphere

    New Jersey, United States,-The latest report published by Market Research Intellect presents an in-depth analysis of the global animal prescription drug market. This research report assesses ever-changing market dynamics that are expected to affect the trajectory of the overall market. Analysts have studied historical market performance and compared it to current market trends, charting the trajectory. For a detailed discussion of the global animal prescription drugs market, analysts have segmented the market on the basis of applications, products, and end users. The research reports have been collated using primary as well as secondary research methodologies to provide readers with a precise understanding of the ongoing development of the Animal Prescription Drugs market.

    Analysts used Porter’s Five Forces Analysis, Study Worm Analysis, and Pestle Analysis to determine the path major vendors should follow in the coming years. The research report also includes the assessment of these vendors’ financial prospects, Pet Prescription Drugs market growth strategy and expansion plan during the forecast period. All information presented in the Global Animal Prescription Drugs Market research report has been certified by market experts.

    Get | Download Sample Copy with TOC, Charts and List of Figures @ https://www.marketresearchintellect.com/download-sample/?rid=228630

    The report includes a detailed segmentation study of the global Animal Prescription Drugs market, in which all the segments are analyzed in terms of market growth, share, growth rate and other important factors. It also provides the attractiveness index of the segment, allowing players to inform about the profitable revenue pockets of the global Animal Prescription Drugs Market. A broad assessment of the segments provided in the report enables investments, strategy, and teams to focus on the right areas of the global Animal Prescription Drugs Market.

    Major Players Covered in Animal Prescription Drugs Market:

    • Elanco Animal Health
    • Ceva Animal Health
    • MSD Animal Health
    • Zoetis
    • Virbac
    • Dechra
    • Vetoquinol
    • animal group
    • Ourofino Sauce Animal
    • Boehringer Ingelheim

    Animal Prescription Drugs Market Split By Type:

    • oral-type
    • Smear type
    • Type of injection
    • Type of spray

    Animal Prescription Drugs Market Split By Application:

    • Pet
    • Livestock

    The Animal Prescription Drugs Market report has been segregated into distinct categories such as product type, application, end-user, and region. Each segment is valued based on CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is expected to generate opportunities in the Global Animal Prescription Drugs Market in the coming years. This segmental analysis will surely prove to be a helpful tool for readers, stakeholders, and market players to get a complete picture of the global Animal Prescription Drugs market and its growth potential in the coming years. .

    Get | Discount on the purchase of this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=228630

    Scope of the Animal Prescription Drugs Market Report

    Report attribute Details
    Market size available for years 2021 – 2028
    Base year considered 2021
    Historical data 2015 – 2019
    Forecast period 2021 – 2028
    Quantitative units Revenue in USD Million and CAGR from 2021 to 2027
    Segments Covered Types, applications, end users, and more.
    Report cover Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    Scope of customization Free report customization (equivalent to up to 8 analyst business days) with purchase. Added or changed country, region and segment scope.
    Pricing and purchase options Take advantage of personalized purchasing options to meet your exact research needs. Explore purchase options

    Regional Analysis of the Animal Prescription Drugs Market can be represented as follows:

    Each regional Veterinary Drugs industry is carefully researched to understand its current and future growth scenarios. This helps players strengthen their position. Use market research to get a better perspective and understanding of the market and target audience and ensure you stay ahead of the competition.

    Based on geography, the global animal prescription drug market has been segmented as follows:

      • North America includes the United States, Canada and Mexico
      • Europe includes Germany, France, UK, Italy, Spain
      • South America includes Colombia, Argentina, Nigeria and Chile
      • Asia Pacific includes Japan, China, Korea, India, Saudi Arabia and Southeast Asia

    For more information or query or customization before buying, visit @ https://www.marketresearchintellect.com/product/global-animal-prescription-drugs-market-size-and-forecast/

    About Us: Market Research Intellect

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations, in addition to the goal of providing customized and in-depth research studies. range of industries including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. etc Our research studies help our clients to make decisions based on higher data, to admit deep forecasts, to grossly capitalize with opportunities and to optimize efficiency by activating as their belt in crime to adopt a mention precise and essential without compromise. customers, we have provided expert behavior assertion research facilities to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

    Contact us:
    Mr. Edwyne Fernandes
    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    Website: –https://www.marketresearchintellect.com/

    read more
    Prescription drugs

    Teenagers target prescription drugs and cash in armed robbery at Sycamore Walgreens: Police – Shaw Local

    read more
    Medical products

    Global Nasal Splints Market Forecast 2029 | Network Medical Products, Summit Medical, Surgiform, Mentor – Sox Sphere

    A Global Market Study nasal splints market examines the performance of the nasal splints market in 2022. It contains an in-depth analysis of the nasal splints market status and competitive landscape globally. Global Nasal Splints Market can be obtained through market details such as growth drivers, latest developments, Nasal Splints Market business strategies, regional study and future market status. The report also covers information, including the latest opportunities and challenges in the nasal splints industry, as well as historical and future trends in the nasal splints market. It focuses on the market dynamics which are constantly changing due to technological advancements and socio-economic status.

    Recent market research on the Nasal Splints market analyzes the crucial factors of the Nasal Splints market based on the current industry situation, market demands, business strategies adopted by the Nasal Splints market players, and their growth scenario. This report isolates the Nasal Splints market based on key players, type, application, and region. First of all, the Nasal Splints Market report will offer in-depth knowledge of the company profile, its core products and specifications, revenue generated, production cost, who to contact. The report covers forecast and analysis of the Nasal Splints market on a global and regional level.

    Get a Free Copy of the Nasal Splints Market Report 2022: https://calibreresearch.com/report/global-nasal-splints-market-253116#request-sample

    COVID-19 impact analysis:

    In this report, the pre and post COVID impact on market growth and development is well described for better understanding of the Nasal Splints market on the basis of financial and industry analysis. The COVID-19 pandemic has affected a number of markets and the global nasal splints market is no exception. However, the dominant players in the global nasal splints market are determined to adopt new strategies and seek new funding resources to overcome the growing hurdles for market growth.

    Key Players Studied in the Nasal Splints Market Report:

    Networked medical products
    Medical Summit
    Surgical
    Mentor
    DTR Medical
    Boston Medical Product Inc.

    Product Types uploaded in the Nasal Splints Market are:

    Malleable nose splints
    Airway Nasal Splints
    Bivalve nasal splints

    The main applications of this report are:

    Plastic surgery
    rhinological operations
    ENT surgery

    Point COVERED DETAILS
    ESTIMATED YEAR 2022
    YEAR OF REFERENCE 2021
    FORECAST YEAR 2029
    HISTORICAL YEAR From 2017 to 2021
    VALUE (USD million/billion)
    SECTORS COVERED Competitors, types, applications, and more.
    REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    CUSTOMIZATION SCOPE The report can be customized to your needs when purchasing. Any additional requirements (regional breakdown of data, addition/removal of top players) will be incorporated into the final report.

    Nasal Splints report provides past, present and future Nasal Splints industry size, trends, and forecast information related to expected Nasal Splints revenue, growth, demand and supply scenario nasal splints. In addition, the opportunities and threats to the development of the Nasal Splints market forecast period from 2022 to 2029 are also covered extensively in this research document.

    Get a full report for better understanding : https://calibreresearch.com/report/global-nasal-splints-market-253116

    In addition, the Nasal Splints report gives insights into the company profile, market share, and contact information along with an analysis of the Nasal Splints industry value chain, industry rules and methodologies. Nasal Splints industry, circumstances driving market growth and restraints blocking growth. The scope of the nasal splints market development and various business strategies are also mentioned in this report.

    read more
    Medical supplies

    2021-2026 Disposable Medical Supplies Market Growth Trend Analysis





    In the latest research report on Disposable Medical Supplies Market, researchers and analysts have made optimum use of various multidisciplinary approaches to arrive at the mentioned conclusion and forecast. It offers an in-depth analysis of key opportunities over the forecast years, while simultaneously preparing stakeholders to deal effectively with the threats and challenges of this business domain. Additionally, the authors rigorously assessed the current global Covid-19 crisis for a stronger realization of revenue prospects in the coming years.

    Main indicators of the Covid-19 impact assessment:

    • Impact of the Covid-19 pandemic on the global economy.
    • Evolution of supply and demand.
    • Short-term and projected outlook of the Covid-19 pandemic on market compensation.

    Request a sample copy of this report @ https://www.getnewsalert.com/request-sample/19505

    An overview of the regional analysis:

    • North America, Europe, Asia-Pacific, South America, Middle East & Africa, Southeast Asia are the major regional contributors of the disposable medical supplies market.
    • The study assesses the region’s contribution to the overall growth of the industry.
    • The total sales, net revenue and projected growth rate of each geographic area are listed.

    Other Vital Points of the Disposable Medical Supplies Market Report:

    • The report fragments the Disposable Medical Supplies market product terrain into Infusion and Hypodermic Products, Diagnostic Supplies, Dialysis Consumables, Radiology Consumables, Intubation and Ventilation Supplies, Sterilization Consumables, Nonwoven Medical Supplies, Consumables wound care and more.
    • Revenue projections and volume share held by each product type are highlighted.
    • The data supporting the projected market share values, production patterns and growth rate for each product category over the period of analysis are discussed in detail.
    • The report also categorizes the various product offerings based on their scope of application, which is divided into cardiovascular, cerebrovascular, ophthalmology, gynecology, urology, orthopedics, and others.
    • The market share guaranteed by each application segment along with their growth rate on the expected course is also indicated.
    • Medtronic, Teleflex, Terumo Corporation, Baxter, 3M, Ansell, Smiths Group, Novartis, Nitto Medical, Smith & Nephew, Medline, Coloplast, Abbott, Lohmann & Rauscher, ConvaTec, Fresenius, Johnson & Johnson, Boston Scientific, BD, Weigao, B Braun, BSN Medical, Halyard Health and CR Bard are the major players in the disposable medical supplies market.
    • Each competitor’s product portfolio, business profiles, production models, and market compensation are housed in the study.
    • The market share gained by industry leaders, along with their pricing model and gross margins are explained.
    • The latest competition trends are explained in detail.
    • A new project feasibility study leveraging Porter’s Five Forces Analysis and SWOT analysis is contained within the research document.

    Main features of the report:

    • Intricate details of each organization.
    • Information regarding market share, product selling price, manufacturing base distribution, total revenue generated and sales.
    • Latest developments from the main players.
    • Sales amassed by each company in relation to their areas of activity.

    Report Highlights:

    • Accurate predictions of market size and CAGR for the period 2020-2025
    • Identification and in-depth assessment of growth opportunities in key segments and regions
    • Detailed company profile of the major players of the Global Disposable Medical Supplies Market
    • In-depth research on innovation and other trends in the global disposable medical supplies market
    • Reliable industry value chain and supply chain analysis
    • Comprehensive analysis of significant growth drivers, restraints, challenges and growth prospects

    The scope of the report:

    The report offers a comprehensive company profile of key players competing in the global market disposable medical supplies market with a focus on market share, gross margin, net profit, sales, product portfolio, new applications, recent developments and several other factors. It also throws light on the vendor landscape to help players realize about the future competitive changes in the global Disposable Medical Supplies market.

    Reasons to buy the report:

    • Enhance your market research resources with this comprehensive and accurate report on the Global Disposable Medical Supplies Market
    • Obtain a comprehensive understanding of the general market scenarios and future market situations to prepare for challenges and ensure strong growth
    • The report offers in-depth research and various trends of the global Disposable Medical Supplies market
    • It provides a detailed analysis of changing market trends, current and future technologies utilized, and various strategies adopted by the key players of the global Disposable Medical Supplies market.
    • It offers recommendations and guidance for new entrants in the global Disposable Medical Supplies market and carefully guides established players for future market growth.
    • Along with the hottest technological advancements in the global Disposable Medical Supplies market, it sheds light on the plans of the dominating industry players

    Contents:

    • Disposable Medical Supplies Market Industry Overview
    • Industry Chain Analysis of Disposable Medical Supplies Market
    • Disposable Medical Supplies Market Manufacturing Technology
    • Disposable Medical Supplies Market Major Manufacturers Analysis
    • Global Disposable Medical Supplies Market Production, Revenue and Price Analysis by Regions, Manufacturers, Types and Applications
    • Consumption volumes, consumption value, import, export and sales price analysis of Disposable Medical Supplies by Region
    • Gross and Gross Margin Analysis of Disposable Medical Supplies Market
    • Disposable Medical Supplies Market Trader or Distributor Analysis
    • Global and Chinese Economic Impacts on the Disposable Medical Supplies Industry
    • Disposable Medical Supplies Market Development Trend Analysis
    • Disposable Medical Supplies Market Details
    • New Project Investment Feasibility Analysis of Disposable Medical Supplies Market
    • Conclusion of the Global Disposable Medical Supplies Market Industry 2020 Market Research Report

    Customization request on this report @ https://www.getnewsalert.com/request-for-customization/19505





    read more
    Medical products

    Swab Market Size and Growth

    New Jersey, United States,- This swab market The report includes an in-depth competitive analysis with the aim of estimating financial growth and maximizing the company’s profit potential. It helps in making reasonable investment decisions based on consumer needs. It also forecasts the overall growth of the market over the years 2022-2029. It displays objective data useful for professional industry analysis, as well as consumer buying habits. This Swab market research also makes it easy to know the likes and dislikes of different customers, which helps the company generate significant revenue. It serves as a comprehensive reference guide for key new businesses to learn about industry variables and business methodologies that will help them grow their business in the market. New participants will gain a solid understanding of how to run a successful business by executing tactics such as acquisitions, partnerships and new product launches. The market growth statistics presented here are backed by hard facts and figures. The data collected here at a granular level is very useful for predicting productivity.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketreports.com/download-sample/?rid=32528

    This Swabs Market report study examines the sales in depth. It is also a useful tool for participants, suppliers and players. Market research assessment constantly attempts to conduct surveys to provide accurate market insights. It explains how COVID-19 has impacted key market segments. It also explains how COVID-19 will impact each industry for years to come. Business owners can make the right decisions to stand out from their competitors with the help of such unique and excellent market analysis. The scope of this Swabs market report also helps in identifying the best opportunities to earn big profit. When launching a new product or entering the market as a beginner, it’s usually a good idea to check out a solid market report. It also describes how these industries are trying to recover from their dire situation. This Swabs Market report helps companies to increase sales and maintain reputation by providing up-to-date marketing data.

    Key Players Mentioned in the Swabs Market Research Report:

    Puritan Medical Products, Sarstedt, MWE, SARSTEDT, Clean Cross, GPC Medical, Citotest Labware Manufacturing, Q-TIPS, ELMEX

    Swabs Market Segmentation:

    By Product Type, the market is primarily split into:

    • Absorbent cotton
    • Non-absorbent cotton

    By application, this report covers the following segments:

    • Pharmaceutical
    • Microbiological
    • Laboratory
    • Others

    Get a discount on the purchase of this report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=32528

    Scope of Swabs Market Report

    ATTRIBUTES DETAILS
    ESTIMATED YEAR 2022
    YEAR OF REFERENCE 2021
    FORECAST YEAR 2029
    HISTORICAL YEAR 2020
    UNITY Value (million USD/billion)
    SECTORS COVERED Types, applications, end users, and more.
    REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

    Geographic segment covered in the report:

    The Swab report provides information on the market area, which is further sub-divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region over the estimated period.

    • North America (USA and Canada)
    • Europe (UK, Germany, France and rest of Europe)
    • Asia-Pacific (China, Japan, India and the rest of the Asia-Pacific region)
    • Latin America (Brazil, Mexico and rest of Latin America)
    • Middle East and Africa (GCC and Rest of Middle East and Africa)

    Answers to key questions in the report:

    1. Who are the top five Swab market players?

    2. How will the swab market evolve over the next five years?

    3. Which product and application will occupy the lion’s share of the Swab market?

    4. What are the Swab Market drivers and restraints?

    5. Which regional market will show the strongest growth?

    6. What will be the CAGR and size of the Swab market throughout the forecast period?

    For more information or query or customization before buying, visit @ https://www.verifiedmarketreports.com/product/global-swab-market-size-and-forecast-to-2025/

    Visualize the swab market using verified market intelligence:-

    Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

    VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

    Visualize Swab Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

    Most Popular Reports

    Global Wearable Skin Patches Market Size and Forecast

    Global Fetal Monitoring Market Size and Forecast

    Global dental consumables market size and forecast

    Global Automated Hospital Bed Market Size and Forecast

    Global Urinalysis Testing Market Size and Forecast

    Global Swabs Market Size and Forecast

    Global Lichen Nitidus Treatment Market Size and Forecast

    Global Wolff Parkinson White Syndrome Market Size and Forecast

    Global Hammertoe Market Size and Forecast

    Global Hydronephrosis Market Size and Forecast

    About Us: Verified Market Reports

    Verified Market Reports is a leading global research and advisory company serving over 5000 global clients. We provide advanced analytical research solutions while delivering information-enriched research studies.

    We also provide insight into the strategic and growth analytics and data needed to achieve business goals and critical revenue decisions.

    Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on over 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

    Our research spans a multitude of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served many Fortune 2000 organizations, we bring a wealth of reliable experience that covers all kinds of research needs.

    Contact us:

    Mr. Edwyne Fernandes

    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    E-mail: [email protected]

    Website: – https://www.verifiedmarketreports.com/

    read more
    Medical supplies

    Trinity students pack medical supplies

    Trinity students help pack medical supplies for countries in need



    50,000 SUBSCRIBERS ON TIK K.TO A NON-PROFIT ORGANIZATION COLLECTS UNUSED MEDICAL SUPPLIES TO DONATE TO COUNTRIES IN NEED. VICKI: TODAY THE STUDENTS OF TRINITY HIGH SCHOOL CAME TO HELP. WLKY’S ADDIE MEINERS CAUGHTP U WITH SOME OF THE VOLUNTEERS WORKING ON T PHEROJECT. JOURNALIST: THIS FACILITY HOSTS THE SOS FOUNDATION, A LOCAL NON-PROFIT ORGANIZATION THAT RECOVERS SURPLUS MEDICAL SUPPLIES TO DONATE TO COUNTRIES IN NEED. >> UR O MISSION IS NON PROT.FI REPORT: MEET RAMAZIAN JUMA. >> WE HELP HOSPITALS WITH SUPPLIES. REPORT: FIRST PRESIDENT OF THE GOOD HELPER FOUNDATION, RAMAZANI DAN HIS FOUNDATION IS ONE OF MANY WHO RECEIVE HELP DIRECTLY FROM THE FACILITY. DOZENS OF BOXES OF MEDICAL SUPPLIES ARE DONATED TO THE FOUNDATION EACH YEAR. EYTH ARE SHIPPED TO THIS FACILITY, SORTED AND SHIPPED WHERE NEEDED. THE LEG WORK DONE HERE COMES MAINLY FROM VOLUNTEERS, ON THURSDAY THE STUDENTS OF TRINITY HIGH SCHLOO COME TO LEND A HELP. >> I REAZELI NOW THAT EVERYTHING WAS A PACKAGE TODAY WILL BE UD, SE EVERY UNIQUE ITEM IT WILL HELP OTHERS AND THAT MEANS A LOT. REPORTER: THE SORTED SUPPLIES GO TO CONGO, A WORLD AWAY FROM MOST OF THESE YOUNG MEN. BUT GIVING THEIR TIME SOMETHING THEY FEEL IS NECESSARY. >> WE NEED MORE POSITIVITY IN THE WORLD AND THE FACT THAT I CAN GET OUT OF SCHOOL TODAY AND COME TO HELP AND MAKE AN IMPACT FOR PEOPLE WHO REALLY NEED IT MESAN A LOT. JOURNALIST: AS TO WHAT HE SHOW ABOUT THIS LOCAL COMMUNITY, ANYBODY COULD USE SOMETHING FROM MOROF. ADDIE MEINERS, WLKY NEWS. RICK: THROUGH HIS EFFORTS, SOS DIVERTS OVER

    Trinity students help pack medical supplies for countries in need

    A Louisville-area nonprofit collects unused medical supplies to donate to countries in need, and they received help from students at a high school. joins Thursday to help the SOS Foundation, which collects excess medical supplies and then donates them overseas. Donations are then used to help orphans, widows and people with disabilities. Some of them are also going to hospitals in need of supplies and equipment. Much of the field work is done with the help of volunteers. On Thursday, Trinity students sorted through supplies heading to Congo. The students said volunteering their time was something they felt was necessary not only to show that the community cares, but also to help those around the world who need it most. Through its efforts, SOS diverts more than 18 million unused medical items each year.

    A Louisville-area nonprofit collects unused medical supplies to donate to countries in need, and it’s got help from high school students.

    Students at Trinity High School lent their aid on Thursday to the SOS Foundation, which collects excess medical supplies and then donates them overseas.

    Donations are used to help orphans, widows and people with disabilities. Some of them also go to hospitals in need of supplies and equipment.

    Much of the work is done with the help of volunteers. On Thursday, Trinity students sorted through supplies heading to Congo.

    The students said volunteering their time is something they believe is necessary not only to show the community cares, but also to help those around the world who need it most.

    Through its efforts, SOS diverts more than 18 million unused medical items each year.

    read more
    Generic drugs

    Inhalation & Nasal Spray Generic Drugs Market Size, Scope, Growth – Teva, Sandoz (Novartis AG), Mylan, Allergan PLC – Sox Sphere

    New Jersey, United States,- the Generic Inhalation and Nasal Spray Market The report covers the entire global market scenario including key players, their future promotions, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. It aims to rationalize the expenses of the company. You can also find the current revenue generation rate and spend score here. The best thing about the Generic Drugs for Inhalation and Nasal Spray market report is the provision of guidelines and strategies followed by leading market players. The investment opportunities in the market highlighted here will be of great help in moving the business forward. Knowing the current state of the market is the most important thing covered here to help big players survive in the cutthroat market.

    This Generic Inhalation and Nasal Spray Drugs Market study outlines the economic catastrophe induced by the COVID-19 outbreak, which has affected all sectors of the business. A great global economic loss has occurred due to several industrial closures and loss of income. Here, a high degree of information is offered to assess the market situation.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketreports.com/download-sample/?rid=128218

    Key market observation is conducted to draw key conclusions about the growth of the business. In the Competitive Assessment section, this Generic Inhalation and Nasal Spray Drugs Market report sheds light on the list of manufacturers, market conditions, current trends, company profiles and market innovations. It becomes easy for the market players to seize the right opportunities as this report analyzes the weaknesses and strengths of the various competitors in detail. The regional market as well as applications analyzed here to provide the right business opportunities for the business players. This Generic Inhalation and Nasal Spray Drugs Market report is the perfect blend of customer performance and economic trends to enhance business ideas. It also facilitates the task of the main actors of the company by reducing the risks associated with the activity.

    Key Players Covered in the Generic Inhalation and Nasal Spray Market Research Report:

    Teva, Sandoz (Novartis AG), Mylan, Allergan PLC, Cipla, Akorn, Apotex, Sun Pharma (Ranbaxy), Nephron Pharma, Beximco Pharma, Hikma (Roxane), XIANJU PHARMA

    Generic Inhalation and Nasal Spray Market Segmentation:

    By Product Type, the market is primarily split into:

    • Corticosteroids
    • Bronchodilators
    • Combinations
    • Decongestant sprays
    • Others

    By application, this report covers the following segments:

    • Asthma
    • COPD
    • Allergic rhinitis
    • Other

    Get a discount on the purchase of this report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=128218

    Scope of the Generic Drugs for Inhalation and Nasal Spray Market Report

    ATTRIBUTES DETAILS
    ESTIMATED YEAR 2022
    YEAR OF REFERENCE 2021
    FORECAST YEAR 2029
    HISTORICAL YEAR 2020
    UNITY Value (million USD/billion)
    SECTORS COVERED Types, applications, end users, and more.
    REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

    Geographic segment covered in the report:

    The Inhalation & Nasal Spray Generic Drugs report provides information about the market, which is sub-divided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region over the estimated period.

    • North America (USA and Canada)
    • Europe (UK, Germany, France and rest of Europe)
    • Asia-Pacific (China, Japan, India and the rest of the Asia-Pacific region)
    • Latin America (Brazil, Mexico and rest of Latin America)
    • Middle East and Africa (GCC and Rest of Middle East and Africa)

    Answers to key questions in the report:

    1. Who are the top five players in the Generic Inhalation and Nasal Spray market?

    2. How will the generic inhaler and nasal spray market develop over the next 5 years?

    3. Which products and applications will capture the lion’s share of the Generic Inhalation and Nasal Spray market?

    4. What are the drivers and restraints of the Generic Inhalation and Nasal Spray market?

    5. Which regional market will show the strongest growth?

    6. What will be the CAGR and size of the Generic Inhalation and Nasal Spray market throughout the forecast period?

    For more information or query or customization before buying, visit @ https://www.verifiedmarketreports.com/product/global-inhalation-nasal-spray-generic-drugs-market-report-2019-competitive-landscape-trends-and-opportunities/

    Visualize the Generic Inhalation and Nasal Spray Market using Verified Market Intelligence:-

    Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

    VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

    Visualize the Generic Inhalation and Nasal Spray Market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

    Most Popular Reports

    Global Pediatric Pulse Oximeter Market Size and Forecast

    Global Guanine Market Size and Forecast

    Global Solid Oral Contraceptives Market Size and Forecast

    Global Personal Emergency Response Systems (Pers) Market Size and Forecast

    Global Pipette Fillers Market Size and Forecast

    Global Heparin Market Size and Forecast

    Global Vacutainer Tubes Market Size and Forecast

    Global Generic Drugs for Inhalation and Nasal Spray Market Size and Forecast

    Global Capillary Blood Collection Tube Market Size and Forecast

    Global Nasal Cannulas Market Size and Forecast

    About Us: Verified Market Reports

    Verified Market Reports is a leading global research and advisory company serving over 5000 global clients. We provide advanced analytical research solutions while delivering information-enriched research studies.

    We also provide insight into the strategic and growth analytics and data needed to achieve business goals and critical revenue decisions.

    Our 250 analysts and SMEs offer a high level of expertise in data collection and governance using industry techniques to collect and analyze data on over 25,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

    Our research spans a multitude of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage, and more. Having served many Fortune 2000 organizations, we bring a wealth of reliable experience that covers all kinds of research needs.

    Contact us:

    Mr. Edwyne Fernandes

    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US toll free: +1 (800)-782-1768

    E-mail: [email protected]

    Website: – https://www.verifiedmarketreports.com/

    read more
    Prescription drugs

    Biden aims to revive efforts to fight expensive prescription drugs

    President Joe Biden will address the high cost of prescription drugs at an event on Thursday, an issue for which there is some bipartisan support and which could help the White House make progress on its stalled national agenda.

    AP: Biden stresses drug prices as he tries to revive agenda

    President Joe Biden is trying to revive progress on his stalled national agenda by refocusing attention on one of his most popular proposals, limiting the cost of prescription drugs. Biden is traveling to Culpeper, Va., on Thursday, where White House press secretary Jen Psaki said the president would draw attention to the “unacceptable” cost of the drugs. (Megerian, 2/10)

    Fox Business: Biden Trip to Emphasize Lower Drug Prices as He Tries to Revive Agenda

    President Biden will travel to Culpeper, Va., on Thursday and is expected to draw attention to the “unacceptable” cost of drugs in the United States as part of his effort to realize one of his key program proposals: limiting the cost of prescription drugs. The trip is seen as a chance to get his stalled national agenda back on track. Biden’s trip will also be an opportunity for him to begin promoting his party’s candidates in the November midterm elections. He is expected to appear alongside Rep. Abigail Spanberger, D-Va., who faces losing her seat representing a central Virginia district. Prescription drugs will be the focus of Biden’s visit. (Martin, 2/10)

    And the White House pushes back on crack pipe ‘misinformation’ –

    The Hill: White House challenges reports on federal funds for crack pipes

    The Biden administration on Wednesday pushed back against what it called “misinformation,” saying a federal grant program intended to reduce harm to drug users does not include taxpayer funding for pipes that can be used. to smoke crack or methamphetamine. The Department of Health and Human Services (HHS) released a statement clarifying “no federal funding will be used directly or through subsequent reimbursement to recipients to put pipes into safe smoking kits.” (Samuel, 2/9)

    AP: No money for drug pipes: Feds quell social media storm

    Putting out a firestorm on social media, the Biden administration said Wednesday that a grant program to combat the harms of illicit drugs would not pay for safer pipes for smoking crack or meth. The White House has been put on the defensive as outrage from the political right, some of it racially charged, mounts online. “No federal funding will be used directly or through subsequent reimbursement to recipients to put pipes into safe smoking kits,” said Health and Human Services Secretary Xavier Becerra and drug policy adviser of White House Rahul Gupta in a joint statement. (Alonso-Zaldivar and Dupuy, 2/9)

    More details emerge after Biden science adviser resigns –

    Politico: Lander held on to vaccine maker’s stock for months

    As Biden’s top science adviser, Eric Lander, the head of the Office of Science and Technology Policy, publicly promoted Covid-19 vaccination efforts while having a significant financial investment in one of the vaccine makers, according to financial disclosures. Under the White House ethics accord Lander signed, he had 90 days to dispose of his shares after being confirmed by the Senate on May 28. While Lander lost most of those shares in June — including shares of BioNTech SE, the German biotech company and Pfizer’s Covid-19 vaccine partner — he waited until August 5 to sell the $500,000 to $1 million of remaining stock he held in that company. When Lander finally sold the stock 69 days after it was confirmed, it was the company’s second-highest price ever at $404.92 per share, after climbing more than $50 per share two days earlier. . (Thompson, 2/9)

    Stat: The fall of Eric Lander and the end of science’s ‘big ego’ era

    Eric Lander’s resignation as President Biden’s chief science adviser is not just a blow to a president’s plans to advance research, but a sign on the death march in a way to do science. It’s not quite “big science”, which leads nowhere. Call it “big ego”. In science, the “big ego” is not exactly a new phenomenon. But in recent decades it has grown with the emergence of researchers who can both handle the kind of gloveless debate that can mark academic discourse and mobilize vast resources to make certain kinds of scientific discoveries, like mapping genomes or understanding molecular changes in a cell. lead to cancer. (Herper, 2/9)

    This is part of the KHN Morning Briefing, a summary of health policy coverage by major news outlets. Sign up for an email subscription.

    read more
    Generic drugs

    Generic Drug Industry Trends, Share, Size, Growth and Forecast to 2026 – Sox Sphere

    According to the latest report of the IMARC group, entitled “Generic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, the global generic drug market share reached a value of US$386 billion in 2020. Looking ahead, IMARC Group expects the market to show moderate growth over the period 2021-2026. A generic drug is an off-patent drug that is identical to other brand name drugs in terms of effect, form, dosage, intended use, quality, and safety. These drugs can only be manufactured after the brand name drug’s patent has expired. Compared to other branded drugs, these are cheaper and do not require extensive research and testing.

    We regularly monitor the direct effect of COVID-19[female[feminine in the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

    Request a free sample report: https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample

    Market Trends and Drivers:

    The global market is mainly driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, Alzheimer’s disease and Parkinson’s disease. Additionally, the significant growth in the pharmaceutical industry has boosted the growth of the market across the globe. Apart from this, increased expenditure by the government as well as private companies to manufacture generic drugs that can improve the healthcare system has created a positive outlook for the market. Additionally, the growing geriatric population has positively influenced the growth of the market. Additionally, the upcoming patent expiration of many branded drugs is expected to drive the market towards growth.

    Explore the full report with table of contents and list of figures: https://bit.ly/3AbtDoN

    Competitive landscape:

    By IMARC Group, Global Generic Drugs Market report also analyzed the competitive landscape of the market with some of the major generic drug manufacturing companies being

    Some of these key players include:

    • Teva Pharmaceuticals Industries Ltd.
    • Mylan AG
    • Novartis AG
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Fresenius SE & Co.
    • Lupine Limited
    • Endo Pharmaceuticals Inc.
    • Aurobindo Pharma Limited
    • Aspen Pharmacare Holdings Limited

    Key Market Segmentation:

    Breakdown by therapeutic area:

    • Central nervous system
    • Cardiovascular
    • Dermatology
    • Genitourinary/Hormonal
    • Respiratory
    • Rheumatology
    • Diabetes
    • Oncology
    • Others

    Rupture by administration of drugs:

    • Oral
    • Injectables
    • Dermal/Topical
    • Inhalers

    Breakdown by distribution channel:

    • Retail pharmacies
    • Hospital pharmacies

    Breakdown by region:

    • North America (USA, Canada)
    • Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
    • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
    • Latin America (Brazil, Mexico, Others)
    • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

    Main highlights of the report:

    • Market Performance (2015-2020)
    • Market Outlook (2021-2026)
    • Impact of COVID-19 on the market
    • Porter’s Five Forces Analysis
    • Historical, current and future market trends
    • Market drivers and success factors
    • SWOT analysis
    • Market structure
    • Value chain analysis
    • Complete mapping of the competitive landscape

    Note: If you need specific information that is not currently covered by the report, we can provide it to you as part of the customization.

    About Us

    The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.

    IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

    Contact us

    IMARC Group
    30 N Gould St, Ste R
    Sheridan, WY (Wyoming) 82801 United States
    Email: [email protected]
    Phone. :(D) +91 120 433 0800
    Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

    Browse more report:

    read more
    Medical supplies

    Medical Supplies Market 2022 Key Global Industry Players, Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2028

    Overview of the medical supplies market

    Market Research Future (MRFR) expects medical supplies market reach around $132 billion by 2027. The market will continue to flourish at a breathtaking rate from 2020 to 2027, adds MRFR.

    Growth drivers and challenges

    Growing number of surgeries across the globe coupled with increasing cases of acute and chronic diseases would favor the medical supplies market over the next few years. The global market size is also aided by growing concerns over cross-contamination in hospitals as well as increasing base of elderly patients affected by a wide range of diseases. The notable increase in bone fractures along with the growing number of medical facilities in emerging countries would present exciting opportunities for major industry players in the coming years.

    The modernization of healthcare institutions in emerging countries, coupled with the dramatic increase in hospital admission rate due to the increase in disposable income, will also benefit the global market in the future. Manufacturers are focusing their efforts on developing medical supplies for a wide range of end-use sectors, for which they are increasingly using modern technologies. They use their own technologies or deploy technologies licensed from other vendors. These efforts by players to develop high-quality and efficient medical supplies, while keeping in mind the growing consumer demand and preferences, will be a major growth driver in the years to come.

    Get sample copy from “Medical Supplies Marketplace” @ https://www.marketresearchfuture.com/sample_request/2433

    Medical supplies market

    Key players

    Some of the major players in the medical supplies market are 3M Company (USA), Braun Melsungen AG (Germany). Johnson & Johnson (USA), Baxter International Inc. (USA), Medtronic plc (Ireland), Boston Scientific Corporation (USA), Thermo Fisher Scientific Inc. (USA) and Halyard Health, Inc. (United States)

    Medical supplies market Segmentation

    The medical supplies market has been considered for type, application, as well as end users.

    The types of medical suppliers listed in the MRFR analysis are blood collection tubes, infusion products, blood glucose test strips, dialysis consumables, wound care products, adult incontinence products, surgical fields, etc.

    The application-based segments covered by the MRFR study include wound care, urology, sterilization and anesthesia.

    The main end users in the global industry are clinics, nursing homes and hospitals.

    Browse full report details @ https://www.marketresearchfuture.com/reports/medical-supplies-market-2433

    Regional Analysis of the Medical Supplies Market

    During the assessment period, the global medical supplies market will be led by North America, given the surge in COVID-19 cases and the resulting increase in demand for a variety of medical supplies. Business growth in the United States is quite robust in response to frequent technical innovations and the launch of highly advanced new products. The North American market has a number of large manufacturers, such as Johnson & Johnson (USA), Boston Scientific Corporation (USA) and Thermo Fisher Scientific Inc. (USA), which offer extensive ranges of medical supplies with multiple applications.

    The second position in the global medical supplies market belongs to Europe, thanks to the booming healthcare sector and the imposition of strict policies and regulations aimed at reducing cross-contamination in hospitals. Medical supply manufacturers in Europe are focusing on strengthening their distribution networks and supply chains to meet growing demand, which is also supporting business growth.

    Asia-Pacific is expected to become the fastest growing market for medical supplies, owing to the incredible expansion of the healthcare industry and the accelerating number of surgeries. The rapid industrialization and growing manufacturing capabilities of emerging countries like the Philippines, India, China, and Vietnam are also adding value to the APAC market. Additionally, Japan and South Korea are gradually using industrial robots during the manufacturing process to increase the supply rate of medical supplies, which is expected to further expand the market share in the region.

    About the future of market research

    AT Future Market Research (MRFR), we enable our clients to unravel the complexity of various industries through our Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous Feed Research (CFR) and Studies market and advisory services .

    The MRFR team has the overriding goal of providing our clients with the highest quality market research and intelligence services. Our market research by products, services, technologies, applications, end users and market players for market segments at global, regional and country level, enables our clients to see more, know more and do more, which helps answer all their most important questions.

    In order to stay up to date with technology and industry work processes, the MRFR often plans and organizes meetings with industry experts and industrial visits for its research analyst members.

    Contact us:

    Market Research Future (part of Wantstats Research and Media Private Limited),

    99 Hudson Street, 5th Floor,

    New York, New York 10013

    united states of america

    +1 646 845 9312

    E-mail: [email protected]

    read more
    Prescription drugs

    What’s in the WateRx: New study finds ‘massive cocktail’ of prescription drugs in South Florida bonefish – WSVN 7News | Miami News, Weather, Sports

    (WSVN) – We’ve all heard of the opioid epidemic, but a new study reveals that these same drugs, and more, are leaching into the sea. ‘water ? Karen Hensel of 7 shows us.

    South Florida is famous for its beautiful water, fun in the sun, and some of the best fishing in the world.

    But, the reality is that our paradise has a secret under the surface.

    Dr Aaron Adam, Director of Science and Conservation, Bonefish & Tarpon Trust: “Yes, this is very concerning.”

    Researchers from Florida International University and the Bonefish & Tarpon Trust have teamed up to test Biscayne Bay bonefish in the Florida Keys.

    They tested 93 fish, and each of them was contaminated with pharmaceuticals, including drugs like antidepressants, heart medications and painkillers.

    Dr Aaron Adams: “We weren’t surprised there were pharmaceuticals in the fish, but the number really blew us away: seven on average per fish. It’s a pretty massive cocktail.

    A huge cocktail with a prescription for trouble.

    Dr Aaron Adams: “To find a fish that had, I think it was 17 pharmaceuticals in a single fish, I can’t even imagine the changes in the brain chemistry and physiology of that fish. Imagine if you went to your pharmacist. The first thing the pharmacist would do would be to check the interactions between these different drugs. Bonefish do not have this option.

    Although you must release any bonefish caught in Florida, researchers believe the problem in the water is also impacting other marine species.

    Dr Jennifer Rehage, CRF Coastal Fisheries Research Laboratory: “We sampled small crabs, small fish and small prawns in particular, the ones we actually eat in the bay, and we sampled those as well, and these contained even more pharmaceuticals. ”

    So how is it going?

    When we take drugs, what our bodies don’t metabolize is flushed down the toilet to Florida’s old sewage treatment plants.

    Dr Jennifer Rehage: “These plants were designed in the 60s and 70s to manage nutrients and human waste. They are not designed to deal with these high-end pharmaceuticals.

    This means that the drugs are not filtered before flowing from sewage treatment plants to the ocean.

    Dr Jennifer Rehage: “We can also think about the human side, the fact that we have all these unknowns about what it means to be exposed to pharmaceuticals for long periods of time at low doses. I don’t know about you, but I don’t want to be exposed to these drugs without a choice.

    The concern is not just for human health, but also for Florida’s economic health.

    Recreational saltwater fishing brings in $9.2 billion a year to the state.

    Dr Aaron Adams: “A lot of the pharmaceuticals in these bonefish affect behavior, and that behavior will have repercussions. They are probably eaten by predators more frequently. This could affect their spawning migrations.

    Dr Jennifer Rehage: “Our goal was not to alarm people, but to let people know that this is another aspect of water quality.

    So what about the Florida fish we eat?

    The researchers say they are certain that when they test other fish, they will find pharmaceuticals. The question is, how many different drugs and at what level?

    For more information on the CRF and Bonefish & Tarpon Trust study, click here.

    Copyright 2021 Sunbeam Television Corp. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Join our newsletter for the latest news straight to your inbox
    read more
    Medical products

    Protek Medical Products in Iowa City will close, eliminating 53 jobs

    Protek Medical Products in Iowa City last month announced it would be closing effective April 29.

    The closure will affect 53 employees, who will be made redundant when the business closes.

    News of the impending closure came on January 26, when Protek filed a required worker accommodation and retraining notification.

    Protek Medical Products is a Coralville-based manufacturer of medical supplies. The company manufactures probe covers and needle guides for ultrasound used in tissue biopsies, fluid aspiration and vascular access procedures, as well as protective covers for medical equipment and instruments. It was founded in 1996 by Rick Pruter.

    In November 2020, Aspen Surgical Products acquired Protek for an undisclosed amount. Aspen has also secured the rights to Protek’s patented Pull-Up probe technology, which claims to help produce efficacy in clinical settings. Based in Caledonia Michigan, Aspen hoped to boost its medical, patient and staff safety product profile with the acquisition.

    Messages to Protek’s Coralville office on Monday were not returned.

    This article originally appeared on Iowa City Press-Citizen: Protek Medical Products in Iowa City to close, costing 53 jobs

    read more
    Medical supplies

    Medical Supplies Market to Witness Huge Growth by 2027

    New Jersey, United States,- The research approach of this Medical supplies market report is a mix of primary research, secondary research and expert panel assessments. Secondary research includes industry-related documents as well as press releases, annual reports, and research reports. Other sources for obtaining specific data on strategic expansion opportunities in this market report are trade journals, industry magazines, government websites and associations. The primary research involves conducting phone interviews with numerous industry experts as well as sending email questionnaires (email interactions) and in some cases face-to-face contact for a more comprehensive and unbiased review of this Medical Supplies Market report across multiple regions.

    Also, it captures the adverse effects of the COVID-19 virus on each country business sector. Some other crucial elements discussed here are buying attitude of customers, strategies followed by major players, key developments, price structure and market share. Topographical observation of the market is also done here on the market environment as well as competitor details. This Medical Supplies Market report helps in making the right investment in launching the product and earning huge profits.

    Get Sample Full PDF Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.verifiedmarketresearch.com/download-sample/?rid=144345

    Business owners need to be aware of the latest marketing environment. With this knowledge, business owners thrive. The Medical Supplies market maps competitor reactions and enables business players to remain innovative and reduce business risks. This allows players to avoid repetitive mistakes in the business. One of the easiest ways to run a successful business is to get insightful data on market growth and learn more about market segmentation. The Medical Supplies Market report focuses on market segmentation to enable business owners to compare the progress. The competitive analysis conducted here for the forecast period 2022-2029 is of great help in helping market players to make relevant changes for the launch of the new product. It helps in understanding important statistics and the level of competition in the market.

    Key Players Mentioned in the Medical Supplies Market Research Report:

    Johnson & Johnson, Coloplast Group, Fresenius Medical care AG & Co. KGaA, Teleflex Incorporated, Terumo Japan, Stryker, Merit Medical Systems, Cook Medical, Abbott ConvaTec Group Plc.

    Medical Supplies Market Segmentation:

    Medical Supplies Market, By Type

    • Individual protection equipment
    • Disinfectants
    • Intubation and ventilation supplies
    • Infusion and injectable supplies
    • Diagnostic supplies
    • Others

    Medical Supplies Market, By Application

    • Cardiology
    • Infection control
    • Respiratory
    • Radiology
    • Wound care
    • Others

    Medical Supplies Market, By End User

    • Hospitals
    • Clinics/Doctors’ offices
    • Others

    Get a discount on the purchase of this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=144345

    Scope of the Medical Supplies Market Report

    ATTRIBUTES DETAILS
    ESTIMATED YEAR 2022
    YEAR OF REFERENCE 2021
    FORECAST YEAR 2029
    HISTORICAL YEAR 2020
    UNITY Value (million USD/billion)
    SECTORS COVERED Types, applications, end users, and more.
    REPORT COVER Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends
    BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
    CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst business days) with purchase. Added or changed country, region and segment scope.

    It becomes easy to determine the pulse of the market with this detailed analysis of the medical supplies market. Key players can find all competitive data and market size of major regions like North America, Europe, Latin America, Asia-Pacific and Middle East. As part of the competitive analysis, certain strategies are profiled which are pursued by key players such as mergers, collaborations, acquisitions and new product launches. These strategies will greatly help industry players to strengthen their position in the market and grow their business.

    Answers to key questions in the report:

    1. Who are the top five players in the medical supplies market?

    2. How will the medical supplies market evolve over the next five years?

    3. Which product and which application will occupy the lion’s share of the medical supplies market?

    4. What are the drivers and restraints of Medical Supplies Market?

    5. Which regional market will show the strongest growth?

    6. What will be the CAGR and size of the Medical Supplies market throughout the forecast period?

    For more information or query or customization before buying, visit @ https://www.verifiedmarketresearch.com/product/medical-supplies-market/

    Visualize the Medical Supplies Market Using Verified Market Intelligence:-

    Verified Market Intelligence is our BI platform for market narrative storytelling. VMI offers in-depth forecast trends and accurate insights on over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

    VMI provides a global overview and competitive landscape with respect to region, country and segment, as well as key players in your market. Present your market report and results with an integrated presentation function that saves you more than 70% of your time and resources for presentations to investors, sales and marketing, R&D and product development. products. VMI enables data delivery in Excel and interactive PDF formats with over 15+ key market indicators for your market.

    Visualize the medical supplies market using [email protected] https://www.verifiedmarketresearch.com/vmintelligence/

    About Us: Verified Market Research®

    Verified Market Research® is a leading global research and advisory firm that for over 10 years has provided advanced analytical research solutions, personalized advice and in-depth data analysis to individuals and businesses seeking accurate research, reliable and up to date. data and technical advice. We provide insight into strategic and growth analytics, the data needed to achieve business goals, and help make critical revenue decisions.

    Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and maximize efficiency by working as a partner to deliver accurate and valuable insights. The industries we cover span a wide spectrum, including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and the gas. etc

    At Verified Market Research, we help in understanding holistic market indicator factors and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and review data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise and years of collective experience to produce informative and accurate research.

    Having served over 5000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s leading consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for companies around the world.

    Contact us:

    Mr. Edwyne Fernandes

    Verified Market Research®

    USA: +1 (650)-781-4080
    UK: +44 (753)-715-0008
    APAC: +61 (488)-85-9400
    US Toll Free: +1 (800)-782-1768

    E-mail: [email protected]

    Website:- https://www.verifiedmarketresearch.com/

    read more
    Medical products

    3 medical products stocks poised to beat this earnings season

    Despite the resurgences of COVID-19, so far the fourth quarter reporting cycle has shown improvement for the Medical products companies in the wider medical sector. It should be mentioned that the Medical is expected to be one of the seven fastest growing sectors in earnings in the fourth quarter.

    By the last Earnings overview, 33.9% of companies in the medical sector, accounting for nearly 53.7% of the market capitalization of the sector, reported profits through February 2. Profits improved 10% year over year on revenue up 12.1%. A total of 36.8% of corporate earnings and revenue beat Zacks’ consensus estimate.

    This dashboard highlights stability in the United States, thanks to the continued economic reopening amid the resurgence of COVID-19 cases. However, this resurgence has led to supply chain disruptions that persist. Additionally, several of the international markets affected by COVID are still suffering due to lower cash flow and difficult economic conditions.

    Companies in the medical products sector saw a sequential decline in collective business versus legacy core business in the third quarter. On a positive note, the fourth quarter reporting cycle so far has shown a recovery in these activities despite the resurgence of COVID-19. The substantial increase in vaccination campaigns has helped people gradually return to pre-pandemic normality. This, in turn, has likely resulted in some recovery in hospital visits and core hospital activities in the current reporting cycle, which in turn may have boosted non-COVID legacy activities and electives in the medical sector. Although companies are seeing a sequential recovery in their core business, the improvement in the overall trend is still below pre-COVID levels.

    Meanwhile, due to the resurgence of COVID-19 and rising case numbers, manufacturers of tests, vaccines and therapeutics have witnessed massive market uptake of their products and services. of COVID-related healthcare support in the fourth quarter. Diagnostic test stocks have so far seen phenomenal growth, driven by an increase in demand for COVID-19 tests, in line with industry trends. For example, in the fourth trimester, Abbott Laboratories‘ABT’s underlying legacy diagnostic activity continued to improve. This was due to strong sales of ABT’s COVID-19 tests thanks to strong demand for the BinaxNOW, Panbio and ID NOW rapid test platforms. Sales of Abbott’s rapid diagnostics and point-of-care diagnostics both grew organically.

    Stocks set to beat fourth-quarter earnings estimates

    Given the high degree of diversity in the medical products industry, finding the right stocks with the potential to beat estimates could be quite a task.

    However, our proprietary Zacks methodology makes this quite simple.

    We focus on actions that combine a positive effect ESP Earnings and a Zacks rank #1 (strong buy), 2 (buy) or 3 (hold). You can see the full list of today’s Zacks #1 Rank stocks here.

    Our research shows that for stocks with this combination, the chance of a positive earnings surprise is as high as 70%.

    The ESP of earnings provides the percentage difference between the most accurate estimate and the Zacks consensus estimate. You can discover the best stocks to buy or sell before they’re flagged with our Income ESP filter.

    Here we feature three stocks that are expected to top earnings estimates in this reporting cycle.

    Baxter International, Inc. BAX: Increased demand for acute therapy products due to the COVID-19 pandemic, and continuous renal replacement therapy (CRRT), related devices and consumables are likely to have boosted Acute business performance Baxter’s Therapies in Q4 2021. BAX’s strong product pipeline and expected launch of therapies and products may be reflected in Q4 revenue.

    The combination of Baxter’s ESP gains of +3.50% and a Zacks #2 ranking raises the possibility of an earnings surprise in the quarter to report.

    The company is expected to release its fourth quarter results on Feb. 17, before the market opens.

    Baxter International Inc. Awards and EPS Surprise

    Baxter International Inc. price-eps-surprise | Baxter International Inc. Quote

    Henry Schein, Inc. HSIC: According to the third quarter 2021 earnings call, the company has seen stronger demand in the global dental and medical markets as practices gradually reopen and global patient traffic has stabilized over the past few months. months, even in countries with stricter lockdown rules. . This recovery trend is expected to have continued through the fourth quarter, boosting the company’s revenue.

    HSIC is expected to release its fourth quarter 2021 results on February 15.

    Henry Schein has a +1.94% Earnings ESP and a #2 Zacks rank.

    Henry Schein, Inc. Awards and EPS Surprise

    Henry Schein, Inc. Awards and EPS Surprise

    Henry Schein, Inc. price-eps-surprise | Quote from Henry Schein, Inc.

    DENTSPLY SIRONA Inc. XRAY: DENTSPLY SIRONA’s Consumables segment is expected to have seen improved revenue in the fourth quarter. The rebound in sales of all product categories may have contributed to the increase. The Technology & Equipment segment may have shown growth in the reportable quarter, driven by recovery across all product categories.

    XRAY is expected to report its fourth quarter 2021 results on February 28.

    DENTSPLY SIRONA has a Gain ESP of +1.06% and a Zacks Rank #3.

    DENTSPLY SIRONA Inc. Price and EPS Surprise

    DENTSPLY SIRONA Inc. Price and EPS Surprise

    DENTSPLY SIRONA Inc. price-eps-surprise | Quote DENTSPLY SIRONA Inc.

    Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

    Just Released: Zacks Top 10 Stocks for 2022

    In addition to the investment ideas discussed above, would you like to know our top 10 buy and hold tickers for all of 2022?

    Last year 2021 Zacks Top 10 Stocks the portfolio generated gains as high as +147.7%. Now, a brand new portfolio has been selected from over 4,000 companies covered by the Zacks ranking. Don’t miss your chance to participate in this long term shopping

    Access the Top 10 Zacks Stocks for 2022 today >>

    Click to get this free report

    Abbott Laboratories (ABT): Free Inventory Analysis Report

    Baxter International Inc. (BAX): Free Stock Analysis Report

    DENTSPLY SIRONA Inc. (XRAY): Free Stock Analysis Report

    Henry Schein, Inc. (HSIC): Free Stock Analysis Report

    To read this article on Zacks.com, click here.

    Zacks Investment Research

    The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

    read more
    Generic drugs

    U.S. Generic Drugs Market Report 2021: Small

    Dublin, 07 Feb. 2022 (GLOBE NEWSWIRE) — The “Generic Drug Market in the United States, by Type (Generic to Small Molecule vs. Biosimilars), by Application, by Mode of Drug Delivery, by Form, by Source, by Distribution The Report Channel, by Region, Competition, Forecast and Opportunities, 2026” has been added to from ResearchAndMarkets.com offer.

    The U.S. Generic Drugs Market was valued at USD 70.78 Billion in 2020 and is expected to grow at a CAGR of 9.43% during the forecast period and may reach the market value of USD 126.74 Billion by 2026 .

    Factors such as the cost-effective nature of generic drugs and growing demand from developing economies are majorly responsible for this futuristic growth estimate of the generic drugs market in the United States over the next five years. Generic drugs do not require extensive research and development as in the case of prescription drugs and patent drugs.

    Market players and research institutes are investing heavily in patented pharmaceuticals. Moreover, FDA approvals for generic drugs are not required as generic drugs contain the same composition as that of the previously patented drug and thus support the growth of the generic drug market in the United States over the next five years . The healthcare industry in the United States, in terms of generic drugs, has gone from an 80% growth in 2020 to a previous growth of 20% in 2015.

    The increase in generic drug exports to developing economies like Kenya, India, etc. also justifies the growth of the US generic drug market over the next five years.

    The US generic drugs market is segmented on the basis of type, drug delivery route, form, manufacturing source, application, company, and regional distribution. Based on type, the market can be divided into generics and small molecule biosimilars. Small molecule generics are expected to register the largest market revenue shares and dominate the market segment over the next five years owing to their simpler and easier manufacturing processes.

    When producing small molecule generics, generic drug manufacturers are required to prove that the final product contains the same chemical compounds as the patented drug. With similar functions and pharmacokinetic properties, the generic small molecule is accepted. Additionally, the demand for cost-effective generic drugs is expected to further support the growth of the generic drug market in the United States over the next five years.

    Based on applications, the market can be fragmented into cardiovascular diseases, diabetes, neurology, oncology, infectious diseases, and others. Cardiovascular diseases are expected to dominate the market segment while recording the highest market revenue shares over the next five years owing to the increasing cases of cardiovascular diseases in the United States.

    Additionally, increased demand for treatment and extended medication protocols is driving the growth of cardiovascular disease sub-segment while sustaining the growth of the generic drug market in the United States over the next five years.

    The increase in pharmaceutical research and development for the oncology disease is expected to drive the growth of the oncology sub-segment and drive the growth of the US generic drug market over the next five years.

    Major market players in the United States leading the growth of the generic drugs market include:

    • Teva Pharmaceuticals USA, Inc.
    • Pfizer Inc.
    • Sandoz US
    • Endo Pharmaceuticals Inc.
    • Aurobindo Pharma USA, Inc.
    • Abbott Laboratories Inc.
    • Eli Lilly and company
    • Sun Pharma Inc.
    • Lupine Pharmaceuticals, Inc.
    • Zydus Pharmaceuticals USA Inc.

    Report Scope:

    Years considered for this report:

    • Historical years: 2016-2019
    • Reference year: 2020
    • Estimated year: 2021
    • Forecast period: 2022-2026

    Generic Drugs Market in the United States, by Type:

    • Generic Small Molecule
    • Biosimilars

    Generic Drugs Market in the United States, by Application:

    • Cardiovascular illnesses
    • Diabetes
    • Neurology
    • Oncology
    • Infectious diseases
    • Others

    Generic Drugs Market in the United States, by Mode of Drug Delivery:

    • Oral
    • Parenteral
    • Topical
    • Others

    Generic Drugs Market in the United States, by Form:

    • Tablet
    • Capsule
    • Injection
    • Others

    Generic drugs in the United States, by source:

    • In-house manufacturing
    • Contract manufacturing organizations

    Generic Drugs Market in the United States, by Distribution Channels:

    • Retail pharmacies
    • Online pharmacies
    • Hospital pharmacies
    • Others

    For more information on this report visit https://www.researchandmarkets.com/r/3b41r9

    • Generic drugs market in the United States

    
            
    read more
    Medical products

    Hot Melt Extrusion Medical Products Market Growth Analysis 2022, Industry Dynamics 2026

    The global Hot Melt Extrusion Medical Devices industry market study provides important insights that can help companies to set priorities, better position their businesses, devise well-thought-out business strategies and make business decisions. investment for the future. The report mainly includes the current status of the Hot Melt Extrusion Medical Products market, products, materials, services and other key aspects of the market. In this research, the report explores the status of the Hot Melt Extrusion Medical Products market in key regions. It includes an overview of how the Hot Extrusion Medical Devices industry fits into the global market landscape, key trends influencing market companies and consumers, and information about what players in the hot extrusion medical products market might want to focus to support and be competitive in the market. Marlet. The report studies the segments that are major contributors to the market and are expected to dominate the hot melt extrusion medical products market in the coming years.

    Request a sample report: https://www.orbisresearch.com/contacts/request-sample/6249201?utm_source=SLP

    Hot Extrusion Medical Products Market Key Players

    AbbVie
    Formex
    BASF Pharmaceuticals
    omipa
    Biogrund
    Lubrizol

    The report studies key parameters of the Medical Hot Melt Extrusion Products industry, including the macroeconomic situation, current status, research and development initiatives, and ongoing merger and acquisition activities. The report studies key indicators of the Hot Melt Extrusion Medical Devices industry defining the current economic situation and financial performance of the market. The major ongoing developments in the industry such as mergers and acquisitions and research and developments locally and globally are highlighted in the report.

    Hot Extrusion Medical Products Industry Different product categories include:

    Movies
    Taste masking
    Drug eluting devices
    Others

    The global hot extrusion medical products industry has a number of end-user applications, including:

    Research Laboratory
    Contract manufacturing organization
    Pharmaceutical companies

    The above mentioned activities from 2019 to 2021 are covered in the report with an assessment of pandemic effect on Medical Hot Melt Extrusion Products industry. Additionally, the changes that the pandemic brings to the market, new business models, supply and demand scenario, regulatory framework, technological innovations shaping the market. Then, the report focuses on the key developments that the hot melt extrusion medical products market will witness in 2021 and the developments that occurred in 2020 due to the pandemic. The hot melt extrusion medical products market drivers evident in the market in recent years are studied in the report. This detailed information presented in the report enables market players to make informed decisions and design innovative and sustainable business models.

    Investigate before accessing the report at: https://www.orbisresearch.com/contacts/enquiry-before-buying/6249201?utm_source=SLP

    What does the Hot Extrusion Medical Products Market report include?

    – Factors that may affect future business ventures.
    – The future growth rate and expected growth of the Medical Extruders industry and your business.
    – The business models and business strategies executed by players of the Hot Melt Extrusion Medical Products market.
    – Market, financial and other risks related to local and international commercial activities of hot melt extrusion medical products.
    – Global hot extrusion medical products market industry-related revenue.
    – The report highlights the opportunities arising from the pandemic for the hot melt extrusion medical products market players over the current and upcoming years.
    – The report includes details of revenue and market share losses suffered during the pandemic.
    – The report recognizes the drivers of change in the Hot Melt Extrusion Medical Devices industry ahead of 2020.
    – The risks and uncertainties that may arise in the Hot Melt Extrusion Medical Devices market are discussed in the report.
    – Segments or regions that have extreme growth potential and are expected to witness huge growth in the Hot Melt Extrusion Medical Devices market in the future are detailed in the report.
    – The report provides a neutral perspective of the global hot extrusion medical products market and its performance.
    – The report explains how players in the hot extrusion medical products market can adapt to the changing market.
    – Detailed details of supply chain operations by segment.
    – Financial and economic conditions of the Hot Extrusion Medical Products industry market.
    – Analysis of revenue growth of all business segments.

    About Us:

    Orbis Research (orbisresearch.com) is a one-stop-shop for all your market research needs. We have an extensive database of reports from leading publishers and authors around the world. We specialize in delivering customized reports according to our clients’ requirements. We have complete information about our publishers and therefore are sure of the accuracy of the industries and verticals of their specialization. This helps our clients map their needs and we produce the perfect market research required for our clients.

    Contact us:

    Hector Costello
    Senior Manager – Client Engagements
    Central Highway 4144N,
    Suite 600, Dallas,
    Texas – 75204, USA
    Telephone number: United States: +1 (972)-362-8199 | IND: +91 895 659 5155
    Email ID: [email protected]

    Click here to see the full table of contents: https://www.orbisresearch.com/contact/purchase-single-user/6249201?utm_source=SLP



    read more
    Prescription drugs

    A man has been investigated for supplying counterfeit prescription drugs after a raid on Jarrow’s property

    Video released by Northumbria Police showed officers breaking down the front door to enter the property where they found a supply of painkillers including pregablin, temazepam and oxycodone, all of which failed been prescribed to the occupier.

    Read more

    Read more

    Homeless man racks up £11,000 legal debt after damaging police stations for…

    While searching the rooms, officers also found a quantity of cannabis which was also seized.

    Register to our daily newsletter

    The newsletter mute the noise

    Officers carried out the search after a warrant was issued following concerns raised by the local community.

    The warrant was executed at the property on Wednesday morning (February 2) after police learned that suspected illicit substances were being supplied from the property.

    A man in his 40s has since been questioned on bail in connection with the findings.

    Chief Inspector Neil Hall, of Northumbria Police, praised the public who provided information about the alleged drug supply linked to the address.

    Some of the counterfeit prescription drugs seized following a raid on a house in Jarrow.

    He said: ‘These illicit prescription drugs could have caused serious harm if they got into the hands of someone for whom they were not prescribed.

    “We are therefore delighted to have been able to seize various medicines from this address – and this was only possible thanks to the public coming forward and raising their concerns.

    “Their information, along with our own intelligence on the drug supply in the area, enabled us to deploy officers and execute a morning warrant – with excellent results.

    Officers raided a property in Jarrow over concerns that illicit substances were being supplied from the property.

    “I hope this warrant shows the merits of the public who come forward and speak to us. Your information can help us to take action and get a clearer picture of the identity of potential perpetrators – and to ensure that we protect some of the most vulnerable in our communities.

    The man, who voluntarily surrendered to the police station for questioning, is still under investigation.

    Anyone with information about crime in their area is asked to report it via the ‘Tell us something’ page on the Northumbria Police website or by calling 101.

    People can also submit information anonymously via Crimestoppers, an independent charity, by calling 0800 555 111.

    A message from the editor:

    Support your Gazette and subscribe today.

    Enjoy unlimited access to all our news and sports, see fewer ads, enjoy faster loading times, test your brain with daily puzzles and access to exclusive newsletters.

    Your support for our journalism means we can continue to tell the stories of South Tyneside for generations to come. Click here to subscribe – and click here to get the latest Gazette news and sport delivered to your inbox via our email newsletters.

    read more
    Prescription drugs

    Cheaper prescription drug formulations could cut costs by 40%, study finds

    Rising prescription drug costs paid by insurers and consumers may be partly due to ordering more expensive formulations, according to a new study. File photo by John Angelillo/UPI | License picture

    February 4 (UPI) — In the United States, people can save up to 40% on prescription drug costs by switching to different formulations of the same drug, when available, according to research published Friday by the JAMA Health Forum.

    In the cost analysis of 28 drugs available in tablet or capsule form, 33% of prescription orders were placed for the high-priced formulation, the data showed.

    Similarly, for 21 drugs distributed as a cream or ointment, 47% of orders were for the most expensive formulation, the researchers said.

    If the lower-cost formulation had been ordered, expenses for the analyzed drugs — both in terms of out-of-pocket expenses and those covered by health insurance — would have been reduced by 42%, according to the researchers.

    “Our results shed light on the abrupt and often unexplained price variation that can exist between similar drug treatments,” study co-author Sunita Desai told UPI in an email.

    “They also underscore the need for greater price transparency to enable patients and providers to balance clinical and cost considerations when making treatment decisions,” said Desai, assistant professor of health at the population NYU School of Medicine in New York.

    Out-of-pocket costs, or expenses beyond what is covered by insurance, have increased in recent years in the United States, fueled at least in part by rising prices for brand name drugs and reduced availability of alternatives. generics, according to research.

    Studies have found that up to 18 million people nationwide cannot afford the medications they have been prescribed and an estimated 13 million skip doses or delay taking medication due to costs.

    According to Desai and his colleagues, drug prices can differ depending on a number of factors, including the formulation used.

    For example, amoxicillin, a commonly used antibiotic, is available in tablet or capsule form.

    In their analysis, the researchers found that the most expensive tablet formulation was ordered about 45% of the time, they said.

    If the cheaper capsule had been ordered instead, users of the prescription drug would have saved around 30% on out-of-pocket costs, according to the data.

    Similarly, hydrocortisone, which is used to treat rheumatoid arthritis, among other conditions, was ordered in its more expensive ointment formulation when the cheaper cream option would have saved patients around 10% of expenses, the researchers said.

    Although prescribing healthcare providers may prefer one formulation over another for convenience, safety, or effectiveness, increased transparency regarding price differences would allow patients and providers to make more informed decisions, according to the researchers.

    “Many drugs come in multiple formulations, and prices between two formulations can vary significantly,” Desai said.

    “In many cases, the convenience or clinical differences may be minor, and in those cases the patient and payer could save money if they knew about those price differences,” she said.

    read more
    Medical supplies

    Emergency Medical Supplies Market Expected For Unexpected Growth Globally, Key Players -Smith and Nephew Bayer Corporation. – Cleveland Sports Area

    New York, United States: Prospecting Emergency Medical Supplies Market report created by DECISIVE MARKET OVERVIEW explains an overview of global companies, including definitions, applications, industry chain construction and characterizations, etc. A precise evaluation of the CAGR rate over the forecast period of 2020-2027 has been instilled. A portion of the global market essentials are clarified like general usage and creation volume, absolute transaction and layout volume, importing, sending, hard stage examination, sales methodologies. expanded authorization, trading scenes, imperative limits for sufficient market valuation, market size, net margins, top-down value investigation, modern market guideline, asset management, etc. There are a portion of presentation designs in the world that are actually quite difficult to sort through. Along these lines, appropriate graphical representations are presented like bars, charts, graphs, etc. for an accurate understanding of these core presentation designs over the planned period of 2020-2027. The Gross Domestic Product is most likely the main element of the advertisement as it deals with the general development rate of the market. Different explanations behind its enhancement just like corruption are comprehensively amalgamated.

    To benefit from a sample copy of the report, visit @ https://www.decisivemarketsinsights.com/emergency-medical-supplies-market/15524773/request-sample

    Emergency Medical Supplies Market Segmentation-
    By type:
    Respiratory therapy devices, cardiac equipment, wound care consumables, diagnostic and monitoring equipment, patient treatment equipment, infection control products, personal protective equipment, other
    Per application:
    (cardiac care, respiratory care, traumatic injuries, other applications) End user (hospitals, ambulatory surgery centers, research and diagnostic laboratories, others)
    By key players: Smith and Nephew Bayer Corporation Becton and Dickinson Company Johnson and Johnson B. Braun Melsungen AG Stryker Corp. Medtronic plc Asahi Kasei Corporation Koninklijke Phillips NV GE Healthcare

    The COVID-19 pandemic has overwhelmed the entire global market and hampered its development significantly. Irrespective of these prevailing unfavorable circumstances, sorting out some vital systems is extremely crucial to track the maintainability of the overall market development.

    Please click on the link below if you intend to make a direct purchase @:-https://www.decisivemarketsinsights.com/emergency-medical-supplies-market/15524773/buy-now

    Why this Emergency Medical Supplies Market The report is valuable to the business:-
    Ø The most revised advances, just like the main continuous models of the world market, are completely clarified.
    Ø It contains a strong exam strategy with BCG and SWOT investigation inside and out and very framed.
    Ø The report outlines different effective methodologies as well as a set of refined approaches for additional essential business advancements.
    Ø An overview of the conduct and usefulness of the global market just like a global perspective available across the world has been given everywhere.
    Ø The CAGR rate over the fixed period of 2020-2027 has been accurately described.
    Ø Various time-limited procedures such as affiliate introduction, email promotion, etc. are completely joined.

    To inquire about the discount, please complete the form by clicking the link below:-https://www.decisivemarketsinsights.com/emergency-medical-supplies-market/15524773/request-discount

    Value chain investigation is a profoundly competent and modernized procedure applied by global market pioneers to properly sort out the arrangement of prime exercises that enhance the value of its end result and dissect these exercises as a whole for a huge cost reduction.

    Answers to key questions in this Emergency Medical Supplies Market report: –
    Ø What will be the effect of the COVID-19 pandemic on the development of the global market and what are the chances after the COVID-19 pandemic?
    Ø What are the fundamental limits that are vital for an accurate assessment of the market?
    Ø What are the important systems received by global pioneers for successful market development?
    Ø What will be the general economic situation in the next 6-7 years alongside its CAGR?
    Ø What are the various difficulties that a company is likely to face and what are the effective methods offered by mechanical specialists to overcome these overwhelming difficulties?

    In order to make a pre-order request, please click on the link below:-https://www.decisivemarketsinsights.com/emergency-medical-supplies-market/15524773/pre-order-enquiry

    Please contact us and our expert will get back to you within 30 minutes:

    Critical market insights
    Sunil Kumar
    Head of sales
    E-mail -[email protected]
    Website-https://www.decisivemarketsinsights.com/
    United States +18317045538
    UK +441256636046
    Address:- 26 Broadway, Suite 934, New York, 10004

    Social connections:
    Twitter-https://twitter.com/decisivemarket

    Linkedin-https://www.linkedin.com/company/decisive-markets-insights

    read more
    Prescription drugs

    7 foods that don’t mix with prescription drugs


    Some of the most well-known food-drug interactions include the blood thinner warfarin (brand names Jantoven and Coumadin) and foods containing vitamin K, such as broccoli, cabbage, kale, spinach, Swiss chard , seaweed and other leafy greens. Some vegetable oils also contain high amounts of K. These vegetables can reduce the effectiveness of commonly prescribed medications, inhibiting its ability to stop or prevent blood clotting, says Dima Qato, associate professor at the University of Southern California School. of Pharmacy and Senior Fellow at the Schaeffer Center for Health Policy & Economics at USC.

    Before completely getting rid of these foods, ask your doctor if you should avoid them (or any others) while taking warfarin, or if you can eat moderate amounts of them regularly. Some experts now advise people taking warfarin to be very consistent with the amount of vitamin K they get through food, avoiding large amounts at a time. So, “If you like salad, eat it three times a week and the same amount each time,” advises Brown, and your warfarin concentration should stay stable.

    3. Deli meats, soy, other foods containing tyramine, plus MAOIs

    An older class of antidepressants called monoamine oxidase inhibitors (MAOIs) can have dangerous interactions with foods that contain high levels of the amino acid tyramine. Taking MAOIs and eating foods high in tyramine can lead to high levels of tyramine in the body, which can trigger a sudden and dangerous increase in blood pressure. Foods high in tyramine include smoked and cured meats, aged cheeses, fermented foods, red wine, some draft beers, soy products (soy sauce, miso, tofu), and very ripe bananas. These days, MAOIs aren’t used as frequently to fight depression, but they are sometimes used to treat Parkinson’s disease. If you’re taking an MAOI, it’s best to avoid these foods, says Brown. You can also ask your doctor for a complete list of dietary restrictions.

    4. Grapefruit and cholesterol lowering

    Consuming grapefruit or grapefruit juice may inhibit an enzyme necessary for statin metabolism, Qato warns. As a result, “the drug stays in the blood and builds up, increasing the risk of side effects such as muscle aches.”

    Of the statins, atorvastatin, lovastatin, and simvastatin (common brands Lipitor, Altoprev/Mevacor, and Zocor) are the most problematic when it comes to grapefruit juice. To be on the safe side, patients are often advised to avoid grapefruit and grapefruit juice altogether when taking statins, Qato says.

    Grapefruit can also cause problems when mixed with other medications. A few include certain anti-anxiety medications, such as BuSpar, and certain corticosteroids that treat Crohn’s disease or ulcerative colitis, such as Entocort EC and Uceris tablet (both budesonide), according to the U.S. Food and Drug Administration.

    5. Bananas and Other Potassium-Rich Foods Plus ACE Inhibitors

    If you take blood pressure lowering ACE inhibitors with foods high in potassium, including bananas, avocados, tomatoes, and dried apricots, you may get high levels of potassium in your body, which can lead to heart arrhythmias potentially dangerous, warns Brown. That’s why it’s wise to limit your intake of potassium-rich foods while taking an ACE inhibitor. It is recommended that you take some ACE inhibitors, such as captopril and moexipril (brand names Capoten and Univasc), at least one hour before meals.

    6. Fruit juices and some antihypertensives/antihistamines

    If you’re taking a calcium channel blocker (another type of blood pressure medication), avoid grapefruit juice because it can make the drug ineffective, Qato says. Also, if you are taking the beta-blocker atenolol (Tenormin) or the renin blocker aliskiren (Tekturna), you should be aware that drinking apple juice or orange juice may decrease levels of the drug in your body. .​

    In a lesser-known interaction, some of the newer generation antihistamines, namely fexofenadine (Allegra), can also interact with acidic juices, such as apple juice, orange juice, and grapefruit juice, says Qato. . “These acidic juices could affect absorption and neutralize the effect of antihistamines so they don’t really work.” If you’re looking for allergy relief, Qato advises avoiding these juices within two to four hours of taking one of these antihistamines.

    7. High fiber foods and levothyroxine, digoxin

    Eating soy flour, nuts, and other fiber-rich foods may make levothyroxine — a drug listed under several brand names used to treat an underactive thyroid gland — less effective. The same is true if you are taking digoxin, which is sold under several brand names and is used to treat heart failure. High-fiber foods can affect a person’s absorption of the drug, Qato says, so your best bet is to take digoxin at least two hours before or after consuming high-fiber meals or snacks.

    read more
    Medical supplies

    WINTER STORM: Tips for medications, medical supplies in case of power outage

    With possible power outages, Check Medications, Medical Equipment Options, Alternatives Now

    LEXINGTON, Ky. (WTVQ) – Power outages, whether planned for public safety or unexpected due to inclement weather, can be frightening and disrupt your daily life.

    “With a little preparation and planning, people can help mitigate the disruption and inconvenience caused by a planned or unplanned power outage,” said Brian Poer, director of operations for American Medical Response (AMR).

    AMR offers these tips for preparing for and surviving a power outage:

    Preparing for an outage:

    Prepare now if you have special medical needs. If you or a loved one need an electrical medical device or refrigerated medication, work with your healthcare provider to develop a backup plan to ensure your health and safety during a power outage.

    Take a household inventory. Take stock of the essential items you use every day that run on electricity. Once you’ve reviewed your list, research alternative power sources for these devices. Things like batteries can be purchased to help power cell phones and other small electronics.

    Prepare an emergency kit. An emergency kit is essential for unforeseen and planned outages, as it provides necessary items for your household, such as flashlights, batteries, bottled water, first aid kit and non-perishable food . It’s a good idea to store your kit somewhere easily accessible and known to everyone in your household.

    Sign up for emergency alerts. If your city, town, county, or utility company offers an emergency alert system, be sure to sign up to receive notifications.

    When a failure occurs:

    Be careful with perishable foods. Refrigerators will keep food cold for about four hours and freezers for about 48 hours if the doors are left closed. For planned outages longer than 4 hours, use coolers and ice to help keep perishable foods safe for longer consumption.

    Focus on non-perishable foods. During extended outages, be sure to maintain a supply of non-perishable items like cereal, nutrition bars, trail mix, and canned fruits and vegetables. Select foods that you know your family will eat, and always consider any food allergies or special dietary needs.

    Be aware of the risks associated with carbon monoxide. Never use generators, outdoor grills or camp stoves indoors. Make sure outdoor cookers are always placed on level ground away from your home and garage. Do not place outdoor stoves on wooden decks, near woodpiles or under trees.

    Don’t fall vulnerable to extreme temperatures. If an outage occurs during an extreme weather event, find a local community heating or cooling shelter and seek refuge.

    Avoid voltage surges and spikes. When power is restored to your home, it may do so with momentary surges or spikes, which can damage your appliances and electronics. Be sure to turn off or disconnect these items before restoring power.

    read more
    Medical supplies

    37 Ghanaian health facilities receive medical supplies from ADDRA

    Adventist Development and Relief Agency (ADRA) International presented a number of personal protective equipment (PPE) and other medical supplies to thirty-seven (37) Adventist and non-Adventist health facilities to protect frontline health workers against contamination with the deadly COVID-19. 19.

    The items worth US$500,000.00 were presented to institutions through Adventist Health Services (GAHS) at its headquarters at Kwadaso in Kumasi.

    This is the fourth time ADRA has donated supplies to hospitals since 2020, when the pandemic hit Ghana.
    Items from the latest shipment include patient gowns – 9600 pieces, N95 surgical masks – 33,120 pieces, face masks (ear loops) – 96,000 pieces
    Speaking to the press after the presentation, Mr. John Schroer, director of Global Missions System Outreach of Adventist Health (worldwide), said his goal is to help build programs that will be sustainable over the long term. and not to provide few resources. .

    Mr. Schroer commended Adventist Health Services Ghana for its incredible performance which influenced ADRA International’s decision to select Ghana as a recipient country.

    ADRA Ghana Country Director Dr. William Y. Kpakpo Brown said the organization’s commitment is to support health workers in the fight against the spread of COVID-19.

    “It is about showing support at this crucial time. This initiative also serves health workers, protecting them from contracting the deadly virus and improving the delivery of health care across the country,” he said. -he adds.

    Dr Kpakpo Brown explained that since the lives of frontline health workers were crucial to the survival of the industry, the items would help minimize infections through body-to-body contact.

    He gave assurances that ADRA will continue to support health workers to ensure they work in a safer environment to save lives.

    Ghana Adventist Health Services (GAHS) Director, Pastor Dr. Paul Amoh Kyeremeh, who received the items on behalf of the 37 beneficiary institutions, expressed his gratitude to ADRA for this wonderful gesture.

    He revealed that with the support of ADRA, GAHS was able to improve its services and expand some of its facilities and expressed the hope that GAHS would become a center of medical excellence in Ghana in a few years.

    Dr Amoh emphasized that the war against COVID-19 could not be fought alone but required cross-sectoral collaboration for Ghana to win the war.

    He expressed his delight at the praise from ADDRA International on the performance of Adventist health services in Ghana, and promised to lead GAHS to higher levels in health care delivery.
    ADRA is the humanitarian wing of the Seventh-day Adventist Church. Since 1983, ADRA has partnered with governments, local communities and organizations to provide crisis relief and sustainable development interventions to improve lives.

    read more
    Generic drugs

    Generic Drug Markets Over $125 Billion in the United States, Competition, Forecast and Opportunities, 2026

    DUBLIN, February 2, 2022 /PRNewswire/ — The “Generic Drugs Market in the United States, by Type (Small Molecule Generics vs. Biosimilars), by Application, by Mode of Drug Delivery, by Form, by Source, by Distribution Channel, by Region, Competition, Forecast and Opportunity, 2026” report has been added to from ResearchAndMarkets.com offer.

    Research and Markets Logo

    The generic drug market in the United States has been assessed $70.78 billion in 2020 and is expected to grow at a CAGR of 9.43% over the forecast period and could reach the market value of $126.74 billion by 2026.

    Factors such as the cost-effective nature of generic drugs and growing demand from developing economies are majorly responsible for this futuristic growth estimate of the generic drugs market in the United States over the next five years. Generic drugs do not require extensive research and development as in the case of prescription drugs and patent drugs.

    Market players and research institutes are investing heavily in patented pharmaceuticals. Moreover, FDA approvals for generic drugs are not required as generic drugs contain the same composition as that of the previously patented drug and thus support the growth of the generic drug market in the United States over the next five years . United States The healthcare industry, in terms of generic drugs, has gone from 80% growth in 2020 to a previous growth of 20% in 2015.

    Increased generic drug exports to developing economies such as Kenya, Indiaetc also justifies the growth of the generic drugs market in the United States over the next five years.

    The US generic drugs market is segmented on the basis of type, drug delivery route, form, manufacturing source, application, company, and regional distribution. Based on type, the market can be divided into generics and small molecule biosimilars. Small molecule generics are expected to register the largest market revenue shares and dominate the market segment over the next five years owing to their simpler and easier manufacturing processes.

    When producing small molecule generics, generic drug manufacturers are required to prove that the final product contains the same chemical compounds as the patented drug. With similar functions and pharmacokinetic properties, the generic small molecule is accepted. Additionally, the demand for cost-effective generic drugs is expected to further support the growth of the generic drug market in the United States over the next five years.

    Based on applications, the market can be fragmented into cardiovascular diseases, diabetes, neurology, oncology, infectious diseases, and others. Cardiovascular diseases are expected to dominate the market segment while recording the highest market revenue shares over the next five years owing to the increase in the cases of cardiovascular diseases in United States.

    Additionally, increased demand for treatment and extended medication protocols is driving the growth of cardiovascular disease sub-segment while sustaining the growth of the generic drug market in the United States over the next five years.

    The increase in pharmaceutical research and development for the oncology disease is expected to drive the growth of the oncology sub-segment and drive the growth of the US generic drug market over the next five years.

    The main market players in United States that are driving the growth of the generic drugs market include:

    • Teva Pharmaceuticals United StatesInc.

    • Pfizer Inc.

    • Sandoz US

    • Endo Pharmaceuticals Inc.

    • Aurobindo Pharmacy United StatesInc.

    • Abbott Laboratories Inc.

    • Eli Lilly and company

    • Sun Pharma Inc.

    • Lupine Pharmaceuticals, Inc.

    • Zydus Pharmaceuticals United States Inc.

    Report Scope:

    Years considered for this report:

    Generic Drugs Market in the United States, by Type:

    • Generic Small Molecule

    • Biosimilars

    Generic Drugs Market in the United States, by Application:

    • Cardiovascular illnesses

    • Diabetes

    • Neurology

    • Oncology

    • Infectious diseases

    • Others

    Generic Drugs Market in the United States, by Mode of Drug Delivery:

    • Oral

    • Parenteral

    • Topical

    • Others

    Generic Drugs Market in the United States, by Form:

    • Tablet

    • Capsule

    • Injection

    • Others

    Generic drugs in the United States, by source:

    Generic Drugs Market in the United States, by Distribution Channels:

    • Retail pharmacies

    • Online pharmacies

    • Hospital pharmacies

    • Others

    For more information about this report visit https://www.researchandmarkets.com/r/k9pvax

    Media Contact:

    Research and Markets
    Laura Woodsenior
    [email protected]

    For EST office hours, call +1-917-300-0470
    For USA/CAN call toll free +1-800-526-8630
    For GMT office hours call +353-1-416-8900

    US Fax: 646-607-1904
    Fax (outside the US): +353-1-481-1716

    Quote

    Quote

    View original content: https://www.prnewswire.com/news-releases/united-states-125-billion-generic-drugs-markets-competition-forecasts-and-opportunities-2026-301473690.html

    SOURCE Research and Markets

    read more
    Prescription drugs

    In-depth research on emerging growth trends, regional status of major key players, driving factors, business strategies and industry size forecast to 2026 – Bristol City Supporters Trust

    The Non-prescription Drugs market report covers the whole scenario of the global market including key players, their future promotions, preferred vendors, market shares along with historical data and price analysis. It continues to offer key details on changing dynamics to generate market improving factors. It aims to rationalize the expenses of the company. You can also find the current revenue generation rate and spend score here. The best thing about the Non-Prescription Drugs market report is the provision of guidelines and strategies followed by leading market players. The investment opportunities in the market highlighted here will be of great help in moving the business forward. Knowing the current market status is the most important thing covered here to help big players survive in the compatiator analysis market.

    This Non-Prescription Drugs Market study depicts the economic catastrophe induced by the COVID-19 outbreak, which has affected all sectors of the business. A major global economic loss has occurred due to several industrial closures and loss of income. Here, a high degree of information is offered to assess the market situation.

    Get Full Sample PDF Copy of Report: https://www.worldwidemarketreports.com/sample/720473

    The report helps to identify the major players in the non-prescription drugs market. It helps to analyze the competitive environment of the Non-Prescription Drugs market, including company overview, company total revenue, market opportunities, value, production sites and facilities , SWOT analysis, product details. The study also reveals the sales, revenue and market share of each market player included in this report for the period 2022-2026. It also helps to determine growth drivers and future prospects for the forecast schedule.

    The main key vendors in this market are: Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences, GlaxoSmithKline (GSK), Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly , Teva, Bayer

    To understand how the impact of covid-19 is covered in these reports: https://www.worldwidemarketreports.com/covidimpact/720473

    By Product Type, the market is primarily split into: Branded Drugs, Generic Drugs

    By application, this report covers the following segments: Hospital, Clinic

    Regions Covered in the Non-prescription Drugs Market Report 2022:

    ✤ The Middle East and Africa (GCC countries and Egypt)
    ✤ North America (United States, Mexico and Canada)
    ✤ South America (Brazil etc.)
    ✤ Europe (Turkey, Germany, Russia UK, Italy, France etc.)
    ✤ Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia and Australia)

    Additionally, the report provides an overview of key market drivers, challenges, opportunities, and risks and vendor strategies. Key players are also profiled with their market shares in the discussed Global Non-prescription Drugs Market. Overall, this report covers the historical status, current status and future prospects of the global Non-prescription Drugs Market for 2016-2026.

    This Non-Prescription Drugs report provides a superior market perspective in terms of product trends, marketing strategy, future products, new geographic markets, future events, sales strategies, or actions or behaviors of clients. This market research presents actionable market insights with which sustainable and profitable business strategies can be created.

    For more information or query or customization before buying: https://www.worldwidemarketreports.com/quiry/720473

    Important report features:

    ✤ Detailed analysis of the Non-Prescription Drugs market
    ✤ Fluctuating industry market dynamics
    ✤ Detailed market segmentation
    ✤ Historical, current and projected market size in terms of volume and value
    ✤ Recent industry trends and developments
    ✤ Competitive Landscape of Non-prescription Drugs Market
    ✤ Strategies of key players and product offerings
    ✤ Potential and niche segments/regions showing promising growth
    ✤ A neutral perspective on the performance of the non-prescription drug market.

    Report on reasons to buy:

    ✤ The report analyzes the future growth of the non-prescription drugs market.
    ✤ To analyze various perspectives of the Non-prescription Drugs market using Porter’s Five Forces Analysis.
    ✤ Study on which product type is expected to dominate the market and which regions are expected to grow fastest during the forecast period.
    ✤ To recognize the new developments, Non-Prescription Drugs Market shares, and policies employed by key market players.
    ✤ Competitive landscape, including Non-Prescription Drugs market share of major players along with key policies accepted for development over the past five years.
    ✤ Comprehensive company profiles covering product offerings, key financial information, recent developments, SWOT analysis and strategies employed by the leading player in the non-prescription drugs market.

    Click here for full report: https://www.worldwidemarketreports.com/buy/720473

    Report customization : In any case, please contact our sales team, who will ensure that your requirements are met.

    Contact us:

    Global Market Reports,

    Tel: USA +1-415-871-0703

    UK +44-203-289-4040

    Japan +81-50-5539-1737

    E-mail: [email protected]

    Website: https://www.worldwidemarketreports.com/

    read more
    Medical products

    Foreign medical products attract medical travel to Hainan, China

    Lecheng International Medical Tourism Zone in eastern Hainan Island, says it is three years ahead of schedule for the registration of foreign medical products, with the authorization of more than 200 medical devices and drugs requiring a special license for use. With the advanced foreign medical technology in the area, the local authority says Chinese citizens and foreigners have the opportunity to seek treatment on the island without having to travel to other countries where these drugs and equipment are produced. . They also note that treatment costs have come down and claim that corneal transplants in Hainan will now cost seven times less than in the United States.

    By the end of 2021, the Zone had registered more than 200 imported medical devices and medicines. The list of reimbursable drugs covered by its insurance system includes 100 types of special medical products, 75% of which are produced by foreign pharmaceutical companies.

    39 of these devices and drugs are designed to treat cancer, 38 help in the rehabilitation of patients after injuries and illnesses, 31 are used in the field of ophthalmology and 28 are used in cardiology.

    The minimum “Lecheng” national insurance package for the purchase of pharmaceuticals is 39 yuan per year (6 US dollars) and 29 yuan (5 US dollars) for residents of Hainan. Over 1.7 million people bought it in 2020.

    The number of patients using them in Hainan has increased by 454 percent according to the Lecheng area administration, reaching its goal not in 2025, but three years earlier.

    Authorities remain vague on actual numbers for 2021 but the 2025 target is 250,000 medical tourists. Almost all come from mainland China.

    Hainan reported 19,000 medical tourists in 2017, 32,000 in 2018, 68,000 in 2019, and 83,900 in 2020. An increase of 83,900 by 454% is 382,630. If the five years are added together, that’s about 250,000 .

    read more
    Medical products

    Medical Products Stock Earnings Feb. 2: BSX, TMO and More

    The last Revenue overview reflects a considerably strong quarterly performance for the Medical sector so far this reporting cycle. According to the sector scorecard, 8.9% of companies in the medical sector, constituting nearly 29.2% of the sector’s market capitalization, reported profits through January 26. Of these, 80% beat earnings estimates and 60% beat the same for revenue. Profits were up 27% year over year on revenue up 12.2%.

    This dashboard reflects stability in the United States on continued economic reopening amid the resurgence of COVID-19 cases. However, supply chain disruptions are still significant, thanks to the emergence of the Omicron variant. Additionally, many parts of the COVID-affected international market are still suffering due to lower cash flow and tough economic conditions.

    Overall, fourth-quarter profits for the medical sector are expected to rise 18.4% on a 12.2% increase in sales. That compares to reported earnings growth of 29.7% and revenue growth of 15.7% in the third quarter. It is worth mentioning that the medical sector is expected to be one of the seven sectors with the strongest earnings growth in the fourth quarter.

    Quarterly summary of medical products

    The dynamic nature of the COVID-19 crisis is rapidly transforming the landscape of the medical products industry. Medical products Corporate collective activities (within the broader medical sector) showed a sequential decline in terms of legacy core activity in the third quarter. So far, the fourth quarter reporting cycle has shown a sequential rebound in terms of the companies’ legacy core business despite the emergence of the new Omicron variant. This rebound can be attributed to the fiscal and monetary stimulus measures and the mass vaccination campaign at home and abroad. Although companies are seeing a sequential recovery in basic activity, the improvement in the overall trend is still below the pre-COVID level.

    It should be mentioned here that disruptions in the form of the emergence of newer, more infectious variants of COVID-19 have again begun to delay non-COVID-19 elective hospital admissions and procedures. Meanwhile, with resurgences of COVID-19 and rising case numbers, manufacturers of tests, vaccines and therapeutics have witnessed massive market uptake of their products and support services. COVID-related health care in the fourth quarter.

    Specifically, fourth-quarter diagnostic test inventory results have so far shown considerable growth, driven by an increase in demand for COVID-19 tests, which had seen a slowdown in demand in the third quarter, a report said. gained momentum in the fourth quarter, in line with industry trends.

    Let’s take a look at four Medical Products players who are due to announce their results on February 2.

    Boston Scientific Society BSX: In the fourth quarter, within the Urology/Pelvic Health division of Boston Scientific, sales of the Stone, Prostate Health and Pelvic Health franchises are expected to have recorded strong growth. The acquisition of Lumenis (closed in September) should have contributed a full quarter to the company’s sales. The LithoVue, SpaceOAR and Rezum product lines should have performed well. The company continues to expect urology/pelvic health to have one of the fastest potential recovery curves, aided by a higher in-office ASE mix for most elective procedures. (Read more: What do Boston Scientific’s fourth quarter results have in store for us?)

    Zacks’ consensus estimate for fourth-quarter earnings per share is pegged at 44 cents and revenue at $3.10 billion.

    Boston Scientific Corporation Award and EPS Surprise

    Boston Scientific Corporation price-eps-surprise | Boston Scientific Corporation Quote

    Boston Scientific doesn’t have the right combination of the two key ingredients – a silver lining ESP Earnings and a Zacks Rank #3 (Hold) or better. BSX has an ESP on gains of 0.00% and carries a Zacks rank of #4 (sell). You can discover the best stocks to buy or sell before they’re flagged with our Income ESP filter.

    You can see the full list of today’s Zacks #1 Rank (Strong Buy) stocks here.

    Thermo Fisher Scientific Inc. TMO: Thermo Fisher’s Life-Science Solutions segment is expected to have seen strong revenue contributions driven by growing demand for COVID-19 testing with the emergence of the Omicron variant during the fourth quarter. Additionally, vaccine and therapeutics production supplies (recognized in the BioProduction and Biosciences businesses) are expected to have contributed strongly to the company’s growth in the fourth quarter. Thermo Fisher is expected to have seen robust growth in the areas of genetic sciences, biosciences and biomanufacturing thanks to the surge in economic activity globally and the company’s response to the pandemic. (Read more: Increase in COVID testing to boost Thermo Fisher Q4 revenue)

    Zacks’ consensus estimate for its fourth-quarter earnings per share is set at $5.22. Revenue is expected to be $9.03 billion.

    Thermo Fisher Scientific Inc. Prize and EPS Surprise

    Thermo Fisher Scientific Inc. Prize and EPS Surprise

    Thermo Fisher Scientific Inc. price-eps-surprise | Quote from Thermo Fisher Scientific Inc.

    TMO has a +12.77% win ESP and a #3 Zacks rank.

    Hologic, Inc. HOLX: Hologic’s diagnostics business likely experienced robust growth in the first quarter of fiscal 2022 due to increased demand for COVID-19 testing. With that in mind, in November 2021, the company confirmed that its three SARS-CoV-2 tests detect the recently emerged Omicron variant of the coronavirus. This development should have boosted Hologic’s diagnostics revenue in the first fiscal quarter. The same month, Hologic launched the Novodiag system for on-demand molecular testing in Europe. This should have witnessed strong market uptake in the fiscal first quarter as it capitalized on the surge in coronavirus cases induced by the Omicron variant, thus adding to revenue. (Read more: Hologic to Report First Quarter Results: What’s in the Cards?)

    Zacks’ consensus estimate for its first-quarter earnings per share is set at $1.21. Revenue is expected to be $1.12 billion.

    Hologic, Inc. Price and EPS Surprise

    Hologic, Inc. Price and EPS Surprise

    Hologic, Inc. price-eps-surprise | Hologic, Inc. Quote

    The company has an ESP on Earnings of -1.65% and a #2 Zacks Rank (Buy).

    McKesson Corporation MCK: The company’s US pharmaceutical and specialty solutions segment likely acted as a key growth driver in the third quarter of fiscal 2022. The segment should have benefited from market growth and higher volumes of specialties during the quarter to appear. However, brand-to-generic conversions may have weighed on segment performance. The growing demand for COVID-19 testing (due to the resurgence of COVID-19) and improved primary care patient visits have likely positively impacted the company’s medical-surgical solutions segment. (Read more: McKesson to Report Third Quarter Results: What’s in the Cards?).

    Zacks’ consensus estimate for its third-quarter earnings per share is set at $5.38. Revenue is expected to be $66.13 billion.

    McKesson Corporation and EPS Surprise Award

    McKesson Corporation and EPS Surprise Award

    McKesson Corporation price-eps-surprise | Quote from McKesson Corporation

    MCK has a +1.86% earnings ESP and a #3 Zacks rank.

    Stay up to date with upcoming results announcements with the Zacks Earnings Schedule.

    7 best stocks for the next 30 days

    Just Released: Experts distill 7 elite stocks from the current Zacks No. 1 Ranking 220 Strong Buys list. They consider these tickers “most likely for early price increases.”

    Since 1988, the full list has beaten the market more than 2 times with an average gain of +25.3% per year. So be sure to give your immediate attention to these 7 handpicked ones.

    Discover them now >>

    Click to get this free report

    Boston Scientific Corporation (BSX): Free Stock Analysis Report

    Thermo Fisher Scientific Inc. (TMO): Free Inventory Analysis Report

    McKesson Corporation (MCK): Free Stock Analysis Report

    Hologic, Inc. (HOLX): Free Stock Analysis Report

    To read this article on Zacks.com, click here.

    Zacks Investment Research

    The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

    read more